syndrome	score	normalized_score
NEUROFIBROMA	6.54625669	100.0
TUBEROUS SCLEROSIS COMPLEX	5.140619899999999	78.52762492269456
MUIR-TORRE SYNDROME; MRTES	3.7293866	56.96975808628122
BIRT-HOGG-DUBE SYNDROME	3.4739060999999998	53.067062055582184
FAMILIAL MULTINODULAR GOITER	3.2573062	49.75830240472895
JUVENILE POLYPOSIS SYNDROME	3.13951764	47.95897546755076
CARNEY COMPLEX	3.1337352000000003	47.870643459292765
GARDNER SYNDROME	3.0455758	46.52392877676784
UVEAL MELANOMA	3.0	45.8277171529612
CUTANEOUS NEUROENDOCRINE CARCINOMA	2.991486	45.6976580916811
PITUITARY CARCINOMA	2.67294605	40.83167184817496
PEUTZ-JEGHERS SYNDROME	2.5923393600000004	39.60033165152282
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	2.57797253	39.38086531098126
TUBEROUS SCLEROSIS-1	2.5506009	38.96273887176276
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	2.5073806000000003	38.302509643874046
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	2.5044332000000002	38.25748543936184
PHACE ASSOCIATION	2.500545554	38.19809812560222
NEUROENDOCRINE NEOPLASM OF APPENDIX	2.41446867	36.883195761148805
TUBEROUS SCLEROSIS 2; TSC2	2.3006009	35.14376244234933
BASAL CELL NEVUS SYNDROME	2.23688585	34.17045734575373
MENINGIOMA	2.2005789700000005	33.615836869971574
BROOKE-SPIEGLER SYNDROME	2.19199295	33.484677637961674
NEUROFIBROMATOSIS, TYPE II	2.1826862499999997	33.34250936621918
RETINOBLASTOMA	2.10727493	32.19053315185537
NUT MIDLINE CARCINOMA	2.08125	31.79297877486683
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	2.0494505	31.3072126109983
FAMILIAL PAPILLARY THYROID CARCINOMA WITH RENAL PAPILLARY NEOPLASIA	2.0097431	30.70064611230514
FAMILIAL GLUCOCORTICOID DEFICIENCY	2.00922439	30.692722347250335
MSH3-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.9713477	30.114121601913535
HYPERPARATHYROIDISM 2	1.9417748999999997	29.662370297306502
MUIR-TORRE SYNDROME	1.9375210999999997	29.597389649564743
WERNER SYNDROME	1.92846543	29.459056088434565
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	1.9024853	29.06218607202218
TURCOT SYNDROME WITH POLYPOSIS	1.8841790099999998	28.782540911942146
PRIMARY SCLEROSING CHOLANGITIS	1.8697913300000002	28.562756068766383
PARAGANGLIOMAS 1	1.82152137	27.82538871081146
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	1.8155619	27.734352408964273
BENIGN SCHWANNOMA	1.7982143	27.469352106936707
HEREDITARY MIXED POLYPOSIS SYNDROME	1.7487487999999998	26.7137217926601
NTHL1-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.7432851000000003	26.630258826590563
APC-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.7269252	26.380346536640314
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	1.7116410340000001	26.14686705785135
NEUROFIBROMATOSIS TYPE 1	1.6982937400000002	25.942975053121547
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	1.6931597999999999	25.86454946972145
POLYEMBRYOMA	1.6666660000000002	25.459832678819076
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	1.6607143	25.368915070759318
VON HIPPEL-LINDAU DISEASE	1.6431111599999997	25.100011163784654
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	1.63518653	24.97895526305737
LYSINE-SPECIFIC METHYLTRANSFERASE 2A; KMT2A	1.632857	24.94336958241092
HYPERPLASTIC POLYPOSIS SYNDROME	1.620902	24.76074612955637
COWDEN SYNDROME 7; CWS7	1.6042999999999998	24.507135542831882
FAMILIAL COLORECTAL CANCER TYPE X	1.5937041	24.3452735734382
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	1.5811966	24.154210182674642
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	1.5811688	24.15378551249569
PTEN HAMARTOMA TUMOR SYNDROME	1.5473105999999999	23.63657084152623
ADENOCARCINOMA OF OVARY	1.5454545	23.60821723292369
CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS	1.5333329999999998	23.423050341767148
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	1.53208553	23.40399410766155
ANAPLASTIC THYROID CARCINOMA	1.50899583	23.05127802741264
NEUROFIBROMATOSIS, TYPE I	1.4529325	22.19485988411493
PARAGANGLIOMAS 2	1.45	22.150063290597913
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	1.4335498	21.898771586361367
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	1.4285075	21.821745886961242
AICARDI SYNDROME; AIC	1.40092853	21.40045214145124
COWDEN SYNDROME	1.396194194	21.328130871079544
PEUTZ-JEGHERS SYNDROME	1.3897747999999999	21.23006881357107
SILVER-RUSSELL SYNDROME; SRS	1.3878558539999997	21.200755175397802
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	1.370208	20.93116822157489
CARNEY COMPLEX, TYPE 1; CNC1	1.3669841999999999	20.881921756722313
ADENOCARCINOMA OF THE ANAL CANAL	1.3621212	20.807635027217366
LYNCH SYNDROME	1.3506482999999998	20.63237608850929
NORRIE DISEASE	1.35050819	20.630235781359193
LI-FRAUMENI SYNDROME; LFS	1.3464224	20.567821638537062
AL AMYLOIDOSIS	1.311111	20.028408021378702
PARAGANGLIOMAS 4	1.3030023	19.904540284685964
ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	1.3009495	19.873181905428766
BECKWITH-WIEDEMANN SYNDROME	1.2958812599999998	19.795759949034323
MAFFUCCI SYNDROME	1.2806114	19.562499007352553
ATELOSTEOGENESIS TYPE II	1.25765804	19.211865644089183
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	1.25	19.094882147067167
HEMANGIOBLASTOMA	1.20613497	18.424804084485114
VIPOMA	1.1612657	17.739385346345163
MONOSOMY 9Q22.3	1.156923774	17.673058494136136
ZOLLINGER-ELLISON SYNDROME	1.14106023	17.43072849164428
PARATHYROID CARCINOMA	1.1379915	17.38385086149135
ACQUIRED HYPERTRICHOSIS LANUGINOSA	1.13778413	17.380683096922677
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME	1.1348213999999999	17.33542471277581
GASTROINTESTINAL STROMAL TUMOR	1.1156589700000001	17.042701238774676
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	1.1154524540000001	17.03954651982949
SAGLIKER SYNDROME	1.11480104	17.029595580982328
MIDDLE EAR NEUROENDOCRINE TUMOR	1.11261476	16.99619817382994
OSTEOID OSTEOMA	1.111111	16.973226877847956
METACHONDROMATOSIS	1.1	16.803496289419108
NOONAN SYNDROME 7; NS7	1.09761891	16.76712298307386
SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM	1.0960603	16.743313803663266
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	1.08485045	16.572073191954225
STURGE-WEBER SYNDROME	1.0833333	16.54889735159469
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	1.083333	16.548892768822974
NON-INVOLUTING CONGENITAL HEMANGIOMA	1.083333	16.548892768822974
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	1.0769231	16.450975740763383
FOCAL DERMAL HYPOPLASIA	1.0741913799999998	16.40924624359635
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	1.06378252	16.250241479608096
CATECHOLAMINE-PRODUCING TUMOR	1.0555556	16.124567825341416
THYMIC NEUROENDOCRINE TUMOR	1.05441493	16.10714305796646
OTOSCLEROSIS 7	1.05030887	16.044419272535432
DEAFNESS, AUTOSOMAL DOMINANT 1	1.04695826	15.993235670078803
BRANCHIOOTORENAL SYNDROME 1	1.0357143	15.821473997225732
KINDLER SYNDROME	1.025641	15.667595216160093
DEAFNESS, AUTOSOMAL DOMINANT 6	1.0232558	15.631159125842345
HEMIHYPERPLASIA, ISOLATED	1.0227273	15.623085809670565
N SYNDROME	1.021378854	15.602487075709218
EMANUEL SYNDROME	1.0155418339999998	15.513321308517156
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	1.01373517	15.485722879589678
PYOMYOSITIS	1.00520833	15.355467675680162
BLAU SYNDROME	1.00178253	15.303135477872623
PSEUDOAMINOPTERIN SYNDROME	1.000545554	15.28423954912162
CURRARINO SYNDROME	1.000545554	15.28423954912162
137245 GASTRIC LYMPHOMA, PRIMARY	1.0	15.275905717653734
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	15.275905717653734
GIGANTIFORM CEMENTOMA, FAMILIAL	1.0	15.275905717653734
SARCOMA, SYNOVIAL	1.0	15.275905717653734
ADIPOSIS DOLOROSA	1.0	15.275905717653734
URETER, CANCER OF	1.0	15.275905717653734
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	1.0	15.275905717653734
AASE-SMITH SYNDROME I	1.0	15.275905717653734
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	15.275905717653734
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	1.0	15.275905717653734
ACATALASEMIA	1.0	15.275905717653734
POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE	1.0	15.275905717653734
MESOTHELIOMA, MALIGNANT	1.0	15.275905717653734
CHRONIC ACTINIC DERMATITIS	1.0	15.275905717653734
TERATOMA, OVARIAN	1.0	15.275905717653734
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	1.0	15.275905717653734
SESSILE SERRATED POLYPOSIS CANCER SYNDROME	1.0	15.275905717653734
RETINOBLASTOMA; RB1	0.9988035000000001	15.257628096462561
LYMPHANGIOLEIOMYOMATOSIS	0.97619	14.912186402516397
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.9537042999999998	14.56869696932095
PROTEUS SYNDROME	0.9469049199999998	14.464830281502447
EPENDYMOMA	0.93962216	14.353579526378152
SUBEPENDYMOMA	0.93962216	14.353579526378152
GANGLIONEUROMA	0.9307693	14.218344071686564
GRFOMA	0.9179290999999999	14.022198387090745
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.908878554	13.883943099701456
FAMILIAL PAPILLARY OR FOLLICULAR THYROID CARCINOMA	0.9020199	13.77917094784745
ATYPICAL WERNER SYNDROME	0.9010400999999999	13.764203615425291
EXOSTOSES, MULTIPLE, TYPE I	0.894444	13.663442213721074
EXOSTOSES, MULTIPLE, TYPE II	0.894444	13.663442213721074
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.873333	13.340952568115688
COLORECTAL CANCER	0.8530023	13.030382711741783
FAMILIAL ADENOMATOUS POLYPOSIS	0.8489899000000001	12.96908966764027
LI-FRAUMENI SYNDROME	0.8419582	12.861674081405445
KASABACH-MERRITT SYNDROME	0.818287	12.500075061981718
PARAGANGLIOMAS 3	0.816667	12.475328094719123
DUODENAL NEUROENDOCRINE TUMOR	0.8030305999999999	12.267019733990907
NELSON SYNDROME	0.777778	11.881263397265284
NIJMEGEN BREAKAGE SYNDROME	0.7674354	11.72327081478988
SCHINZEL-GIEDION SYNDROME	0.7619297900000002	11.63916763551171
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.750545554	11.465263119708188
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.7372113600000001	11.261571229343286
JUVENILE POLYPOSIS OF INFANCY	0.7352887399999999	11.232201467492407
OVARIAN CANCER	0.7243902	11.06571639799233
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.71467535	10.917313265331185
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.70911563	10.83238350679463
PALLISTER-HALL SYNDROME	0.708878554	10.82876195617071
FRONTONASAL DYSPLASIA 1; FND1	0.7066369	10.79451866101511
LARYNGEAL NEUROENDOCRINE TUMOR	0.7052083299999999	10.77269596038404
BAZEX SYNDROME	0.7	10.693134002357613
CARNEY TRIAD	0.6967040699999999	10.642785686425626
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.6926913339999999	10.581487509619791
COSTELLO SYNDROME; CSTLO	0.675914824	10.325211124588517
CARCINOID SYNDROME	0.67280197	10.277659460371694
AICARDI-GOUTIÈRES SYNDROME	0.667212554	10.19227606853895
OVARIAN FIBROTHECOMA	0.65	9.929338716474927
PINEOBLASTOMA	0.64914631	9.916297828522822
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.64806533	9.899784879960153
POLYMERASE PROOFREADING-RELATED ADENOMATOUS POLYPOSIS	0.6322656000000001	9.65842969411577
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.6267297000000001	9.57386380765341
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.6253919	9.553427700984333
NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI	0.625	9.547441073533584
MONOSOMY 22	0.6190473000000001	9.456508189568106
RING CHROMOSOME 7 SYNDROME	0.6136363	9.373850263729882
TUMOR PREDISPOSITION SYNDROME; TPDS	0.6125259000000001	9.356887898021
46,XY PARTIAL GONADAL DYSGENESIS	0.6060603	9.258120002012937
INSULINOMA	0.60434131	9.231860872843347
LHERMITTE-DUCLOS DISEASE	0.6033566699999998	9.216819605037514
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.602597	9.205214957740987
TESTICULAR GERM CELL TUMOR; TGCT	0.5958330000000001	9.101888731466778
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.5921565	9.045726864095823
NEUROFIBROMATOSIS TYPE 2	0.5844550900000001	8.928080851042829
NK-CELL ENTEROPATHY	0.5833333	8.91094449276782
NIEMANN-PICK DISEASE TYPE B	0.5666667	8.656347082533971
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.56400376	8.615668262162202
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.5630902	8.601712805734783
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.56177353	8.581599478953521
PPOMA	0.5593429	8.54446940423902
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.5547619	8.474490480146448
ALPORT SYNDROME	0.55417768	8.46556599050808
COWDEN SYNDROME 6; CWS6	0.5520248400000001	8.432679409642889
COWDEN SYNDROME 5; CWS5	0.5520248400000001	8.432679409642889
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.5454545	8.332311515269957
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.5447616000000001	8.321726840198197
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.54	8.248989087533017
EAR EXOSTOSES	0.53855445	8.226907002022863
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.5352561	8.176521718399037
MILROY DISEASE	0.53494004	8.171693615637917
SÉZARY SYNDROME	0.53494004	8.171693615637917
CLASSIC MYCOSIS FUNGOIDES	0.53125	8.115324912503546
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.530303	8.100858629788927
DIAPHANOSPONDYLODYSOSTOSIS	0.529957354	8.095578574081243
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.527220024	8.053763379083138
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.5257934	8.031970405364595
MUTYH-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	0.5245421	8.012855664540096
DEAFNESS-HYPOGONADISM SYNDROME	0.5232558	7.993206267015479
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.5208333	7.956200385414464
MEDULLOBLASTOMA	0.517785734	7.9096460545301355
SOMATOSTATINOMA	0.5176759	7.907968240701542
LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES	0.515873	7.880427310283185
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.5142965039999999	7.856344906022924
FAMILIAL PANCREATIC CARCINOMA	0.510481	7.798059626653594
DOWN SYNDROME	0.50788223	7.758361061151728
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.507138474	7.746999514618789
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.50671757	7.740569824798604
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.50613497	7.7316700821275
AUTOSOMAL DOMINANT EPIDERMOLYTIC ICHTHYOSIS	0.50520833	7.717514816853294
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.50485437	7.712107757265474
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.504235594	7.702655393429126
CRYPTOCOCCOSIS	0.50401606	7.6993018127433075
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.50178253	7.665182619045755
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.500545554	7.6462866902947555
NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3	0.5	7.637952858826867
CHILBLAIN LUPUS	0.5	7.637952858826867
LUNG CANCER	0.5	7.637952858826867
ANGIOMA, TUFTED	0.5	7.637952858826867
FAMILIAL HYPERALDOSTERONISM TYPE I	0.5	7.637952858826867
MEIGE DISEASE	0.5	7.637952858826867
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	7.637952858826867
FAMILIAL HYPERALDOSTERONISM TYPE II	0.5	7.637952858826867
FANCONI-LIKE SYNDROME	0.5	7.637952858826867
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	7.637952858826867
RHABDOMYOSARCOMA 1	0.5	7.637952858826867
RHABDOMYOSARCOMA 2; RMS2	0.5	7.637952858826867
LAMBERT-EATON MYASTHENIC SYNDROME	0.5	7.637952858826867
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	0.5	7.637952858826867
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.5	7.637952858826867
HIS BUNDLE TACHYCARDIA	0.5	7.637952858826867
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5	7.637952858826867
%300228 TESTICULAR GERM CELL TUMOR 1; TGCT1	0.5	7.637952858826867
UPINGTON DISEASE	0.5	7.637952858826867
REFRACTORY ANEMIA	0.5	7.637952858826867
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.5	7.637952858826867
%607107 NASOPHARYNGEAL CARCINOMA;;NPCA;;NPC;;NASOPHARYNGEAL CANCERNASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 1, INCLUDED; NPCA1, INCLUDED	0.5	7.637952858826867
ANAL CANAL CARCINOMACLOACOGENIC CARCINOMA, INCLUDED	0.5	7.637952858826867
17Q24.2 MICRODELETION SYNDROME	0.5	7.637952858826867
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.5	7.637952858826867
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.5	7.637952858826867
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.5	7.637952858826867
FUNCTIONING GONADOTROPIC ADENOMA	0.5	7.637952858826867
DEAFNESS, UNILATERAL	0.5	7.637952858826867
PLEOMORPHIC LIPOSARCOMA	0.5	7.637952858826867
OCULOCEREBRORENAL SYNDROME OF LOWE	0.49557821999999996	7.570406164442659
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.48629959	7.428666687373667
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.4813851	7.353593401483314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.47769376	7.29720483967151
OVARIAN FIBROMA	0.4738095	7.237869250128656
PALLISTER-HALL SYNDROME	0.470114554	7.181425603400834
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.4541394	6.937390657071836
FRONTORHINY	0.45302786	6.920410876830435
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.45	6.8741575729441795
GONADOBLASTOMA	0.45	6.8741575729441795
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.4464909	6.820552892190361
XERODERMA PIGMENTOSUM	0.43959622000000004	6.715230410556969
GANGLIOCYTOMA	0.43926080000000006	6.710106566261153
RHABDOID TUMOR	0.439121	6.707970994641825
CARNEY-STRATAKIS SYNDROME	0.43333299999999997	6.619554052348045
BLOOM SYNDROME	0.424847	6.489922716428036
MELANOMA, CUTANEOUS MALIGNANT	0.4242424	6.480686903831143
MULTIPLE OSTEOCHONDROMAS	0.411111	6.280092875490344
PITUITARY ADENOMA, PROLACTIN-SECRETING	0.4047616	6.183100039726673
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.404087	6.172794913729543
PLEUROPULMONARY BLASTOMA	0.40384620000000004	6.169116475632733
NEUROENDOCRINE TUMOR OF STOMACH	0.4022524	6.144769737099937
MCCUNE-ALBRIGHT SYNDROME	0.40181275999999994	6.138053837910226
OROFACIODIGITAL SYNDROME TYPE 1	0.40151714999999993	6.133538127421031
MELANOSIS, NEUROCUTANEOUS; NCMS	0.399895854	6.108771362584623
POLAND SYNDROME	0.39934094	6.100294548639216
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.395833	6.04670758793603
POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS	0.392857	6.001246492520293
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.39130580000000004	5.977550507571069
CRONKHITE-CANADA SYNDROME	0.39120563	5.976020320095332
WHIM SYNDROME	0.3888889	5.94063017104207
DERMATOMYOSITIS	0.38832853	5.932070011755069
ATYPICAL TERATOID RHABDOID TUMOR	0.38708697000000003	5.91310405825226
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.386718914	5.907481669497443
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.383878554	5.864092597933247
PUNCTATE PALMOPLANTAR KERATODERMA TYPE 1	0.3769648	5.758478743674196
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.375	5.72846464412015
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.3749997	5.728460061348435
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q) CHROMOSOME ABNORMALITY	0.37333299999999997	5.702999709288821
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.37333299999999997	5.702999709288821
YELLOW NAIL SYNDROME	0.3732325	5.701464480764197
GALLBLADDER NEUROENDOCRINE TUMOR	0.37187533	5.680732479801369
THYMIC TUMOR	0.366667	5.601170521774942
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.36464855	5.570336869879144
LINEAR IGA DERMATOSIS	0.36111099999999996	5.516297589607657
OLLIER DISEASE	0.35873	5.479925658093924
SCHWARTZ-JAMPEL SYNDROME	0.35868159999999993	5.479186304257188
BAZEX SYNDROME; BZX	0.3571425	5.455675157767148
MEDULLARY THYROID CARCINOMA	0.35621843	5.441559151570636
MASTOCYTOSIS	0.35613497	5.4402842244794405
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.35	5.346567001178807
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.34999969999999997	5.346562418407091
SOTOS SYNDROME	0.349502254	5.338963480211468
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.3446763	5.265242661909733
JEJUNAL NEUROENDOCRINE TUMOR	0.34157193	5.2178205984770205
ILEAL NEUROENDOCRINE TUMOR	0.34157193	5.2178205984770205
CRANIOPHARYNGIOMA	0.341530974	5.217194958482448
FAMILIAL ADENOMATOUS POLYPOSIS 3	0.3413545	5.214499158296832
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.3409091	5.207695269890189
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.33946797	5.185680703883306
BRONCHIAL NEUROENDOCRINE TUMOR	0.33854133	5.171525438609099
KLATSKIN TUMOR	0.33854133	5.171525438609099
DEAFNESS AND MYOPIA; DFNMYP	0.33818737	5.166118379021278
PAPILLOMA OF CHOROID PLEXUS	0.33734906	5.153312434499112
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.337178534	5.150707495400703
NIJMEGEN BREAKAGE SYNDROME	0.3363862000000001	5.138603875919814
C SYNDROME	0.33457833	5.110987024250037
OTODENTAL SYNDROME	0.33456232999999996	5.110742609758555
ACROMELIC FRONTONASAL DYSPLASIA	0.333878554	5.100297312050561
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4	0.333333	5.091963480582671
ANGIOLIPOMATOSIS, FAMILIAL	0.333333	5.091963480582671
CHOLANGIOCARCINOMA	0.333333	5.091963480582671
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.333333	5.091963480582671
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.333333	5.091963480582671
FAMILIAL ATRIAL MYXOMA	0.333333	5.091963480582671
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.333333	5.091963480582671
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.333333	5.091963480582671
MYOFIBROMATOSIS, INFANTILE, 2; IMF2	0.333333	5.091963480582671
PAPILLOMA OF CHOROID PLEXUS	0.333333	5.091963480582671
TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC	0.333333	5.091963480582671
PAI SYNDROME	0.333333	5.091963480582671
SALIVARY GLAND ADENOMA, PLEOMORPHIC	0.333333	5.091963480582671
IMMUNODEFICIENCY 16	0.333333	5.091963480582671
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.333333	5.091963480582671
LEYDIG CELL HYPOPLASIA	0.333333	5.091963480582671
GESTATIONAL CHORIOCARCINOMA	0.333333	5.091963480582671
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.333333	5.091963480582671
BURKITT LYMPHOMA; BL	0.333333	5.091963480582671
RARE CIRCULATORY SYSTEM DISEASE	0.3309091	5.054936212713651
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.33034759	5.046358638894131
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.3286003	5.019667201592732
ROTHMUND-THOMSON SYNDROME	0.32831850400000007	5.0153625124651215
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.326984	4.994976755181288
FAMILIAL MULTIPLE LIPOMATOSIS	0.3269231	4.994046452523084
FAMILIAL MELANOMA	0.32634060000000004	4.985148237442551
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.32158697999999997	4.912532386504996
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.32007503000000004	4.889435980855191
WISKOTT-ALDRICH SYNDROME	0.31587299999999996	4.825246166752438
DIETHYLSTILBESTROL SYNDROME	0.31309656	4.782833531081716
MOHR-TRANEBJAERG SYNDROME	0.3125	4.773720536766792
INFANTILE MYOFIBROMATOSIS	0.31144259999999996	4.757567794060944
45,X/46,XY MIXED GONADAL DYSGENESIS	0.31034095	4.740739092527091
SYSTEMIC MASTOCYTOSIS	0.30613497	4.676488938596754
WALDENSTRÖM MACROGLOBULINEMIA	0.29625945	4.52563142616395
ADRENOCORTICAL CARCINOMA	0.29611743	4.523461942033929
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.29554130399999995	4.5146610955764395
MALAKOPLAKIA	0.291667	4.455477592950912
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.291667	4.455477592950912
SEBOCYSTOMATOSIS	0.29090910000000003	4.443899984007502
THYROID CANCER, NONMEDULLARY, 1; NMTC1	0.29090910000000003	4.443899984007502
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.29	4.4300126581195824
FRONTOOCULAR SYNDROME	0.288827884	4.412107524613429
FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4	0.2835497	4.3314784834690006
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.28180676	4.304853496357473
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.27777759999999996	4.243304428076131
ESOPHAGEAL ATRESIA	0.27708055	4.232656357995641
PGM3-CDG	0.27441741	4.1919744824427285
FAMILIAL BREAST-OVARIAN CANCER-1	0.27439020000000003	4.191558825048152
ADENOCARCINOMA OF THE ESOPHAGUS	0.27399197000000003	4.185475501114211
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.2717391	4.15106087140008
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.2712766	4.1439957650056645
FAMILIAL THROMBOCYTOSIS	0.26793563000000004	4.092959422280155
GLUCAGONOMA	0.2676759	4.088991811288109
GLIOMA SUSCEPTIBILITY 3	0.2652346	4.0516987426596005
RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	0.2625	4.0099252508841055
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.26182261	3.999577505110024
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.26099161400000004	3.986883288562277
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.26081207	3.984140591346106
ROBERTS SYNDROME	0.26073144400000003	3.982908956171715
NON-FUNCTIONING PARAGANGLIOMA	0.2600627	3.9726932858784676
46,XY SEX REVERSAL 6; SRXY6	0.2588235	3.953763383513151
46,XY SEX REVERSAL 10; SRXY10	0.2588235	3.953763383513151
MUCOLIPIDOSIS TYPE II	0.25861929	3.950643890806549
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.25821357	3.9444461503387824
CUTANEOUS MASTOCYTOSIS	0.25805807000000003	3.942070746999687
IMMUNODEFICIENCY 36; IMD36	0.25757610000000003	3.9347082187209503
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.25667106	3.9208829130102445
BURKITT LYMPHOMA	0.25613497	3.912693652714068
DUBOWITZ SYNDROME	0.25542982999999997	3.90192200055632
PULMONARY BLASTOMA	0.25520833	3.898538387439861
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.2551938	3.8983164285297836
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.25444171400000004	3.8868276337022167
MALARIA	0.25375397	3.876321721200334
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.253512914	3.8726393724716592
OTOMANDIBULAR SYNDROME	0.25274909	3.860971269062778
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.252049314	3.850281556863302
NOONAN SYNDROME 6; NS6	0.252049314	3.850281556863302
ROBERTS SYNDROME; RBS	0.25178253	3.8462061896323227
ALPORT SYNDROME, X-LINKED; ATS	0.25150376	3.841947725395413
HALLERMANN-STREIFF SYNDROME	0.25124533	3.837999973080799
ACUTE MONOBLASTIC LEUKEMIA	0.25066283	3.829101758000266
NOONAN SYNDROME 3; NS3	0.250545554	3.8273102608813225
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.250545554	3.8273102608813225
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.250545554	3.8273102608813225
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.250545554	3.8273102608813225
FUMARASE DEFICIENCY; FMRD	0.250545554	3.8273102608813225
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.2500003	3.8189810121851484
COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	0.2500003	3.8189810121851484
OSSICULAR MALFORMATIONS, FAMILIAL	0.25	3.8189764294134334
MELANOMA, UVEAL	0.25	3.8189764294134334
ORAL SUBMUCOUS FIBROSIS	0.25	3.8189764294134334
FRASIER SYNDROME	0.25	3.8189764294134334
GAMMA-HEAVY CHAIN DISEASE	0.25	3.8189764294134334
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.25	3.8189764294134334
PLATELET DISORDER, UNDEFINED	0.25	3.8189764294134334
ATAXIA-PANCYTOPENIA SYNDROME	0.25	3.8189764294134334
LYMPHANGIOLEIOMYOMATOSIS	0.25	3.8189764294134334
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.25	3.8189764294134334
JUVENILE MYELOMONOCYTIC LEUKEMIA	0.25	3.8189764294134334
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.25	3.8189764294134334
SMALL CELL CARCINOMA OF THE BLADDER	0.25	3.8189764294134334
LICHEN PLANOPILARIS	0.25	3.8189764294134334
MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR	0.25	3.8189764294134334
CARNEY-STRATAKIS SYNDROME	0.24958278	3.812603016029914
CUSHING SYNDROME	0.24940153	3.809834258118589
MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1	0.247123	3.7750276486637437
BIRT-HOGG-DUBÉ SYNDROME	0.2464003	3.763987751601595
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.245639414	3.7523645288037124
BECKWITH-WIEDEMANN SYNDROME	0.2438885	3.7256177316199928
ONDINE SYNDROME	0.24359010000000003	3.7210594013538447
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.24359010000000003	3.7210594013538447
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.240504554	3.673924891570361
GCGR-RELATED HYPERGLUCAGONEMIA	0.23846150000000002	3.6427153912902863
WATSON SYNDROME	0.236111	3.6068093749009407
PRIMARY MYELOFIBROSIS	0.235628	3.5994311124393135
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.23376609999999998	3.570988903583614
MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	0.2328501	3.5569961739462435
ENCHONDROMATOSIS, MULTIPLE	0.2328501	3.5569961739462435
DERMATOFIBROSARCOMA PROTUBERANS	0.23125	3.532553197207426
HENNEKAM SYNDROME	0.22985437	3.5112336849106964
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.2281746	3.485573676763354
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.2273234	3.4725708258164865
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10	0.22275640000000002	3.402805764403962
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.22161059	3.385302478873617
OCULOCEREBROCUTANEOUS SYNDROME	0.22127660000000002	3.3802004791229785
DESMOID TUMOR	0.21875	3.3416043757367544
PARANEOPLASTIC PEMPHIGUS	0.21783220000000003	3.327584149469092
117600 CEREBRAL SARCOMA	0.21666670000000002	3.3097800813551665
INSULIN-RESISTANCE SYNDROME TYPE B	0.21631932999999998	3.3044736899860245
EPIDERMAL NEVUS SYNDROME	0.21554609400000002	3.2926618097525293
DUPLICATION OF THE PITUITARY GLAND	0.21522090400000002	3.287694237972205
FAMILIAL PARATHYROID ADENOMA	0.214286	3.273412732613148
CLAPO SYNDROME	0.21396010000000004	3.268434314939765
MODY	0.211236	3.2268212201743043
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.20940313	3.1988224708615878
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.20932245	3.197590010788288
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.20772889000000003	3.1732469384728637
SCARF SYNDROME	0.20670981	3.1576795684741166
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.20666700000000002	3.157025606950344
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.20666700000000002	3.157025606950344
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.2066369	3.156565802188243
CROUZON SYNDROME	0.2060997	3.148359585636719
POLYARTERITIS NODOSA	0.20520833000000002	3.1347431015571745
NEUROENDOCRINE TUMOR OF THE RECTUM	0.20520833000000002	3.1347431015571745
NEUROENDOCRINE TUMOR OF THE COLON	0.20520833000000002	3.1347431015571745
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.20520833000000002	3.1347431015571745
OCULOAURICULOFRONTONASAL SYNDROME	0.20485437	3.1293360419693537
PAPILLORENAL SYNDROME	0.20328629	3.1053821997316153
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.20206300400000002	3.0866953981298897
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.20178253000000002	3.0824109037496363
OSTEOGENIC SARCOMA	0.20168049999999998	3.0808523030892636
PROTEUS SYNDROME	0.20086799	3.0684404769346125
TETRASOMY 5P	0.20054555400000001	3.0635149749986357
HEPATIC ADENOMAS, FAMILIAL	0.2	3.055181143530747
POLYNEUROPATHY ASSOCIATED WITH IGM MONOCLONAL GAMMAPATHY WITH ANTI-MAG	0.2	3.055181143530747
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.2	3.055181143530747
%606960 INSULINOMA TUMOR SUPPRESSOR GENE LOCUS	0.2	3.055181143530747
THYROID CANCER, NONMEDULLARY, 3; NMTC3	0.2	3.055181143530747
ACQUIRED VON WILLEBRAND SYNDROME	0.2	3.055181143530747
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4	0.2	3.055181143530747
THYROID CANCER, NONMEDULLARY, 4; NMTC4	0.2	3.055181143530747
TERATOMA, PINEAL	0.2	3.055181143530747
CURRARINO SYNDROME	0.2	3.055181143530747
THYROID CANCER, NONMEDULLARY, 5; NMTC5	0.2	3.055181143530747
OVARIAN FIBROMATA	0.2	3.055181143530747
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	3.055181143530747
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.2	3.055181143530747
PACHYONYCHIA CONGENITA 2	0.2	3.055181143530747
LEUKEMIA, ACUTE MONOCYTIC	0.2	3.055181143530747
STEATOCYSTOMA MULTIPLEX	0.2	3.055181143530747
INCESSANT INFANT VENTRICULAR TACHYCARDIA	0.2	3.055181143530747
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.2	3.055181143530747
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.2	3.055181143530747
MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC	0.2	3.055181143530747
RETINAL CAPILLARY MALFORMATION	0.2	3.055181143530747
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.19994943399999998	3.0544087020822275
OROFACIODIGITAL SYNDROME TYPE 6	0.197066624	3.0103711683203183
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.19486773	2.9767810708932037
HEART DEFECT-TONGUE HAMARTOMA-POLYSYNDACTYLY SYNDROME	0.1916667	2.9278824384138225
SOMATOMAMMOTROPINOMA	0.19106266000000002	2.9186551803241314
ACROMEGALY	0.19106266000000002	2.9186551803241314
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.19047599999999998	2.9096934174758124
ZUNICH NEUROECTODERMAL SYNDROME	0.18937806999999998	2.8929215423112287
PITUITARY GIGANTISM	0.18809530000000002	2.8733260687337947
KERATOSIS, FAMILIAL ACTINIC	0.1875	2.864232322060075
HIRSCHSPRUNG DISEASE	0.18645805999999998	2.8483157448566225
INCONTINENTIA PIGMENTI	0.185752414	2.8375363630905834
MÉNÉTRIER DISEASE	0.18346679000000002	2.802621386360577
CARBOXYLESTERASE 1	0.18254	2.7884638297005124
AREDYLD SYNDROME	0.18055590000000002	2.7581549051661156
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.179894	2.7480437831716005
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.179894	2.7480437831716005
BRANCHIOSKELETOGENITAL SYNDROME	0.17981662999999998	2.7468618863462253
ACQUIRED ICHTHYOSIS	0.17698399999999997	2.703590897533228
SMITH-LEMLI-OPITZ SYNDROME	0.17471153400000003	2.668876921170655
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3	0.17424240000000002	2.661710474417709
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.17379712000000003	2.6549084191197525
DIENCEPHALIC SYNDROME	0.1734126	2.6490345278531997
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.17280197	2.639706601544829
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.172619	2.6369115690756697
THYMIC CARCINOMA	0.17187533000000002	2.625551336270622
KAPOSIFORM LYMPHANGIOMATOSIS	0.17142860000000001	2.6187271309093747
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.170240414	2.6005765135983387
HEREDITARY ACROKERATOTIC POIKILODERMA	0.17001544999999998	2.597139984744472
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.169961644	2.5963180493614284
LEGIUS SYNDROME	0.1691918	2.5845579850001266
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.16873000400000002	2.5775036328433374
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.16817076	2.5689606742261737
300270 ADRENOMYODYSTROPHY	0.167212554	2.554323209712084
TETRASOMY 9P	0.167212554	2.554323209712084
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.16697658999999998	2.550718645895323
FECHTNER SYNDROME	0.166667	2.5459893782441947
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.166667	2.5459893782441947
ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT	0.166667	2.5459893782441947
ACUTE ERYTHROID LEUKEMIA	0.166667	2.5459893782441947
THYMOMA	0.166667	2.5459893782441947
CARCINOID TUMORS, INTESTINAL	0.166667	2.5459893782441947
HYPERPARATHYROIDISM 4	0.166667	2.5459893782441947
LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL	0.166667	2.5459893782441947
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.166667	2.5459893782441947
B-CELL MALIGNANCY, LOW-GRADE	0.166667	2.5459893782441947
DERMATOLEUKODYSTROPHY	0.166667	2.5459893782441947
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	2.5459893782441947
CHOLANGIOCARCINOMA	0.166667	2.5459893782441947
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.166667	2.5459893782441947
CEREBROOCULONASAL SYNDROME	0.166667	2.5459893782441947
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	2.5459893782441947
TERMINAL OSSEOUS DYSPLASIA; TOD	0.166667	2.5459893782441947
AICARDI SYNDROME	0.1642316	2.508786437459421
JERVELL AND LANGE-NIELSEN SYNDROME	0.16369029999999998	2.500517589694455
DUBOWITZ SYNDROME	0.16327530999999998	2.4941782415806855
DISTAL MONOSOMY 12Q	0.162559844	2.483248850420499
POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES	0.1625	2.4823346791187317
FAMILIAL KERATOACANTHOMA	0.16233770000000003	2.479855399620757
POTOCKI-SHAFFER SYNDROME	0.16155518400000002	2.467901758982201
LARGE CONGENITAL MELANOCYTIC NEVUS	0.16025640000000002	2.448061657050604
COMMON VARIABLE IMMUNODEFICIENCY	0.15872999999999998	2.4247445145631765
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.157808	2.4106601294915
MONOSOMY 18Q	0.15778677400000002	2.410335883116738
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.1567459	2.39443559002878
DIFFUSE CUTANEOUS MASTOCYTOSIS	0.15625	2.386860268383396
AFRICAN IRON OVERLOAD	0.15625	2.386860268383396
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.15625	2.386860268383396
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.15625	2.386860268383396
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.15588359000000002	2.3812630237693906
PARAGANGLIOMAS 7; PGL7	0.15555560000000002	2.3762526794530574
LINEAR NEVUS SEBACEUS SYNDROME	0.15340910000000002	2.3434629478301137
DESMOID DISEASE, HEREDITARY	0.1527778	2.3338192685505583
AXIN2-RELATED ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS	0.1523199	2.326824431322445
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.15037079399999997	2.2970500718327314
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.14983892999999998	2.2889253675141172
HYDRANENCEPHALY	0.14969186399999998	2.286678801163845
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.14820459	2.2639593437635273
CARCINOMA OF ESOPHAGUS	0.14806533	2.2618320211332867
PYODERMA GANGRENOSUM	0.1477273	2.2566683067235487
IMMUNODEFICIENCY 21; IMD21	0.1477273	2.2566683067235487
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.14771136999999998	2.256424961545466
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.14738861999999997	2.251494662975093
FREE SIALIC ACID STORAGE DISEASE	0.147092594	2.246972597709119
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.14699916999999998	2.2455454614933528
UNILATERAL POLYMICROGYRIA	0.14654704	2.2386387662412304
RING CHROMOSOME 13 SYNDROME	0.14654704	2.2386387662412304
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.14654704	2.2386387662412304
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.14588485999999998	2.228523366993114
SIMPSON-GOLABI-BEHMEL SYNDROME	0.144701454	2.2104457685114087
SARCOSINEMIA	0.14464788399999998	2.2096274382421135
AUTOIMMUNE HYPOPARATHYROIDISM	0.14463953	2.2094998233257486
MONOSOMY 13Q14	0.14463953	2.2094998233257486
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.14463953	2.2094998233257486
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.14463953	2.2094998233257486
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.14436075999999998	2.205241359088838
ATELOSTEOGENESIS TYPE III	0.143402554	2.190603894574748
TREACHER-COLLINS SYNDROME	0.142910584	2.1830886072388345
BLADDER CANCER	0.14285699999999998	2.1822700631068592
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.14285699999999998	2.1822700631068592
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	2.1822700631068592
ODONTOMATOSIS-AORTAE ESOPHAGUS STENOSIS SYNDROME	0.14285699999999998	2.1822700631068592
GLOMUVENOUS MALFORMATION	0.14285699999999998	2.1822700631068592
ARNOLD-CHIARI MALFORMATION TYPE I	0.14285699999999998	2.1822700631068592
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.14285699999999998	2.1822700631068592
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.14285699999999998	2.1822700631068592
ODONTOMA-DYSPHAGIA SYNDROME	0.14285699999999998	2.1822700631068592
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	2.1822700631068592
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.14285699999999998	2.1822700631068592
PERINEURAL CYST	0.14285699999999998	2.1822700631068592
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.14285699999999998	2.1822700631068592
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.14285699999999998	2.1822700631068592
L-2-HYDROXYGLUTARIC ACIDURIA	0.14285699999999998	2.1822700631068592
MUNGAN SYNDROME	0.14285699999999998	2.1822700631068592
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.14285699999999998	2.1822700631068592
GLIOBLASTOMA	0.14285699999999998	2.1822700631068592
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	2.1822700631068592
GASTROESOPHAGEAL REFLUX	0.14285699999999998	2.1822700631068592
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.14285699999999998	2.1822700631068592
%613065 LEUKEMIA, ACUTE LYMPHOBLASTIC; ALLLEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO,INCLUDED	0.14285699999999998	2.1822700631068592
NEUROBLASTOMA	0.14285699999999998	2.1822700631068592
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.14285699999999998	2.1822700631068592
ANAUXETIC DYSPLASIA 2; ANXD2	0.14285699999999998	2.1822700631068592
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14285699999999998	2.1822700631068592
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.14285699999999998	2.1822700631068592
CHROMOSOME 13Q14 DELETION SYNDROME	0.14285699999999998	2.1822700631068592
PSEUDOACHONDROPLASIA	0.14239046	2.175143242053345
DYSSPONDYLOENCHONDROMATOSIS	0.14238459	2.1750535724867825
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.14220453	2.1723029929032616
KBG SYNDROME	0.141790884	2.1659841756067775
KAPOSI SARCOMA	0.14153073000000002	2.162010087630707
OSTEOMA OF MIDDLE EAR	0.14052279999999998	2.146613043980712
NEPHROBLASTOMA	0.14005683000000002	2.139494930193457
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.13977016	2.135115786301377
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12	0.13942310000000002	2.1298141304630085
ROTHMUND-THOMSON SYNDROME TYPE 2	0.1389188	2.1221104912095954
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.138572054	2.1168136320056217
METACHONDROMATOSIS	0.13703700000000002	2.093364291830115
MYXOPAPILLARY EPENDYMOMA	0.13526606	2.066311579358493
PROTEUS-LIKE SYNDROME	0.13198723	2.0162244814142785
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.1319443	2.015568686781819
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.13113497	2.0032054380073503
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.13113497	2.0032054380073503
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.13045630000000003	1.9928381390739511
OROFACIODIGITAL SYNDROME VI	0.130399924	1.991976944613212
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.12985437	1.9836431131453232
HADDAD SYNDROME	0.12967219	1.9808601486416813
MELANOMA-ASTROCYTOMA SYNDROME	0.1287878	1.9673502903840456
RING CHROMOSOME 22 SYNDROME	0.128323254	1.9602539294865322
CHOROIDAL OSTEOMA, BILATERAL	0.1277777	1.9519200980186433
MICROPHTHALMIA, SYNDROMIC 3	0.127049314	1.9407933421565844
OROFACIODIGITAL SYNDROME I; OFD1	0.12651745	1.9326686378379705
RING CHROMOSOME 12 SYNDROME	0.125974694	1.9243775483542793
ALAGILLE SYNDROME 1; ALGS1	0.12518696	1.9123441980396894
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.12511583	1.9112576228659928
BULLOUS DIFFUSE CUTANEOUS MASTOCYTOSIS	0.125	1.9094882147067167
CONGENITAL FACTOR XIII DEFICIENCY	0.125	1.9094882147067167
THYROID CARCINOMA, FAMILIAL MEDULLARY	0.125	1.9094882147067167
PSEUDOXANTHOMATOUS DIFFUSE CUTANEOUS MASTOCYTOSIS	0.125	1.9094882147067167
MASTOCYTOSIS, CUTANEOUS; MASTC	0.125	1.9094882147067167
CUTANEOUS MASTOCYTOMA	0.125	1.9094882147067167
SAPHO SYNDROME	0.125	1.9094882147067167
CHROMOSOME 14Q32 DUPLICATION SYNDROME, 700-KB	0.125	1.9094882147067167
CENTRAL PRECOCIOUS PUBERTY	0.125	1.9094882147067167
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.125	1.9094882147067167
ISOLATED PUNCTATE PALMOPLANTAR KERATODERMA	0.12359660000000001	1.8880500086225616
MARDEN-WALKER SYNDROME	0.12289959	1.8774025495782998
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.1217391	1.8596750137520195
STURGE-WEBER SYNDROME	0.12161563	1.857788897673061
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.12050763	1.8408631941379008
DIAMOND-BLACKFAN ANEMIA 1	0.11897729000000001	1.8174858645819465
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.11827334	1.806732390752004
OPTIC PATHWAY GLIOMA	0.11691794399999998	1.786027489245919
X-LINKED ACROGIGANTISM	0.11666670000000001	1.7821895095897928
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.11657547999999998	1.780796041470228
SYSTEMIC CAPILLARY LEAK SYNDROME	0.11631932999999998	1.7768831182206513
PHACE SYNDROME	0.116007214	1.7721152636316801
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.115518904	1.764655886110693
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.11539680000000001	1.7627906369189446
TUFTED ANGIOMA	0.11458330000000001	1.7503636876176332
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.1145436	1.749757234160642
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.11450211	1.7491234368324167
PETTIGREW SYNDROME	0.11316031399999998	1.7286262876440917
DEAFNESS, X-LINKED 4	0.11261476	1.7202924561762027
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.11228795400000001	1.7153001985322394
9Q31.1Q31.3 MICRODELETION SYNDROME	0.11111099999999999	1.6973211601942237
CONGENITAL MACROGLOSSIA	0.11111099999999999	1.6973211601942237
ATELOSTEOGENESIS, TYPE II	0.11111099999999999	1.6973211601942237
SUBCORNEAL PUSTULAR DERMATOSIS	0.11111099999999999	1.6973211601942237
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.11111099999999999	1.6973211601942237
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.11111099999999999	1.6973211601942237
ANDROGEN INSENSITIVITY SYNDROME	0.11111099999999999	1.6973211601942237
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.11111099999999999	1.6973211601942237
MYELOMA, MULTIPLE	0.11111099999999999	1.6973211601942237
NF1-MICRODELETION SYNDROME	0.11111099999999999	1.6973211601942237
OSTEOMAS OF MANDIBLE	0.11111099999999999	1.6973211601942237
WAGR 11P13 DELETION SYNDROME	0.11111099999999999	1.6973211601942237
GAUCHER DISEASE, TYPE I	0.11111099999999999	1.6973211601942237
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.11111099999999999	1.6973211601942237
POEMS SYNDROME	0.11028073000000001	1.6846380339540274
BLUE RUBBER BLEB NEVUS	0.110119	1.6821674617223115
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.10895433000000002	1.6643760726101318
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.10851126000000001	1.6576077770638111
OROFACIODIGITAL SYNDROME TYPE 3	0.1066667	1.6294304524132557
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.10658909999999999	1.6282450421295656
15Q OVERGROWTH SYNDROME	0.10413143	1.5907019069244595
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.10366646000000002	1.5835990690429222
KNOBLOCH SYNDROME	0.10302786000000001	1.5738438756516284
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.10267860000000001	1.5685086128206807
PENDRED SYNDROME	0.10267860000000001	1.5685086128206807
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.10227273	1.5623085809670565
MALT LYMPHOMA	0.10225240000000001	1.5619980218038167
PITT-HOPKINS SYNDROME	0.10179088400000001	1.5549479469006282
TURNPENNY-FRY SYNDROME; TPFS	0.101773504	1.554682451659255
MELAS	0.10123216	1.5464129317544377
305350 EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2	0.1010101	1.5430207641307754
OCULOCUTANEOUS ALBINISM TYPE 2	0.10081233	1.539999648256995
OCULOCUTANEOUS ALBINISM	0.10081233	1.539999648256995
OCULOCUTANEOUS ALBINISM TYPE 1B	0.10081233	1.539999648256995
OCULOCUTANEOUS ALBINISM TYPE 4	0.10081233	1.539999648256995
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.1	1.5275905717653735
UPINGTON DISEASE	0.1	1.5275905717653735
EXOSTOSES, MULTIPLE, TYPE III	0.1	1.5275905717653735
GENOCHONDROMATOSIS TYPE 1	0.1	1.5275905717653735
LERI-WEILL DYSCHONDROSTEOSIS	0.1	1.5275905717653735
GRANULOMATOUS SLACK SKIN	0.1	1.5275905717653735
POTOCKI-SHAFFER SYNDROME	0.1	1.5275905717653735
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.1	1.5275905717653735
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.1	1.5275905717653735
MADELUNG DEFORMITY	0.1	1.5275905717653735
MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS	0.1	1.5275905717653735
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.1	1.5275905717653735
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.1	1.5275905717653735
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.1	1.5275905717653735
PARAGANGLIOMAS 6	0.1	1.5275905717653735
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.09956699999999999	1.520976104589629
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.09920630000000001	1.5154660853972717
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.09920630000000001	1.5154660853972717
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.09920630000000001	1.5154660853972717
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.09777414000000001	1.4935885442646768
BRANCHIOOCULOFACIAL SYNDROME	0.09653540000000002	1.4746656688159905
WERNER SYNDROME; WRN	0.09632033000000001	1.4713802797732944
MANTLE CELL LYMPHOMA	0.09611743	1.4682807985031827
THROMBOCYTHEMIA, ESSENTIAL	0.09579100000000002	1.463294284599769
HOLOPROSENCEPHALY	0.09514469400000002	1.453421375079015
MOSAIC MONOSOMY X	0.09485664	1.4490210893334219
MONOSOMY X	0.09485664	1.4490210893334219
TURNER SYNDROME	0.09485664	1.4490210893334219
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.09485664	1.4490210893334219
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.09459914000000001	1.4450875436111261
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.09459914000000001	1.4450875436111261
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.09416450000000001	1.4384480239500053
PHEOCHROMOCYTOMA	0.0939614	1.4353454874987495
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.09393696000000001	1.4349721443630103
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.09387646000000001	1.4340479520670921
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0935898	1.4296689609340694
THYMOMA, FAMILIAL	0.0935898	1.4296689609340694
LYMPHATIC MALFORMATION 1	0.0931677	1.4232210011306479
VERRUCOUS HEMANGIOMA	0.0931677	1.4232210011306479
GITELMAN SYNDROME	0.09221547	1.4086748254291261
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.09145465400000001	1.397052671944644
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.09145465400000001	1.397052671944644
BETA-THALASSEMIA MAJOR	0.09124328	1.3938237426494804
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.09111720000000001	1.3918977564565989
ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC	0.0909091	1.3887188404767552
GIANT AXONAL NEUROPATHY	0.0909091	1.3887188404767552
POLYPOSIS, GASTRIC	0.0909091	1.3887188404767552
PRIMARY EFFUSION LYMPHOMA	0.0909091	1.3887188404767552
XQ12-Q13.3 DUPLICATION SYNDROME	0.0909091	1.3887188404767552
LEUKONYCHIA TOTALIS	0.0909091	1.3887188404767552
GOITER, MULTINODULAR 1	0.0909091	1.3887188404767552
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0909091	1.3887188404767552
NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC	0.0909091	1.3887188404767552
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.0909091	1.3887188404767552
DISTAL 17P13.1 MICRODELETION SYNDROME	0.0909091	1.3887188404767552
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.0909091	1.3887188404767552
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0909091	1.3887188404767552
CRANIOACROFACIAL SYNDROME	0.0909091	1.3887188404767552
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0909091	1.3887188404767552
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.0909091	1.3887188404767552
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.0909091	1.3887188404767552
B-CELL CLL/LYMPHOMA 2	0.0909091	1.3887188404767552
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.0909091	1.3887188404767552
POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI	0.0909091	1.3887188404767552
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.090237154	1.3784542567334004
NON-HISTAMINIC ANGIOEDEMA	0.08946827000000002	1.3667088572415882
CHROMOSOME 16P13.3 DELETION SYNDROME	0.08881422400000001	1.3567177122105796
BLACKFAN-DIAMOND ANEMIA	0.0884615	1.3513295336422255
ADDISON DISEASE	0.08826640000000001	1.3483492044367116
NATIVE AMERICAN MYOPATHY	0.08818767000000001	1.3471465323795606
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	0.088141	1.3464336058597177
CHEILITIS GLANDULARIS	0.088141	1.3464336058597177
LICHEN SCLEROSUS ET ATROPHICUS; LSA	0.088141	1.3464336058597177
LARYNGOTRACHEAL ANGIOMA	0.08734936000000001	1.3343405878573946
TRICHOTHIODYSTROPHY	0.08701985400000001	1.3293070852679933
3C SYNDROME	0.08684621400000002	1.32665457699918
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0866532	1.3237061133329924
KAGAMI-OGATA SYNDROME	0.08572510400000001	1.309528606340061
BOHRING-OPITZ SYNDROME	0.08512418400000002	1.3003490090762087
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.08511287000000001	1.300176177478919
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.08387885400000002	1.2813254654088428
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.08333330000000001	1.2729916339409542
ENDOMETRIAL CANCER	0.08333330000000001	1.2729916339409542
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	0.08333330000000001	1.2729916339409542
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.08333330000000001	1.2729916339409542
IMMUNOERYTHROMYELOID HYPOPLASIA	0.08333330000000001	1.2729916339409542
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0833333	1.2729916339409537
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.08314668	1.2701408444159255
CAP POLYPOSIS	0.08213143	1.2546319811360773
THYMIC EPITHELIAL NEOPLASM	0.08213143	1.2546319811360773
FRASIER SYNDROME	0.0815508	1.2457623319992361
EPIDERMODYSPLASIA VERRUCIFORMIS	0.08119660000000001	1.2403516061940432
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.080120794	1.223917695167557
BECKER NEVUS SYNDROME	0.07986044	1.219940552010343
XERODERMA PIGMENTOSUM VARIANT	0.0797535	1.218306946652897
BALLER-GEROLD SYNDROME	0.07955087	1.2152115898773288
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.07936510000000001	1.2123737848721605
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.07870563000000001	1.2022997833285394
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.0786003	1.2006907721792988
CLASSICAL EHLERS-DANLOS SYNDROME	0.0783431	1.1967618092287182
ZIMMERMANN-LABAND SYNDROME 1	0.07829998	1.196103112174173
POLYCYTHEMIA VERA	0.07793563	1.190537335925946
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.07784363999999999	1.1891321053589787
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.07778673000000001	1.1882627535645873
FIBROMATOSIS, GINGIVAL, 5; GINGF5	0.07777780000000001	1.1881263397265287
248100 MACROSOMIA ADIPOSA CONGENITA	0.0776914	1.1868065014725233
HERMANSKY-PUDLAK SYNDROME	0.07750019000000001	1.1838855955402507
GOOD SYNDROME	0.07692310000000001	1.17507002310965
MYASTHENIA GRAVIS; MG	0.07692310000000001	1.17507002310965
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.07692310000000001	1.17507002310965
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.07692310000000001	1.17507002310965
MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE	0.07692310000000001	1.17507002310965
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.07692310000000001	1.17507002310965
JUVENILE XANTHOGRANULOMA	0.07692310000000001	1.17507002310965
MEDULLOBLASTOMA	0.07692310000000001	1.17507002310965
CHRONIC MYELOID LEUKEMIA	0.07692310000000001	1.17507002310965
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.07692310000000001	1.17507002310965
OROFACIODIGITAL SYNDROME TYPE 4	0.07682852400000001	1.1736252890504972
PACHYDERMOPERIOSTOSIS	0.07670450000000001	1.171730710119771
GLIOMA SUSCEPTIBILITY 9; GLM9	0.07670450000000001	1.171730710119771
SYNDROMIC DIARRHEA	0.075664194	1.1558390937462613
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.07549020000000001	1.153181177806824
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.07487627999999999	1.1438029937686416
1P36 DELETION SYNDROME	0.074134904	1.1324778038913106
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.0737813	1.1270761825259252
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.07375496000000002	1.1266738151693227
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.07325580000000001	1.1190486940712985
OROFACIODIGITAL SYNDROME IX; OFD9	0.07321948400000002	1.1184939342792564
OROFACIODIGITAL SYNDROME VIII; OFD8	0.07321948400000002	1.1184939342792564
NEVUS COMEDONICUS SYNDROME	0.07321113000000001	1.118366319362891
PENDRED SYNDROME	0.07293236000000002	1.1141078551259807
BLOOM SYNDROME	0.072764	1.1115360036393562
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0727273	1.1109753778995182
STORAGE POOL PLATELET DISEASE	0.0727273	1.1109753778995182
ESSENTIAL THROMBOCYTHEMIA	0.0727273	1.1109753778995182
CARDIOFACIOCUTANEOUS SYNDROME	0.072694244	1.1104704175601157
COSTELLO SYNDROME	0.07267393000000001	1.1101601028113675
DISTAL TRISOMY 17Q	0.072297834	1.1044148957745805
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.07213117999999999	1.1018691049831104
OROFACIODIGITAL SYNDROME TYPE 2	0.072066624	1.1008829536136018
BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS	0.07142860000000001	1.0911365591440016
LIP, HAMARTOMATOUS	0.07142860000000001	1.0911365591440016
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.07142860000000001	1.0911365591440016
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.07142860000000001	1.0911365591440016
CONGENITAL PANFOLLICULAR NEVUS	0.07142860000000001	1.0911365591440016
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.07142860000000001	1.0911365591440016
SPONDYLO-OCULAR SYNDROME	0.07119433	1.0875578727115267
VACTERL/VATER ASSOCIATION	0.07090336	1.083113042424861
OROFACIODIGITAL SYNDROME XIV; OFD14	0.07090229399999999	1.0830967583093658
OROFACIODIGITAL SYNDROME TYPE 14	0.07090229399999999	1.0830967583093658
DEAFNESS, AUTOSOMAL DOMINANT 50	0.07021406	1.072583360613682
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.07019710000000001	1.0723242812527112
OCULOSKELETODENTAL SYNDROME; OCSKD	0.069840804	1.0668815371491338
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.0694118	1.0603281124926374
OCULOCUTANEOUS ALBINISM TYPE 1A	0.069264	1.0580703336275683
SHWACHMAN-DIAMOND SYNDROME	0.068737334	1.0500250334668744
AURICULOCONDYLAR SYNDROME	0.068729704	1.0499084783062487
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.0687103	1.0496120646317033
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.06791203	1.0374177673744718
VELOCARDIOFACIAL SYNDROME	0.0678733	1.036826131546027
RAMON SYNDROME	0.06764271000000001	1.0333036604465935
OROFACIODIGITAL SYNDROME XVI; OFD16	0.067212254	1.0267280551749949
OROFACIODIGITAL SYNDROME IV; OFD4	0.0666667	1.018394223707106
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0666667	1.018394223707106
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.0666667	1.018394223707106
RARE HEREDITARY HEMOCHROMATOSIS	0.0666667	1.018394223707106
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0666667	1.018394223707106
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.06660245399999999	1.0174128078683695
LIG4 SYNDROME	0.06641855399999999	1.014603568806893
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.06628780000000001	1.0126061830306872
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1	0.0660569	1.0090789764004808
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2	0.0660569	1.0090789764004808
SCLERODERMA	0.06547837000000001	1.0002414066656469
PHELAN-MCDERMID SYNDROME	0.06542953400000001	0.9994953925340194
ALSTROM SYNDROME; ALMS	0.06523021400000001	0.9964505990063768
CZECH DYSPLASIA, METATARSAL TYPE	0.065	0.9929338716474927
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.06428253	0.9819738675722478
FRYNS MICROPHTHALMIA SYNDROME	0.0638946	0.9760478854671982
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.06327285399999999	0.9665501521908697
10Q22.3Q23.3 MICRODELETION SYNDROME	0.063045554	0.9630779388212471
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.06283956	0.9599311938988448
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.06283956	0.9599311938988448
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.0627273	0.9582163207229811
MONOSOMY 7 OF BONE MARROW	0.0627273	0.9582163207229811
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0626959	0.9577366572834466
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0625	0.9547441073533584
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.0625	0.9547441073533584
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.0625	0.9547441073533584
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.0625	0.9547441073533584
HUMERO-RADIO-ULNAR SYNOSTOSIS	0.0625	0.9547441073533584
HEMANGIOMAS OF SMALL INTESTINE	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.0625	0.9547441073533584
ADAMS-OLIVER SYNDROME 5; AOS5	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.0625	0.9547441073533584
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.0625	0.9547441073533584
POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.0625	0.9547441073533584
X-LINKED CENTRONUCLEAR MYOPATHY	0.0625	0.9547441073533584
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.0625	0.9547441073533584
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.062037	0.9476713630060847
LIPOSARCOMA	0.0613433	0.9370744672097484
ACQUIRED GENERALIZED LIPODYSTROPHY	0.0613275	0.9368331078994093
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.0612766	0.9360555642983808
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0608465	0.9294853972492177
PAGET DISEASE OF BONE 3; PDB3	0.060340950000000004	0.921762663113658
PERLMAN SYNDROME	0.060309853999999996	0.9212876435494618
MYCETOMA	0.0597381	0.9125535833517705
NOONAN SYNDROME 2; NS2	0.059573353999999995	0.9100369389884098
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.059343400000000004	0.9065241833650126
HYPOKALEMIC PERIODIC PARALYSIS	0.0588235	0.8985822399824045
OSLAM SYNDROME	0.0588235	0.8985822399824045
46,XY SEX REVERSAL 7	0.0588235	0.8985822399824045
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.0588235	0.8985822399824045
RING CHROMOSOME Y SYNDROME	0.0588235	0.8985822399824045
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.0588235	0.8985822399824045
GONADOBLASTOMA	0.0588235	0.8985822399824045
46,XY SEX REVERSAL 1; SRXY1	0.0588235	0.8985822399824045
DYSKERATOSIS CONGENITA	0.058180034000000005	0.8887527140338888
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.05787022	0.8840200245798794
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.05763261	0.8803903166223077
OSTEOGENESIS IMPERFECTA	0.05756829	0.8794077703665483
ALKAPTONURIA	0.05737916	0.8765186383181683
GLYCEROL KINASE DEFICIENCY; GKD	0.057224734	0.874159641301814
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.05695214	0.8699955210586159
CUTIS LAXA	0.056935934	0.8697479597305556
NOCARDIOSIS	0.05684339	0.868334266311821
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.056690500000000005	0.865998733086649
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.0566667	0.8656351665305688
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.0566667	0.8656351665305688
VASCULAR EHLERS-DANLOS SYNDROME	0.056567914000000004	0.8641261209083447
RAMON SYNDROME	0.05635813	0.8609214803032724
TRISOMY 8P	0.0560997	0.8569737279886592
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.056035989999999994	0.8560005000353874
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.05602236	0.8557922894404558
PAPILLON-LEFÈVRE SYNDROME	0.055944	0.8545952694684205
IMMUNODEFICIENCY 58; IMD58	0.055555600000000004	0.8486621076876838
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.055555600000000004	0.8486621076876838
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.055555600000000004	0.8486621076876838
AUTOSOMAL AGAMMAGLOBULINEMIA	0.055555600000000004	0.8486621076876838
ACROKERATOELASTOIDOSIS OF COSTA	0.055555600000000004	0.8486621076876838
LIPOID PROTEINOSIS	0.055555600000000004	0.8486621076876838
WHIM SYNDROME	0.055555600000000004	0.8486621076876838
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.055555600000000004	0.8486621076876838
VIRAL HEMORRHAGIC FEVER	0.05527142	0.8443210008008409
MAST CELL SARCOMA	0.05520833	0.843357243909114
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.054522853999999996	0.8328859771613996
FETAL HYDANTOIN SYNDROME	0.054171884000000003	0.8275245925316749
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0539773	0.8245521456935109
THAUVIN-ROBINET-FAIVRE SYNDROME	0.053924643999999994	0.823747777602042
SECONDARY POLYCYTHEMIA	0.05390831	0.8234982609580499
EAR WAX, WET/DRY	0.053802	0.8218742794212062
RABIES	0.05375397	0.8211405776695873
SPONTANEOUS PERIODIC HYPOTHERMIA	0.05375397	0.8211405776695873
BENIGN FAMILIAL INFANTILE EPILEPSY	0.05375397	0.8211405776695873
LEGIONELLOSIS	0.05375397	0.8211405776695873
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.05369004	0.8201639890170577
LEPRECHAUNISM	0.053293240000000006	0.8141025096282928
ZIMMERMANN-LABAND SYNDROME	0.05328629	0.8139963420835549
RECURRENT ACUTE PANCREATITIS	0.05325797	0.8135637284336311
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.053030299999999995	0.8100858629788926
TAKAYASU ARTERITIS	0.05282733	0.8069853123953805
CHIME SYNDROME	0.05276278	0.805999252681306
ALG11-CDG	0.052452874	0.8012651578439709
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.052289364	0.7987673945000773
DIASTROPHIC DWARFISM	0.05210381	0.7959328890905438
TIETZ SYNDROME	0.0520833	0.7956195802642747
FABRY DISEASE	0.05189882	0.7928014811774818
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.05174381	0.7904335630321885
COLCHICINE POISONING	0.05163506	0.7887723082853937
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.05163506	0.7887723082853937
PSEUDOXANTHOMA ELASTICUM	0.051579599999999996	0.7879251065542924
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.05150376	0.7867665818646656
19P13.3 MICRODUPLICATION SYNDROME	0.051347644	0.7843817685676484
GABRIELE-DE VRIES SYNDROME	0.051245330000000006	0.7828188295500524
ELLIS VAN CREVELD SYNDROME	0.051245330000000006	0.7828188295500524
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.05091898	0.7778335377190961
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.05089619	0.7774853998277907
DEXTROCARDIA	0.050545554	0.7721291173505754
NASU-HAKOLA DISEASE	0.05	0.7637952858826867
PROGRESSIVE OSSEOUS HETEROPLASIA	0.05	0.7637952858826867
FIBROMATOSIS, GINGIVAL, 1	0.05	0.7637952858826867
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.05	0.7637952858826867
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.05	0.7637952858826867
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.05	0.7637952858826867
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.05	0.7637952858826867
JUVENILE HYALINE FIBROMATOSIS	0.05	0.7637952858826867
HEREDITARY GINGIVAL FIBROMATOSIS	0.05	0.7637952858826867
LEUKEMIA, ACUTE, ?X-LINKED	0.05	0.7637952858826867
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.05	0.7637952858826867
HYALINE FIBROMATOSIS SYNDROME; HFS	0.05	0.7637952858826867
RETICULUM CELL SARCOMA	0.05	0.7637952858826867
CANAVAN DISEASE	0.049682004	0.7589376089680956
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.04961327	0.7578876348644984
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.04945108399999999	0.755410096819775
HYPERKERATOSIS LENTICULARIS PERSTANS	0.04945050000000001	0.7554011756908361
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3	0.04945050000000001	0.7554011756908361
N SYNDROME	0.049434149999999996	0.7551514146323522
FETAL ALCOHOL SYNDROME	0.049409884	0.7547807295042077
APERT SYNDROME	0.04927015999999999	0.7526463188537141
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.04903763	0.7490942124971882
ACUTE INTERMITTENT PORPHYRIA	0.04888260999999999	0.7467261415928375
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.048754479999999996	0.7447688397932345
LINEAR VERRUCOUS NEVUS SYNDROME	0.04848236	0.7406119603293466
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.048164554	0.735757185836842
CUSHING DISEASE	0.04807184	0.7343408955141354
SMITH-MCCORT DYSPLASIA 2; SMC2	0.048034179999999996	0.7337656049048086
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.047782584	0.7299222481298698
PERIORAL MYOCLONIA WITH ABSENCES	0.047619	0.7274233543689531
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.047619	0.7274233543689531
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1	0.047619	0.7274233543689531
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.047619	0.7274233543689531
CEREBRAL ARTERIOVENOUS MALFORMATION	0.047619	0.7274233543689531
HUNTER-MACDONALD SYNDROME	0.04753691	0.7261693552685909
CARTILAGE-HAIR HYPOPLASIA; CHH	0.047123	0.7198465051329969
MYCOSIS FUNGOIDES	0.047123	0.7198465051329969
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.047057600000000005	0.7188474608990624
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.04701429	0.7181858614224307
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.04695826	0.7173299524250707
KID SYNDROME	0.04695826	0.7173299524250707
DEAFNESS, MID-TONE NEURAL	0.04695826	0.7173299524250707
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.04695826	0.7173299524250707
MUCOLIPIDOSIS III GAMMA	0.046893340000000006	0.7163382406258806
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.04678663400000001	0.7147082098303728
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0462766	0.7069169785335748
PITUITARY APOPLEXY	0.04613497	0.7047534520067834
OCCIPITAL HORN SYNDROME	0.046014394	0.7029115443989716
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.046000054	0.7026924879109805
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.045809814	0.699786399607254
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.045753044	0.6989191864396629
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.04546448	0.6945111099821538
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0454545	0.6943586564430917
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.0454545	0.6943586564430917
X-LINKED ADRENOLEUKODYSTROPHY	0.0454545	0.6943586564430917
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.0454545	0.6943586564430917
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0454545	0.6943586564430917
MERCURY POISONING	0.0454545	0.6943586564430917
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.0454545	0.6943586564430917
PEROXISOME BIOGENESIS DISORDER 14B	0.0454545	0.6943586564430917
PERRAULT SYNDROME 4	0.0454545	0.6943586564430917
POROKERATOSIS	0.0454545	0.6943586564430917
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0454545	0.6943586564430917
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.0454545	0.6943586564430917
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.0454545	0.6943586564430917
INHERITED EPIDERMOLYSIS BULLOSA	0.0454545	0.6943586564430917
SMALL CELL CANCER OF THE LUNG	0.0454545	0.6943586564430917
SANDIFER SYNDROME	0.0454545	0.6943586564430917
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.0454545	0.6943586564430917
PALMOPLANTAR KERATODERMA-XX SEX REVERSAL-PREDISPOSITION TO SQUAMOUS CELL CARCINOMA SYNDROME	0.0454545	0.6943586564430917
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.04534759	0.6927255093628172
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.04499575	0.687350834695118
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.044982060000000004	0.6871417075458434
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.04485873	0.6852577300936851
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.044471174	0.679337461177374
RUIJS-AALFS SYNDROME; RJALS	0.0444079	0.6783708935189952
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.044110750000000004	0.6738316581349945
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0440891	0.6735009347762072
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.04400524	0.6722198973227247
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.04380909	0.669223528416207
WILSON DISEASE	0.04366983	0.6670962057859665
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.043478300000000004	0.6641704115638644
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.043478300000000004	0.6641704115638644
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.043478300000000004	0.6641704115638644
LIPOMA OF THE CONJUNCTIVA	0.043478300000000004	0.6641704115638644
RENAL CELL CARCINOMA, NONPAPILLARY	0.043478300000000004	0.6641704115638644
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.043389974000000005	0.6628211519154469
TRISOMY 13	0.04329065	0.6613038878559465
MENKES DISEASE	0.043171970000000004	0.6594909433653755
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.04296736	0.6563653402964864
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.042328083999999995	0.6465998203929274
CITRULLINEMIA TYPE II	0.042100924	0.6431297456501052
FLYNN-AIRD SYNDROME	0.041894589999999995	0.6399778069197589
PINEOCYTOMA	0.04184927000000001	0.639285502872635
PAPILLARY TUMOR OF THE PINEAL REGION	0.04184927000000001	0.639285502872635
ANDROGEN INSENSITIVITY SYNDROME	0.0416667	0.6364965807657629
PREMATURE OVARIAN FAILURE 8; POF8	0.041666699999999994	0.6364965807657627
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.04151745	0.634216651837403
HALLERMANN-STREIFF SYNDROME; HSS	0.04148936	0.6337875516457941
DISTAL MONOSOMY 10Q	0.041444244	0.6330983638834364
WIDOW'S PEAK SYNDROME	0.041428860000000005	0.632863359349876
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.041178780000000005	0.6290431608480053
MACS SYNDROME	0.040935700000000005	0.625329893686158
ACROCRANIOFACIAL DYSOSTOSIS	0.04084093	0.6238821961012959
DOORS SYNDROME	0.040610414	0.6203608554188852
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.040549914	0.6194366631229672
KBG SYNDROME	0.040545554	0.6193700601740382
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.040524504	0.6190485023586817
RUBINSTEIN-TAYBI SYNDROME	0.040345334	0.6163115183312495
NAIL-PATELLA SYNDROME	0.04033698	0.6161839034148843
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.04022387	0.6144560457191606
DYSOSTOSIS, STANESCU TYPE	0.04000436	0.6111028316550783
ACTH-DEPENDENT CUSHING SYNDROME	0.04	0.6110362287061494
PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5	0.04	0.6110362287061494
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.04	0.6110362287061494
PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	0.04	0.6110362287061494
LEUKOCYTE ADHESION DEFICIENCY	0.04	0.6110362287061494
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.04	0.6110362287061494
SJOGREN-LARSSON SYNDROME; SLS	0.04	0.6110362287061494
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.04	0.6110362287061494
LEUKEMIA, ACUTE MYELOID; AML	0.04	0.6110362287061494
DOHLE BODIES AND LEUKEMIA	0.04	0.6110362287061494
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.039963724	0.6104820799503358
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.039882723999999994	0.6092447315872057
ERYTHROKERATODERMIA VARIABILIS	0.03975831	0.6073441950532495
FG SYNDROME TYPE 1	0.039475804	0.6030286600325782
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.039337170000000005	0.600910900119317
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.039337170000000005	0.600910900119317
8P23.1 DUPLICATION SYNDROME	0.039100003999999994	0.5972879746638837
PEROXISOME BIOGENESIS DISORDER 11B	0.03901428	0.5959784629221436
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.03900059	0.5957693357728691
OCULOCEREBROCUTANEOUS SYNDROME	0.038554450000000004	0.588954143195995
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.03846339000000001	0.5875631192213455
EPISODIC ATAXIA, TYPE 1; EA1	0.0384615	0.5875342477595391
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0384615	0.5875342477595391
3Q13 MICRODELETION SYNDROME	0.0384615	0.5875342477595391
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0384615	0.5875342477595391
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.0384615	0.5875342477595391
245800 LAURENCE-MOON SYNDROME	0.0384615	0.5875342477595391
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.0384615	0.5875342477595391
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	0.5875342477595391
PANCREATIC CANCER	0.0384615	0.5875342477595391
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	0.5875342477595391
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	0.5875342477595391
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0384615	0.5875342477595391
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	0.5875342477595391
TROPICAL CALCIFIC PANCREATITIS	0.0384615	0.5875342477595391
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.038389194	0.5864297081207184
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.03832833399999999	0.5855000164987418
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.03804568	0.5811822206440242
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.038042384000000005	0.581131871258779
ECTODERMAL DYSPLASIA SYNDROME	0.0378869	0.5787567123341752
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.03784364	0.5780958766528295
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.03784364	0.5780958766528295
3MC SYNDROME 2	0.037791134000000004	0.5772937999472184
8Q24.3 MICRODELETION SYNDROME	0.037582554	0.5741075515326302
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.037582554	0.5741075515326302
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.037505184000000004	0.5729256547072553
GERMAN SYNDROME	0.037505184000000004	0.5729256547072553
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.037505184000000004	0.5729256547072553
HARLEQUIN ICHTHYOSIS	0.03749683	0.5727980397908901
WAGR SYNDROME	0.03749683	0.5727980397908901
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0373497	0.5705504957826516
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.037231890000000004	0.5687508413300549
PYRUVATE DEHYDROGENASE DEFICIENCY	0.037137864	0.5673145090190467
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.037037	0.5657737200647414
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.037037	0.5657737200647414
LÉRI-WEILL DYSCHONDROSTEOSIS	0.037037	0.5657737200647414
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.037037	0.5657737200647414
EXOSTOSES OF HEEL	0.037037	0.5657737200647414
HYPOPHOSPHATEMIC RICKETS	0.037037	0.5657737200647414
CRANIOLENTICULOSUTURAL DYSPLASIA	0.037037	0.5657737200647414
DENTIN DYSPLASIA	0.037037	0.5657737200647414
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.037037	0.5657737200647414
CRANIOLENTICULOSUTURAL DYSPLASIA	0.037037	0.5657737200647414
PULMONARY ARTERIAL HYPERTENSION	0.037037	0.5657737200647414
FOCAL DERMAL HYPOPLASIA; FDH	0.03695963000000001	0.5645918232393665
BRANCHIOGENIC DEAFNESS SYNDROME	0.03695963000000001	0.5645918232393665
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.03695963000000001	0.5645918232393665
CROSSED POLYSYNDACTYLY	0.03695963000000001	0.5645918232393665
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.03695963000000001	0.5645918232393665
ELSAHY-WATERS SYNDROME; ESWS	0.036810883999999995	0.5623195933674883
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.03643797	0.5566229942626952
MIRAGE SYNDROME; MIRAGE	0.036430753999999996	0.5565127633270366
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.036259854	0.5539021110398895
RAINE SYNDROME	0.036259854	0.5539021110398895
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.036259854	0.5539021110398895
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.036259854	0.5539021110398895
THUMBS, CONGENITAL CLASPED	0.0361093	0.5516022623304739
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.035714300000000004	0.5455682795720008
OTOSCLEROSIS 4	0.035714300000000004	0.5455682795720008
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.035714300000000004	0.5455682795720008
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.035714300000000004	0.5455682795720008
FIBROCHONDROGENESIS	0.035714300000000004	0.5455682795720008
OTOFACIOCERVICAL SYNDROME 2	0.035714300000000004	0.5455682795720008
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.035714300000000004	0.5455682795720008
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.035714300000000004	0.5455682795720008
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.035714300000000004	0.5455682795720008
SECONDARY SYRINGOMYELIA	0.035714300000000004	0.5455682795720008
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.035714300000000004	0.5455682795720008
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.035714300000000004	0.5455682795720008
MUCOLIPIDOSIS TYPE III	0.035714300000000004	0.5455682795720008
ALKAPTONURIA	0.035714300000000004	0.5455682795720008
CHARGE SYNDROME	0.035714300000000004	0.5455682795720008
KNIEST DYSPLASIA	0.03567914	0.545031178726968
DERMOCHONDROCORNEAL DYSTROPHY	0.0355346	0.5428231993145383
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.035485594	0.5420745882789391
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.035485593999999995	0.542074588278939
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.03548075	0.5420005917916426
MAPLE SYRUP URINE DISEASE; MSUD	0.03530537	0.5393215034468806
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.03526606	0.5387210075931196
SPONDYLOCOSTAL DYSOSTOSIS 5	0.034876279999999996	0.5327667650624925
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.034876279999999996	0.5327667650624925
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.03475939	0.530981164443156
CHST3-RELATED SKELETAL DYSPLASIA	0.03475939	0.530981164443156
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.03475939	0.530981164443156
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.034558333999999996	0.5279098519431874
SPINAL INTRADURAL ARACHNOID CYSTS	0.0344828	0.5267560016807102
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.0344828	0.5267560016807102
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0344828	0.5267560016807102
SCIMITAR SYNDROME	0.0344828	0.5267560016807102
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1	0.0344828	0.5267560016807102
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0344828	0.5267560016807102
CERVICAL VERTEBRAL BRIDGE	0.0344828	0.5267560016807102
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.0344828	0.5267560016807102
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.0344828	0.5267560016807102
BRACHYDACTYLY, TYPE A6	0.0344828	0.5267560016807102
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.0344828	0.5267560016807102
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.0344828	0.5267560016807102
FANCONI ANEMIA	0.034012780000000006	0.5195760204752986
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.0339912	0.5192463664299115
MUCOPOLYSACCHARIDOSIS TYPE 6	0.03389661	0.5178014185080787
MORQUIO SYNDROME A	0.03389661	0.5178014185080787
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.033589289999999994	0.5131068271629293
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.033578224000000004	0.5129377839902579
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.033530844000000004	0.5122140115773555
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.033517154	0.5120048844280807
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.03310184	0.5056605869208591
FANCONI ANEMIA	0.033026493999999997	0.5045096085286567
ACITRETIN/ETRETINATE EMBRYOPATHY	0.0329267	0.5029851647934692
PIEBALDISM	0.032767450000000004	0.5005524768079328
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.03275376	0.5003433496586581
WT LIMB-BLOOD SYNDROME	0.03275376	0.5003433496586581
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0325397	0.49707338928073713
X-LINKED RECESSIVE OCULAR ALBINISM	0.03249533	0.496395597344045
WAARDENBURG SYNDROME TYPE 1	0.03249533	0.496395597344045
NOONAN SYNDROME 5; NS5	0.032013394	0.48903358844610173
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03182045	0.48608619409331477
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.031806759999999996	0.48587706694404
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.031806759999999996	0.48587706694404
MERRF	0.031806759999999996	0.48587706694404
DE SANCTIS-CACCHIONE SYNDROME	0.031806759999999996	0.48587706694404
HYDROXYKYNURENINURIA	0.031795554	0.485705885144568
MICROFORM HOLOPROSENCEPHALY	0.03138779	0.4794769207255146
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.03125	0.4773720536766792
AUTOIMMUNE HEPATITIS	0.03125	0.4773720536766792
PERRAULT SYNDROME 3	0.03125	0.4773720536766792
HEPATOCELLULAR CARCINOMA	0.03125	0.4773720536766792
POROKERATOSIS PLANTARIS PALMARIS ET DISSEMINATA	0.03125	0.4773720536766792
FLOTCH SYNDROME	0.03125	0.4773720536766792
PRIMARY BILIARY CHOLANGITIS	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IC	0.03125	0.4773720536766792
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.03125	0.4773720536766792
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IE; USH1E	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IIA	0.03125	0.4773720536766792
TYROSINEMIA, TYPE I; TYRSN1	0.03125	0.4773720536766792
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IF	0.03125	0.4773720536766792
TYROSINEMIA TYPE 1	0.03125	0.4773720536766792
GLYCOGEN STORAGE DISEASE IB	0.03125	0.4773720536766792
POROKERATOSIS 1, MULTIPLE TYPES; POROK1	0.03125	0.4773720536766792
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.03125	0.4773720536766792
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.03125	0.4773720536766792
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.03125	0.4773720536766792
HISTIOCYTOSIS, PROGRESSIVE MUCINOUS	0.03125	0.4773720536766792
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.03125	0.4773720536766792
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.03125	0.4773720536766792
WILDERVANCK SYNDROME	0.03125	0.4773720536766792
ERYTHROKERATODERMA ''EN COCARDES''	0.03125	0.4773720536766792
CYLINDROMATOSIS, FAMILIAL	0.03125	0.4773720536766792
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.03125	0.4773720536766792
RETINITIS PUNCTATA ALBESCENS	0.03125	0.4773720536766792
HEMOCHROMATOSIS, TYPE 1	0.03125	0.4773720536766792
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.03125	0.4773720536766792
BETA-THALASSEMIA INTERMEDIA	0.03125	0.4773720536766792
DEAFNESS, X-LINKED 3	0.03125	0.4773720536766792
XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD	0.03125	0.4773720536766792
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.03125	0.4773720536766792
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.03125	0.4773720536766792
GENERALIZED ERUPTIVE HISTIOCYTOSIS	0.03125	0.4773720536766792
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.03125	0.4773720536766792
WOLFRAM-LIKE SYNDROME	0.03125	0.4773720536766792
GLYCOGEN STORAGE DISEASE IA	0.03125	0.4773720536766792
PORPHYRIA CUTANEA TARDA	0.03125	0.4773720536766792
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.03125	0.4773720536766792
PORPHYRIA CUTANEA TARDA	0.03125	0.4773720536766792
WILSON DISEASE	0.03125	0.4773720536766792
DEAFNESS-OLIGODONTIA SYNDROME	0.03125	0.4773720536766792
FAMILIAL TUMORAL CALCINOSIS	0.03125	0.4773720536766792
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.03125	0.4773720536766792
WAARDENBURG SYNDROME, TYPE 1; WS1	0.03125	0.4773720536766792
USHER SYNDROME, TYPE IIC	0.03125	0.4773720536766792
PRIMARY ERYTHROMELALGIA	0.03125	0.4773720536766792
BLAU SYNDROME	0.03119433	0.4765216440053774
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.03092925	0.4724723069177417
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.03074516	0.4696601654341789
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.03074516	0.4696601654341789
MARFANOID HYPERMOBILITY SYNDROME	0.030464480000000002	0.4653725242173478
FLYNN-AIRD SYNDROME	0.03038592	0.46417244906416893
LIPOMATOSIS, MULTIPLE	0.030302999999999997	0.46290577096206104
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.030302999999999997	0.46290577096206104
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9	0.030302999999999997	0.46290577096206104
ROCH-LERI MESOSOMATOUS LIPOMATOSIS	0.030302999999999997	0.46290577096206104
EXTENSOR TENDONS OF FINGER ANOMALIES	0.030302999999999997	0.46290577096206104
MULTIPLE SYMMETRIC LIPOMATOSIS	0.030302999999999997	0.46290577096206104
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.030302999999999997	0.46290577096206104
NEUROCUTANEOUS MELANOCYTOSIS	0.030302999999999997	0.46290577096206104
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10	0.030302999999999997	0.46290577096206104
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II	0.030302999999999997	0.46290577096206104
INFANTILE SIALIC ACID STORAGE DISEASE	0.030225514000000002	0.46172210213162296
ROSSELLI-GULIENETTI SYNDROME	0.029957354	0.45762571525437695
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.029957354	0.45762571525437695
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.029957354	0.45762571525437695
22Q11.2 DELETION SYNDROME	0.029704384	0.45376136938498207
INTERMEDIATE NEMALINE MYOPATHY	0.02967996	0.4533882706637341
COFFIN-LOWRY SYNDROME	0.02963016	0.4526275305589949
BRANCHIO-OCULO-FACIAL SYNDROME	0.02962133	0.45249264431150804
POLYMYOSITIS	0.02959853	0.4521443536611456
LOEYS-DIETZ SYNDROME 3; LDS3	0.029560330000000003	0.4515608140627312
MUSICAL PERFECT PITCH	0.0294118	0.449291883786488
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.0294118	0.449291883786488
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.0294118	0.449291883786488
OSSIFIED EAR CARTILAGES	0.0294118	0.449291883786488
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0294118	0.449291883786488
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.0294118	0.449291883786488
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.0294118	0.449291883786488
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	0.449291883786488
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.449291883786488
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0294118	0.449291883786488
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.449291883786488
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.0294118	0.449291883786488
AREDYLD	0.0294118	0.449291883786488
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	0.449291883786488
OTOONYCHOPERONEAL SYNDROME	0.0294118	0.449291883786488
HAIRY EARS, Y-LINKED	0.0294118	0.449291883786488
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.449291883786488
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0294118	0.449291883786488
EAR FOLDING	0.0294118	0.449291883786488
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.0294118	0.449291883786488
EAR WITHOUT HELIX	0.0294118	0.449291883786488
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.449291883786488
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	0.449291883786488
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.449291883786488
EAR MALFORMATION	0.0294118	0.449291883786488
DARWINIAN POINT OF PINNA	0.0294118	0.449291883786488
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.02902313	0.4433545975112076
DE BARSY SYNDROME	0.028508974	0.43550039893104164
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0284774	0.43501807748391236
OCULOPHARYNGODISTAL MYOPATHY	0.02846413	0.43481536621503913
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.028323354000000002	0.43266488531173075
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.028323354000000002	0.43266488531173075
2Q37 MICRODELETION SYNDROME	0.028127224	0.4296688219233273
DEAFNESS, X-LINKED 2	0.02811017	0.42940830662721846
COFFIN-SIRIS SYNDROME 1; CSS1	0.028014794	0.42795135184349153
WOLF-HIRSCHHORN SYNDROME	0.028014794	0.42795135184349153
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0279027	0.4262390144679768
RIN2 SYNDROME	0.027777800000000002	0.4243310538438419
THREE M SYNDROME 2; 3M2	0.027777800000000002	0.4243310538438419
MEESTER-LOEYS SYNDROME; MRLS	0.027777800000000002	0.4243310538438419
METHANE PRODUCTION	0.027777800000000002	0.4243310538438419
JEUNE SYNDROME	0.027777800000000002	0.4243310538438419
PENTALOGY OF CANTRELL	0.027777800000000002	0.4243310538438419
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3	0.027777800000000002	0.4243310538438419
NOONAN SYNDROME 10; NS10	0.027777800000000002	0.4243310538438419
IMMUNODEFICIENCY 61; IMD61	0.027777800000000002	0.4243310538438419
LYNCH SYNDROME I	0.027777800000000002	0.4243310538438419
NOONAN SYNDROME 8; NS8	0.027777800000000002	0.4243310538438419
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.027777800000000002	0.4243310538438419
XQ21 MICRODELETION SYNDROME	0.027478554	0.4197598001614568
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.027158450000000004	0.4148699216376131
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.027158450000000004	0.4148699216376131
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.027119374	0.41427300034579007
STICKLER SYNDROME	0.026852360000000002	0.41019411965649644
PELIZAEUS-MERZBACHER DISEASE	0.02677707	0.40904399671501424
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.02662419	0.4067086162488993
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.02651745	0.405078066072597
KEUTEL SYNDROME; KTLS	0.02651745	0.405078066072597
OSTEOGENESIS IMPERFECTA, TYPE I	0.02651745	0.405078066072597
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.02650376	0.4048689389233223
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.02650376	0.4048689389233223
IMMUNODEFICIENCY 55; IMD55	0.026417339999999997	0.4035487951512026
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.02618089	0.3999368072442634
MONOSOMY 22Q13.3	0.026110004	0.3988539593915618
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.02602728	0.3975902753669746
SQUAMOUS CELL CARCINOMA, HEAD AND NECK	0.025641000000000004	0.3916894985063595
ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2	0.025641000000000004	0.3916894985063595
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.025641000000000004	0.3916894985063595
DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS	0.025641000000000004	0.3916894985063595
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.025641000000000004	0.3916894985063595
ESOPHAGEAL CANCER	0.025641000000000004	0.3916894985063595
CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK	0.025641000000000004	0.3916894985063595
CHEILITIS GLANDULARIS	0.025641000000000004	0.3916894985063595
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.025615614000000002	0.391301704363811
ALSTRÖM SYNDROME	0.025583884	0.39081699987538987
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025545554	0.3902314744092322
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.025394913999999998	0.3879303119719248
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.02509854	0.3834029306907609
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.025097389999999997	0.3833853633991856
VELO-FACIAL-SKELETAL SYNDROME	0.025070059999999998	0.3829678728959221
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.02503833	0.382483168407501
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.3818976429413434
HOOFT DISEASE	0.025	0.3818976429413434
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.3818976429413434
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	0.3818976429413434
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.3818976429413434
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.3818976429413434
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.3818976429413434
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.025	0.3818976429413434
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.3818976429413434
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.3818976429413434
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.025	0.3818976429413434
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.3818976429413434
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.3818976429413434
CRISS-CROSS HEART	0.02496664	0.3813880387266024
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.02477325	0.37843383131986535
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.02475956	0.3782247041705907
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.02475956	0.3782247041705907
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.02475956	0.3782247041705907
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.02475956	0.3782247041705907
WITTEVEEN-KOLK SYNDROME	0.024584934	0.3755571338587396
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.02457658	0.3754295189423744
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.024523339999999998	0.37461622972196645
DILATED CARDIOMYOPATHY WITH ATAXIA	0.024523339999999998	0.37461622972196645
BUSCHKE-OLLENDORFF SYNDROME	0.02450188	0.37428840878526565
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.02450113	0.3742769518559774
BREAST CANCER	0.0243902	0.37258239563471807
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.02424475	0.3703605151480853
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02419427	0.36958938742745817
COCKAYNE SYNDROME	0.02416568	0.36915264928299046
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.02396997	0.36616300177498845
FAMILIAL MULTIPLE TRICHOEPITHELIOMA	0.0238095	0.36371167718447656
ROMBO SYNDROME	0.0238095	0.36371167718447656
TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	0.0238095	0.36371167718447656
BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1	0.0238095	0.36371167718447656
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.023801354	0.3635872396565006
11Q22.2Q22.3 MICRODELETION SYNDROME	0.023529984	0.3594418171219009
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.023511729999999998	0.3591629707389308
X-LINKED AGAMMAGLOBULINEMIA	0.02337879	0.3571321918328259
LIG4 SYNDROME	0.023272854	0.35551392348472055
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.023272854	0.35551392348472055
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.023272854	0.35551392348472055
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.023272854	0.35551392348472055
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.02325655	0.35526486511789995
GAPO SYNDROME	0.02325655	0.35526486511789995
CINCA SYNDROME; CINCA	0.0232558	0.3552534081886117
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.0232558	0.3552534081886117
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.0232558	0.3552534081886117
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0232558	0.3552534081886117
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.0232558	0.3552534081886117
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.0232558	0.3552534081886117
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.0232558	0.3552534081886117
USHER SYNDROME, TYPE IV; USH4	0.0232558	0.3552534081886117
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.0232558	0.3552534081886117
DEAFNESS, AUTOSOMAL DOMINANT 70	0.0232558	0.3552534081886117
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0232558	0.3552534081886117
MUCKLE-WELLS SYNDROME	0.0232558	0.3552534081886117
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.0232558	0.3552534081886117
COFFIN-LOWRY SYNDROME; CLS	0.0230935	0.35277412869063646
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.02298443	0.35110798565401197
GAUCHER DISEASE, PERINATAL LETHAL	0.02280659	0.34839131858118444
PRIMARY PERITONEAL CARCINOMA	0.02280167	0.3483161611250536
NEPHROTIC SYNDROME, TYPE 4	0.0227273	0.34718009201683164
ISOLATED HEMIHYPERPLASIA	0.0227273	0.34718009201683164
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.0227273	0.34718009201683164
WILMS TUMOR 1	0.0227273	0.34718009201683164
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0227273	0.34718009201683164
WILMS TUMOR 6	0.0227273	0.34718009201683164
WILMS TUMOR 3	0.0227273	0.34718009201683164
NEUTROPHILIA, HEREDITARY	0.0227273	0.34718009201683164
MULTIPLE TUMOR-ASSOCIATED CHROMOSOME REGION 1	0.0227273	0.34718009201683164
DENYS-DRASH SYNDROME	0.0227273	0.34718009201683164
ALPHA-THALASSEMIA	0.0227273	0.34718009201683164
CHROMOSOME 5Q DELETION SYNDROME	0.0227273	0.34718009201683164
GRAY PLATELET SYNDROME	0.0227273	0.34718009201683164
WILMS TUMOR 5	0.0227273	0.34718009201683164
CAMPOMELIA, CUMMING TYPE	0.0227273	0.34718009201683164
WILMS TUMOR 4	0.0227273	0.34718009201683164
WHITE-SUTTON SYNDROME; WHSUS	0.022624184	0.3456049017228501
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.02261583	0.3454772868064848
NEPHROSIALIDOSIS	0.02255794	0.34459296462448985
MEGAEPIPHYSEAL DWARFISM	0.02255794	0.34459296462448985
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.02252193	0.34404287925959715
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.02252193	0.34404287925959715
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.022455014	0.34302067675259457
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02244973	0.3429399588667825
MARFAN SYNDROME	0.022320740000000002	0.3409695197882624
SILVER-RUSSELL SYNDROME	0.02229226	0.34053446199342363
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.022284654	0.3404182734545352
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.02209577	0.3375328992789618
CAMURATI-ENGELMANN DISEASE	0.02206375	0.33704376477788256
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.02201429	0.33628821848108736
HEPATOCELLULAR CARCINOMA	0.02187503	0.33416089585084696
MALIGNANT PERITONEAL MESOTHELIOMA	0.02187503	0.33416089585084696
PERITONEAL CYSTIC MESOTHELIOMA	0.02187503	0.33416089585084696
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.021822154	0.3333531670601203
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.021757564	0.332366496309817
NON-DISTAL TRISOMY 13Q	0.0217391	0.3320844419866463
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.0217391	0.3320844419866463
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0217391	0.3320844419866463
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0217391	0.3320844419866463
ACROCEPHALOSYNDACTYLY	0.0217391	0.3320844419866463
TEMPI SYNDROME	0.0217391	0.3320844419866463
LUMBAR SYNDROME	0.0217391	0.3320844419866463
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.0217391	0.3320844419866463
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.0217391	0.3320844419866463
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.0217391	0.3320844419866463
KLIPPEL-TRÉNAUNAY SYNDROME	0.0217391	0.3320844419866463
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.0217391	0.3320844419866463
OMODYSPLASIA 1; OMOD1	0.0217391	0.3320844419866463
HISTIOCYTOID CARDIOMYOPATHY	0.02154137	0.3290639371490946
WEAVER SYNDROME	0.021424944	0.3272854245500111
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.021378854	0.3265813580554844
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.0212766	0.3250193355922314
SERTOLI CELL-ONLY SYNDROME	0.0212766	0.3250193355922314
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0212766	0.3250193355922314
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.0212766	0.3250193355922314
BREAST, UNILATERAL GIANT	0.0212766	0.3250193355922314
HERNIA, HIATUS	0.0212766	0.3250193355922314
NIPPLES, SUPERNUMERARY	0.0212766	0.3250193355922314
ACHONDROPLASIA, SO-CALLED, AND SEVERE COMBINED IMMUNODEFICIENCY	0.0212766	0.3250193355922314
CENTRIFUGAL LIPODYSTROPHY	0.0212766	0.3250193355922314
FIBROSCLEROSIS, MULTIFOCAL	0.0212766	0.3250193355922314
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0212766	0.3250193355922314
FASCIAL DYSTROPHY, CONGENITAL	0.0212766	0.3250193355922314
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.0212766	0.3250193355922314
PYLE DISEASE; PYL	0.0212766	0.3250193355922314
GALACTORRHEA	0.0212766	0.3250193355922314
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.0212766	0.3250193355922314
PYCNODYSOSTOSIS	0.0212766	0.3250193355922314
ACROPECTORAL SYNDROME	0.0212766	0.3250193355922314
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0212766	0.3250193355922314
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0212766	0.3250193355922314
FOUNTAIN SYNDROME	0.02113782	0.3228993453967354
PALLISTER-KILLIAN SYNDROME	0.021128900000000003	0.322763084317734
FOLLICULAR LYMPHOMA	0.02108133	0.3220364094827452
CLASSIC HODGKIN LYMPHOMA	0.02108133	0.3220364094827452
HODGKIN LYMPHOMA	0.02108133	0.3220364094827452
FELTY SYNDROME	0.02108133	0.3220364094827452
ENDOCARDIAL FIBROELASTOSIS	0.02093144	0.31974670397472604
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.020902294	0.3193014724266793
11P15.4 MICRODUPLICATION SYNDROME	0.020902294	0.3193014724266793
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	0.31824752658759553
WOODHOUSE-SAKATI SYNDROME	0.0208333	0.31824752658759553
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0208333	0.31824752658759553
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0208333	0.31824752658759553
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0208333	0.31824752658759553
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	0.31824752658759553
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.0208333	0.31824752658759553
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	0.31824752658759553
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.0208333	0.31824752658759553
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	0.31824752658759553
CHROMOSOME 17Q12 DELETION SYNDROME	0.0208333	0.31824752658759553
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	0.31824752658759553
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0208333	0.31824752658759553
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	0.31824752658759553
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0208333	0.31824752658759553
RAMOS-ARROYO SYNDROME	0.0208333	0.31824752658759553
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	0.31824752658759553
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	0.31824752658759553
ISOTRETINOIN-LIKE SYNDROME	0.0208333	0.31824752658759553
WOLMAN DISEASE	0.020569424000000003	0.314216581690444
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.02038535	0.31140468462137255
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02037166	0.3111955574720978
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.020179614	0.3082618808826453
SYSTEMIC SCLEROSIS	0.02002387	0.305882750222555
SHPRINTZEN OMPHALOCELE SYNDROME	0.019815299999999997	0.302696654567024
MULTIPLE CARBOXYLASE DEFICIENCY	0.019695614	0.3008683425153009
GORLIN SYNDROME	0.01969456	0.3008522417106745
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01963936	0.30000901171506006
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.01963406	0.2999280494147564
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.019588314	0.29922923783179667
CLASSIC GALACTOSEMIA	0.01941514	0.2965838481350477
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019413454	0.2965580929580077
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	0.2965580929580077
BAND HETEROTOPIA; BH	0.019413454	0.2965580929580077
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.01940872	0.2964857768203404
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.019051044	0.29102195196687286
COHEN-GIBSON SYNDROME; COGIS	0.018994784	0.29016252951119764
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.28822426149011887
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.28822426149011887
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.28822426149011887
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.28822426149011887
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.28822426149011887
TRACHEOBRONCHOMEGALY	0.0188679	0.28822426149011887
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.28822426149011887
VESICOURETERAL REFLUX 1	0.0188679	0.28822426149011887
THROMBOCYTOPENIA 3	0.0188679	0.28822426149011887
PUBIC BONE DYSPLASIA	0.0188679	0.28822426149011887
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.28822426149011887
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.28822426149011887
RAYNAUD DISEASE	0.0188679	0.28822426149011887
HHHH SYNDROME	0.0188679	0.28822426149011887
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.28822426149011887
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.28822426149011887
LETTERER-SIWE DISEASE	0.0188679	0.28822426149011887
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.28822426149011887
SPINAL ARACHNOIDITIS	0.0188679	0.28822426149011887
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.28822426149011887
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.28822426149011887
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.28822426149011887
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.28822426149011887
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.28822426149011887
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.28822426149011887
TOE, MISSHAPEN	0.0188679	0.28822426149011887
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.28822426149011887
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.28822426149011887
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.28822426149011887
VAN DEN BOSCH SYNDROME	0.0188679	0.28822426149011887
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.28822426149011887
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.28822426149011887
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.28822426149011887
CARPAL DISPLACEMENT	0.0188679	0.28822426149011887
KNUCKLE PADS	0.0188679	0.28822426149011887
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.28822426149011887
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.28822426149011887
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.28822426149011887
MONOPHALANGY OF GREAT TOE	0.0188679	0.28822426149011887
CORNELIA DE LANGE SYNDROME 1	0.01883946	0.2877898147315088
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.018764974	0.28665197361822364
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.01875885	0.28655842397160874
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.018729704	0.286113192423562
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.018716014	0.2859040652742873
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.018557824	0.2834875697488117
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.01850549	0.28268812049898395
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.01850549	0.28268812049898395
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.018457584	0.28195631295967405
LYSOSOMAL ACID LIPASE DEFICIENCY	0.018450514	0.28184831230625024
NEU-LAXOVA SYNDROME	0.01844923	0.2818286980433088
RENPENNING SYNDROME	0.018420520000000003	0.281390126790155
MENTAL RETARDATION, X-LINKED 102	0.01836539	0.2805479661079407
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.01817046	0.27757023380639845
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.01817046	0.27757023380639845
MCDONOUGH SYNDROME	0.01810159	0.27651818217962365
ATAXIA-TELANGIECTASIA	0.01791203	0.2736224814917852
MOMO SYNDROME	0.01791203	0.2736224814917852
INTELLECTUAL DISABILITY, WOLFF TYPE	0.01791203	0.2736224814917852
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.01791203	0.2736224814917852
AASE-SMITH SYNDROME	0.01791203	0.2736224814917852
MICROSPORIDIOSIS	0.01790496	0.2735144808383614
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.01790496	0.2735144808383614
CORNELIA DE LANGE SYNDROME	0.017789350000000002	0.2717484333783435
48,XXYY SYNDROME	0.017663883999999998	0.26983182659157223
CENTRAL DIABETES INSIPIDUS	0.01763261	0.2693540879161584
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.01763261	0.2693540879161584
RIFT VALLEY FEVER	0.01763261	0.2693540879161584
MARBURG HEMORRHAGIC FEVER	0.01763261	0.2693540879161584
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.017393494	0.26570137444457587
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.017393494	0.26570137444457587
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.017393494	0.26570137444457587
EEC SYNDROME	0.017376759999999998	0.2654457474382967
ALCOHOL DEPENDENCE	0.0172414	0.2633780008403551
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.2633780008403551
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.2633780008403551
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.2633780008403551
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.2633780008403551
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.2633780008403551
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.2633780008403551
PALMOMENTAL REFLEX	0.0172414	0.2633780008403551
269800 SENILE PLAQUE FORMATION	0.0172414	0.2633780008403551
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.2633780008403551
MOTION SICKNESS	0.0172414	0.2633780008403551
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.2633780008403551
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.2633780008403551
ERYTHERMALGIA, PRIMARY	0.0172414	0.2633780008403551
MYOPATHY, CONGENITAL	0.0172414	0.2633780008403551
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.2633780008403551
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.2633780008403551
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.2633780008403551
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.2633780008403551
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.2633780008403551
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.2633780008403551
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.2633780008403551
CARDIAC ARRHYTHMIA	0.0172414	0.2633780008403551
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.2633780008403551
SICKLE CELL ANEMIA	0.0172414	0.2633780008403551
DIASTEMATOMYELIA	0.0172414	0.2633780008403551
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.2633780008403551
TRANSSEXUALITY	0.0172414	0.2633780008403551
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.2633780008403551
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.2633780008403551
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.2633780008403551
JUMPING FRENCHMAN OF MAINE	0.0172414	0.2633780008403551
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.2633780008403551
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.2633780008403551
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.2633780008403551
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.2633780008403551
MOSAIC TRISOMY 15	0.0172414	0.2633780008403551
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.2633780008403551
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.2633780008403551
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.2633780008403551
CERVICAL RIB	0.0172414	0.2633780008403551
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.2633780008403551
RHEUMATOID ARTHRITIS	0.0172414	0.2633780008403551
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.2633780008403551
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.2633780008403551
TRISOMY 12P	0.017212254	0.26293276929230835
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.017212254	0.26293276929230835
HOYERAAL-HREIDARSSON SYNDROME	0.017212254	0.26293276929230835
DISTAL TRISOMY 18Q	0.017212254	0.26293276929230835
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.017212254	0.26293276929230835
WEAVER SYNDROME	0.017212254	0.26293276929230835
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.017212254	0.26293276929230835
19Q13.11 MICRODELETION SYNDROME	0.01718888	0.2625757102720639
SHORT STATURE DUE TO GHSR DEFICIENCY	0.017173960000000002	0.2623477937587565
PETERS-PLUS SYNDROME; PTRPLS	0.017003434	0.2597428546603479
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.017003434	0.2597428546603479
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.01685626	0.25749463851225796
RETT SYNDROME; RTT	0.01685626	0.25749463851225796
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.01685626	0.25749463851225796
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.016716924	0.25536615491318293
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0166667	0.2545989378244195
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.0166667	0.2545989378244195
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0166667	0.2545989378244195
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0166667	0.2545989378244195
INTESTINAL LYMPHANGIECTASIA	0.0166667	0.2545989378244195
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0166667	0.2545989378244195
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	0.2545989378244195
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0166667	0.2545989378244195
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0166667	0.2545989378244195
HURIEZ SYNDROME; HRZ	0.0166667	0.2545989378244195
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.0166667	0.2545989378244195
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	0.2545989378244195
ICHTHYOSIS, X-LINKED	0.0166667	0.2545989378244195
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	0.2545989378244195
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0166667	0.2545989378244195
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	0.2545989378244195
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.0166667	0.2545989378244195
NASOPHARYNGEAL CARCINOMA	0.0166667	0.2545989378244195
ACQUIRED PURPURA FULMINANS	0.0166667	0.2545989378244195
DERMATOLEUKODYSTROPHY	0.0166667	0.2545989378244195
CHYLOUS ASCITES	0.0166667	0.2545989378244195
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0166667	0.2545989378244195
TRIGEMINAL NEURALGIA	0.0166667	0.2545989378244195
PITYRIASIS RUBRA PILARIS	0.0166667	0.2545989378244195
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.0166667	0.2545989378244195
TETRASOMY 18P	0.0166667	0.2545989378244195
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.0166667	0.2545989378244195
KYPHOMELIC DYSPLASIA	0.0166667	0.2545989378244195
ANTISYNTHETASE SYNDROME	0.0166667	0.2545989378244195
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0166667	0.2545989378244195
49,XYYYY SYNDROME	0.0166667	0.2545989378244195
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0166667	0.2545989378244195
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0166667	0.2545989378244195
ONCOCYTOMA	0.0166667	0.2545989378244195
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0166667	0.2545989378244195
ADAMANTINOMA OF LONG BONES	0.0166667	0.2545989378244195
PAGET DISEASE, EXTRAMAMMARY	0.0166667	0.2545989378244195
CINCA SYNDROME	0.016587644	0.25339128582200465
MEIER-GORLIN SYNDROME 7	0.016466234	0.25153663810882426
PIERPONT SYNDROME	0.016466234	0.25153663810882426
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.016452544	0.2513275109595496
SPONDYLOOCULAR SYNDROME; SOS	0.01644419	0.2511998960431844
CHÉDIAK-HIGASHI SYNDROME	0.016418554	0.25080828292420654
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01628559	0.24877713739636445
TRISOMY 18	0.016216984	0.24772911860869912
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.01609037	0.2457949750821641
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.015951904000000003	0.2436797815210635
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.015938214000000003	0.2434706543717888
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.015872999999999998	0.24247445145631769
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.015872999999999998	0.24247445145631769
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.015872999999999998	0.24247445145631769
LYMPHOMA, NON-HODGKIN, FAMILIAL	0.015872999999999998	0.24247445145631769
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.015872999999999998	0.24247445145631769
AUTOIMMUNE HEMOLYTIC ANEMIA	0.015872999999999998	0.24247445145631769
FOLLICULAR LYMPHOMA	0.015872999999999998	0.24247445145631769
THYROID LYMPHOMA	0.015872999999999998	0.24247445145631769
SCHNITZLER SYNDROME	0.015872999999999998	0.24247445145631769
ALPHA-HEAVY CHAIN DISEASE	0.015872999999999998	0.24247445145631769
OMENN SYNDROME	0.015872999999999998	0.24247445145631769
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.015872999999999998	0.24247445145631769
MCDONOUGH SYNDROME	0.01574744	0.24055640873440914
HYPERCALCEMIA, INFANTILE, 1	0.015513700000000002	0.23698581853196476
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.0155137	0.2369858185319647
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.015471593999999998	0.23634261124581718
XFE PROGEROID SYNDROME; XFEPS	0.015406350000000001	0.23534595005317463
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.015406350000000001	0.23534595005317463
MOYNAHAN SYNDROME	0.01539266	0.23513682290389992
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.01539266	0.23513682290389992
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.01539266	0.23513682290389992
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.015220904	0.2325130944414586
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.015207214	0.23230396729218392
TETRASOMY 12P	0.01513423	0.23118907058928667
CHRISTIANSON SYNDROME	0.01513423	0.23118907058928667
PEDIATRIC-ONSET GRAVES DISEASE	0.015083884	0.23041998984002568
TRANSKETOLASE DEFICIENCY	0.015081534	0.2303840914615892
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.014948784	0.22835621497757064
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.014948784	0.22835621497757064
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.014948784	0.22835621497757064
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.01492604	0.22800877977792833
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.01492604	0.22800877977792833
GALACTOSEMIA	0.014752364	0.2253557215765091
MARSHALL-SMITH SYNDROME; MRSHSS	0.01467535	0.22417926297356972
OROFACIODIGITAL SYNDROME XVII	0.01467535	0.22417926297356972
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.01466166	0.22397013582429504
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.01466166	0.22397013582429504
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.014530643999999999	0.2219687477607909
JOUBERT SYNDROME 21	0.014530643999999999	0.2219687477607909
COFFIN-SIRIS SYNDROME 6; CSS6	0.014437554	0.2205467136975345
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.014434454000000001	0.2204993583898098
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.014434454000000001	0.2204993583898098
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.014434454000000001	0.2204993583898098
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.014413394	0.220177647815396
KAGAMI-OGATA SYNDROME	0.014296504000000002	0.2183920471960595
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.014171194	0.21647782345058028
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.013998779999999999	0.2138440434421767
LASSA FEVER	0.01394173	0.21297255302098458
SUSAC SYNDROME	0.01392804	0.21276342587170988
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.013888900000000001	0.21216552692192095
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.013888900000000001	0.21216552692192095
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.013888900000000001	0.21216552692192095
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.013888900000000001	0.21216552692192095
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.013888900000000001	0.21216552692192095
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.013888900000000001	0.21216552692192095
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.013888900000000001	0.21216552692192095
MAJEED SYNDROME	0.013888900000000001	0.21216552692192095
WHIPPLE DISEASE	0.013888900000000001	0.21216552692192095
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.013888900000000001	0.21216552692192095
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.013888900000000001	0.21216552692192095
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.013888900000000001	0.21216552692192095
SECKEL SYNDROME	0.013888900000000001	0.21216552692192095
BETHLEM MYOPATHY	0.013888900000000001	0.21216552692192095
FRYNS-SMEETS-THIRY SYNDROME	0.013888900000000001	0.21216552692192095
MULIBREY NANISM	0.013888900000000001	0.21216552692192095
RING CHROMOSOME 10 SYNDROME	0.013888900000000001	0.21216552692192095
INFANTILE NEUROAXONAL DYSTROPHY	0.013888900000000001	0.21216552692192095
IDIOPATHIC BRONCHIECTASIS	0.013888900000000001	0.21216552692192095
RESTRICTIVE DERMOPATHY, LETHAL	0.013750950000000001	0.2100582157281706
N-ACETYLASPARTATE DEFICIENCY; NACED	0.013703454	0.20933267131020492
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.013703454	0.20933267131020492
ALAZAMI SYNDROME; ALAZS	0.013703454	0.20933267131020492
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.013703454	0.20933267131020492
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.013703454	0.20933267131020492
FORSYTHE-WAKELING SYNDROME; FWS	0.013703454	0.20933267131020492
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.013703454	0.20933267131020492
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.013703454	0.20933267131020492
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.013703454	0.20933267131020492
AL KAISSI SYNDROME; ALKAS	0.013703454	0.20933267131020492
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.013703454	0.20933267131020492
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.013703454	0.20933267131020492
GALACTOSE EPIMERASE DEFICIENCY	0.013671384	0.20884277301383974
WILLIAMS SYNDROME	0.01363395	0.20827093475920513
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.013600014	0.20775253162277083
ISOLATED COMPLEX I DEFICIENCY	0.013600014	0.20775253162277083
KLEEFSTRA SYNDROME	0.013299004	0.20315433124269985
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.013299004	0.20315433124269985
BARDET-BIEDL SYNDROME 16; BBS16	0.013299004	0.20315433124269985
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.01328621	0.2029588913049482
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.013285314	0.20294520409342517
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.01325773	0.20252383351010944
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.0131579	0.20099883984231606
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0131579	0.20099883984231606
SECKEL SYNDROME 4	0.0131579	0.20099883984231606
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0131579	0.20099883984231606
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0131579	0.20099883984231606
GRANGE SYNDROME; GRNG	0.0131579	0.20099883984231606
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0131579	0.20099883984231606
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0131579	0.20099883984231606
WEAVER-WILLIAMS SYNDROME	0.0131579	0.20099883984231606
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.0131579	0.20099883984231606
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.0131579	0.20099883984231606
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0131579	0.20099883984231606
FG SYNDROME 2; FGS2	0.0131579	0.20099883984231606
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.0131579	0.20099883984231606
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0131579	0.20099883984231606
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0131579	0.20099883984231606
OVARIAN DYSGENESIS 4; ODG4	0.0131579	0.20099883984231606
FILIPPI SYNDROME; FLPIS	0.0131579	0.20099883984231606
ALG13-CDG	0.0131579	0.20099883984231606
MEIER-GORLIN SYNDROME 8; MGORS8	0.0131579	0.20099883984231606
CHOREOACANTHOCYTOSIS	0.013125830000000002	0.20050894154595092
MALIGNANT ATROPHIC PAPULOSIS	0.013125830000000002	0.20050894154595092
BEHÇET DISEASE	0.013125830000000002	0.20050894154595092
CYCLIC VOMITING SYNDROME	0.01306815	0.19962782730415665
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.013026883999999999	0.1989974517788119
JOUBERT SYNDROME 14	0.013026883999999999	0.1989974517788119
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.01301853	0.19886983686244666
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.01301853	0.19886983686244666
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.012969834	0.19812596135761976
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.012969834	0.19812596135761976
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.012969834	0.19812596135761976
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.012969834	0.19812596135761976
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.012964974	0.19805172045583203
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.012964974	0.19805172045583203
GRANULOMATOSIS WITH POLYANGIITIS	0.01284706	0.19625047730904058
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.012638954	0.19307146967376254
MARFAN SYNDROME; MFS	0.012594600000000001	0.19239392215156173
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.012594600000000001	0.19239392215156173
MOWAT-WILSON SYNDROME; MOWS	0.0125084	0.19107713907869994
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.012481329999999999	0.19066362031092304
DENGUE FEVER	0.01242428	0.1897921298897309
FAMILIAL HYPOALDOSTERONISM	0.01242428	0.1897921298897309
LUJO HEMORRHAGIC FEVER	0.01242428	0.1897921298897309
CENTRAL NEUROCYTOMA	0.01242428	0.1897921298897309
EBOLA HEMORRHAGIC FEVER	0.01242428	0.1897921298897309
YELLOW FEVER	0.01242428	0.1897921298897309
SCRUB TYPHUS	0.01242428	0.1897921298897309
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.01241942	0.18971788898794315
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.01241942	0.18971788898794315
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.012354684000000001	0.18872898795540513
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.012354684000000001	0.18872898795540513
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.01232952	0.18834458506392604
CONGENITAL MYASTHENIC SYNDROME	0.01231583	0.18813545791465136
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.01231583	0.18813545791465136
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.01231583	0.18813545791465136
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.012182454	0.1860980187136536
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.012109734	0.18498715484986583
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.012096254	0.18478123564079185
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.012096254	0.18478123564079185
HEREDITARY FRUCTOSE INTOLERANCE	0.012087900000000002	0.1846536207244266
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0120574	0.1841877056000381
JACOBSEN SYNDROME	0.011976773999999999	0.18295607042564657
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0119173	0.18204755120899482
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.011822820000000001	0.18060428363679093
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.011822820000000001	0.18060428363679093
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.011781554	0.1799739081114462
JOUBERT SYNDROME 7	0.011781554	0.1799739081114462
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.011781554	0.1799739081114462
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.011781554	0.1799739081114462
JOUBERT SYNDROME 2	0.011781554	0.1799739081114462
JOUBERT SYNDROME 1	0.011781554	0.1799739081114462
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.011781554	0.1799739081114462
BARDET-BIEDL SYNDROME 17; BBS17	0.011781554	0.1799739081114462
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.011781554	0.1799739081114462
ACROOSTEOLYSIS DOMINANT TYPE	0.01173182	0.17921417621648442
SIALIDOSIS TYPE 1	0.01171813	0.17900504906720974
ACROOTOOCULAR SYNDROME	0.01170572	0.17881547507725365
YUNIS-VARON SYNDROME	0.01170334	0.17877911842164562
MEVALONIC ACIDURIA; MEVA	0.011691734000000002	0.1786018262598866
PMM2-CDG	0.011691734000000002	0.1786018262598866
ZELLWEGER SYNDROME	0.01168965	0.17856999127237094
SHPRINTZEN-GOLDBERG SYNDROME	0.01156418	0.17665332338197695
ADAMS-OLIVER SYNDROME	0.011431219999999999	0.1746222389577577
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.011357624	0.17349799340056127
CASTLEMAN DISEASE	0.0113433	0.1732791813270616
ACUTE ADRENAL INSUFFICIENCY	0.0113433	0.1732791813270616
TOXIC EPIDERMAL NECROLYSIS	0.0113433	0.1732791813270616
STEVENS-JOHNSON SYNDROME	0.0113433	0.1732791813270616
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.0113433	0.1732791813270616
ERDHEIM-CHESTER DISEASE	0.0113433	0.1732791813270616
NODULAR NON-SUPPURATIVE PANNICULITIS	0.0113433	0.1732791813270616
PFAPA SYNDROME	0.0113433	0.1732791813270616
PSEUDOMYXOMA PERITONEI	0.0113433	0.1732791813270616
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.0113433	0.1732791813270616
NEPHRONOPHTHISIS 20	0.011236	0.17164007664355732
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.011236	0.17164007664355732
MECKEL SYNDROME, TYPE 4; MKS4	0.011236	0.17164007664355732
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.011236	0.17164007664355732
ALAGILLE SYNDROME 2	0.011236	0.17164007664355732
CONGENITAL MEGACALYCOSIS	0.011236	0.17164007664355732
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.011236	0.17164007664355732
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.011236	0.17164007664355732
AXIAL OSTEOMALACIA	0.011236	0.17164007664355732
FRYNS SYNDROME; FRNS	0.011236	0.17164007664355732
BARDET-BIEDL SYNDROME 10; BBS10	0.011236	0.17164007664355732
MECKEL SYNDROME, TYPE 10; MKS10	0.011236	0.17164007664355732
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.011236	0.17164007664355732
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.011236	0.17164007664355732
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.011236	0.17164007664355732
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.011236	0.17164007664355732
GENITOPALATOCARDIAC SYNDROME	0.011236	0.17164007664355732
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.011236	0.17164007664355732
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.011236	0.17164007664355732
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.011236	0.17164007664355732
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.011236	0.17164007664355732
BARDET-BIEDL SYNDROME 6; BBS6	0.011236	0.17164007664355732
BARDET-BIEDL SYNDROME 4; BBS4	0.011236	0.17164007664355732
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.011236	0.17164007664355732
MECKEL SYNDROME, TYPE 6; MKS6	0.011236	0.17164007664355732
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.011236	0.17164007664355732
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.011236	0.17164007664355732
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.011236	0.17164007664355732
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3; CAKUT3	0.011236	0.17164007664355732
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.011219014	0.17138060010903727
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01119462	0.17100795966496085
19P13.12 MICRODELETION SYNDROME	0.011116374	0.1698126811461773
STICKLER SYNDROME, TYPE I	0.01110802	0.16968506622981203
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.01099799	0.16800425832369856
13Q12.3 MICRODELETION SYNDROME	0.010881100000000001	0.16621865770436206
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.010867410000000001	0.16600953055508738
BARATELA-SCOTT SYNDROME	0.010864404000000001	0.1659636111825001
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDURIA, CBLA TYPE	0.010850924000000001	0.16575769197342613
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010850924000000001	0.16575769197342613
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.010850924000000001	0.16575769197342613
CITRULLINEMIA, CLASSIC	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.010850924000000001	0.16575769197342613
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010850924000000001	0.16575769197342613
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDURIA, CBLB TYPE	0.010850924000000001	0.16575769197342613
ARGININOSUCCINIC ACIDURIA	0.010850924000000001	0.16575769197342613
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.010850924000000001	0.16575769197342613
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.010850924000000001	0.16575769197342613
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.010850924000000001	0.16575769197342613
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.010850924000000001	0.16575769197342613
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.010850924000000001	0.16575769197342613
PROPIONIC ACIDEMIA	0.010850924000000001	0.16575769197342613
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.010828514000000001	0.1654153589262935
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010828514000000001	0.1654153589262935
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01081207	0.1651641619326724
LOEYS-DIETZ SYNDROME 5	0.01081207	0.1651641619326724
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.01081207	0.1651641619326724
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.01081207	0.1651641619326724
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.01081207	0.1651641619326724
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.01081207	0.1651641619326724
RICHIERI COSTA-DA SILVA SYNDROME	0.01081207	0.1651641619326724
LARSEN-LIKE SYNDROME	0.010747514	0.16417801056316353
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.010731444	0.16393252675828085
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.010524904	0.16077744119135665
SIALIDOSIS TYPE 2	0.010494844	0.16031824746548395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.010466364	0.15988318967064521
CONGENITAL TOXOPLASMOSIS	0.010466364	0.15988318967064521
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.010305370000000001	0.15742386050553728
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.010305370000000001	0.15742386050553728
CITRULLINEMIA TYPE I	0.010305370000000001	0.15742386050553728
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.010305370000000001	0.15742386050553728
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010305370000000001	0.15742386050553728
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.010305370000000001	0.15742386050553728
LYSINURIC PROTEIN INTOLERANCE	0.010305370000000001	0.15742386050553728
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.010305370000000001	0.15742386050553728
INFANTILE LIVER FAILURE SYNDROME 2	0.010305370000000001	0.15742386050553728
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.010305370000000001	0.15742386050553728
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.010305370000000001	0.15742386050553728
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010305370000000001	0.15742386050553728
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.010305370000000001	0.15742386050553728
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.010305370000000001	0.15742386050553728
CLASSIC HOMOCYSTINURIA	0.01021437	0.15603375308523076
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.01020196	0.15584417909527468
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.010194244	0.15572631020675726
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.01018589	0.15559869529039197
GIANT CELL ARTERITIS	0.0100627	0.15371685646503425
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00997935	0.15244360972346777
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00994929	0.1519844159975951
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00994929	0.1519844159975951
SPONDYLOPERIPHERAL DYSPLASIA	0.0099356	0.15177528884832042
CHROMOSOME 1P36 DELETION SYNDROME	0.009931544	0.15171332977472965
CORNEODERMATOOSSEOUS SYNDROME	0.00992081	0.15154935820275633
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00990712	0.15134023105348166
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00990712	0.15134023105348166
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00990712	0.15134023105348166
LATERAL MENINGOCELE SYNDROME	0.009871043999999999	0.15078913747881156
CROUZON DISEASE	0.00978974	0.14954714524034346
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.009677169999999999	0.14782753653370717
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.009677169999999999	0.14782753653370717
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.009677169999999999	0.14782753653370717
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00960426	0.14671377024783303
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00958929	0.14648508993923978
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.009583184	0.14639181525892775
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.009583184	0.14639181525892775
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.009583184	0.14639181525892775
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.009583184	0.14639181525892775
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.009583184	0.14639181525892775
SSR4-CDG	0.009496984	0.14507503218606604
RIDDLE SYNDROME	0.009443924	0.1442644926286873
ACRO-RENAL-OCULAR SYNDROME	0.00938599	0.14337949830684077
PANCREATOBLASTOMA	0.009224389999999999	0.1409109119428679
RAT-BITE FEVER	0.009224389999999999	0.1409109119428679
TSH-SECRETING PITUITARY ADENOMA	0.009224389999999999	0.1409109119428679
CRYPTOSPORIDIOSIS	0.009224389999999999	0.1409109119428679
BETA-KETOTHIOLASE DEFICIENCY	0.009224389999999999	0.1409109119428679
SECONDARY SHORT BOWEL SYNDROME	0.009224389999999999	0.1409109119428679
EOSINOPHILIC GASTROENTERITIS	0.009224389999999999	0.1409109119428679
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.009193124	0.14043329547469977
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00915452	0.13984358441037545
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00915452	0.13984358441037545
ALEXANDER DISEASE	0.00910233	0.13904633489097112
CEREBROFACIOARTICULAR SYNDROME	0.009089963999999999	0.13885743304086656
MARINESCO-SJÖGREN SYNDROME	0.009037894000000001	0.1380620166301484
COG1-CDG	0.00903763	0.13805798379103892
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00903763	0.13805798379103892
JABERI-ELAHI SYNDROME; JABELS	0.008985484	0.13726140641148613
SRD5A3-CDG	0.008985484	0.13726140641148613
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.008977394	0.1371378243342303
RUVALCABA SYNDROME	0.008977394	0.1371378243342303
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.008977394	0.1371378243342303
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.008977394	0.1371378243342303
MARDEN-WALKER SYNDROME	0.008977394	0.1371378243342303
PRADER-WILLI SYNDROME	0.00895143	0.13674120071817716
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	0.13670276653939156
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.13670276653939156
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.13670276653939156
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008948914	0.13670276653939156
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.008948914	0.13670276653939156
ROIFMAN SYNDROME; RFMN	0.008948914	0.13670276653939156
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008948914	0.13670276653939156
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.13670276653939156
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008948914	0.13670276653939156
TYSHCHENKO SYNDROME	0.008948914	0.13670276653939156
GALLOWAY-MOWAT SYNDROME	0.008948914	0.13670276653939156
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.008948914	0.13670276653939156
HENNEKAM-BEEMER SYNDROME	0.00887043	0.13550385235504722
16P13.2 MICRODELETION SYNDROME	0.008720404000000001	0.1332120693238505
CODAS SYNDROME	0.008686214000000001	0.13268978610736393
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.008642234	0.1320179517739015
DYSTONIA, JUVENILE-ONSET	0.00863388	0.13189033685753623
WAARDENBURG SYNDROME	0.00854441	0.13052360157297774
CLASSIC PHENYLKETONURIA	0.008463054000000001	0.1292808149874123
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.008448284	0.12905518985996256
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.008448284	0.12905518985996256
ACRO-RENAL-MANDIBULAR SYNDROME	0.00843184	0.12880399286634145
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00843184	0.12880399286634145
OSTEOGENESIS IMPERFECTA, TYPE IX	0.00843184	0.12880399286634145
MARFANOID HABITUS WITH SITUS INVERSUS	0.00843184	0.12880399286634145
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00843184	0.12880399286634145
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00843184	0.12880399286634145
RETINOPATHY OF PREMATURITY	0.00840336	0.12836893507150268
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.12836893507150268
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.12836893507150268
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.12836893507150268
EBSTEIN MALFORMATION	0.00840336	0.12836893507150268
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.12836893507150268
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.12836893507150268
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.12836893507150268
HYDROLETHALUS	0.00840336	0.12836893507150268
GMS SYNDROME	0.00840336	0.12836893507150268
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.12836893507150268
TEMPLE SYNDROME	0.00840336	0.12836893507150268
SCHISIS ASSOCIATION	0.00840336	0.12836893507150268
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.12836893507150268
HEC SYNDROME	0.00840336	0.12836893507150268
NEMALINE MYOPATHY 10	0.00840336	0.12836893507150268
CONGENITAL ANALBUMINEMIA	0.00840336	0.12836893507150268
DISTAL MONOSOMY 17Q	0.00840336	0.12836893507150268
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.12836893507150268
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.12836893507150268
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.12836893507150268
FATCO SYNDROME	0.00840336	0.12836893507150268
PEMPHIGOID GESTATIONIS	0.00840336	0.12836893507150268
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.12836893507150268
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.12836893507150268
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.12836893507150268
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.12836893507150268
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.12836893507150268
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00840336	0.12836893507150268
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.12836893507150268
OMPHALOCELE	0.00840336	0.12836893507150268
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.12836893507150268
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.12836893507150268
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.12836893507150268
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.12836893507150268
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.12836893507150268
RENAL TUBULAR DYSGENESIS	0.00840336	0.12836893507150268
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.12836893507150268
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.12836893507150268
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.12836893507150268
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.12836893507150268
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.12836893507150268
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.12836893507150268
TEMPLE SYNDROME	0.00840336	0.12836893507150268
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.12836893507150268
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.12836893507150268
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.12836893507150268
INCONTINENTIA PIGMENTI; IP	0.00837545	0.12794258454292295
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.008368800000000001	0.12784099976990057
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.008352314	0.12758916118823932
BIOTINIDASE DEFICIENCY	0.008352314	0.12758916118823932
SEVERE CANAVAN DISEASE	0.008352314	0.12758916118823932
MEIER-GORLIN SYNDROME 1; MGORS1	0.00822726	0.12567884807462387
NOONAN SYNDROME	0.00821357	0.12546972092534917
WYBURN-MASON SYNDROME	0.008197974	0.12523147789977665
WOLCOTT-RALLISON SYNDROME	0.00817569	0.12489106961676444
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.008149014	0.1244835695558403
RETINITIS PIGMENTOSA	0.008140660000000001	0.12435595463947506
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00811037	0.12389324745528732
WILLIAMS-BEUREN SYNDROME; WBS	0.00809668	0.12368412030601263
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.008080194	0.12343228172435139
COFFIN-SIRIS SYNDROME	0.008058224	0.12309667007573452
OCULODENTODIGITAL DYSPLASIA	0.00788223	0.12040820232486178
CEREBROCOSTOMANDIBULAR SYNDROME	0.00782173	0.11948401002894375
LATERAL MENINGOCELE SYNDROME	0.00782173	0.11948401002894375
ACHONDROPLASIA	0.00782173	0.11948401002894375
CRIGLER-NAJJAR SYNDROME	0.00780676	0.11925532972035047
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00779307	0.11904620257107577
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.007792564	0.11903847296278265
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007792564	0.11903847296278265
3Q29 MICRODELETION SYNDROME	0.007792564	0.11903847296278265
SAUL-WILSON SYNDROME; SWILS	0.007792564	0.11903847296278265
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.0077061000000000004	0.11771765705081143
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.0077061000000000004	0.11771765705081143
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0077061000000000004	0.11771765705081143
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0077061000000000004	0.11771765705081143
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0077061000000000004	0.11771765705081143
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.0077061000000000004	0.11771765705081143
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0077061000000000004	0.11771765705081143
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00763873	0.1166885192826131
FAMILIAL COLD URTICARIA	0.00763873	0.1166885192826131
SAETHRE-CHOTZEN SYNDROME	0.00760346	0.11614973808795145
KABUKI SYNDROME	0.00760346	0.11614973808795145
HEMIFACIAL MICROSOMIA	0.00760346	0.11614973808795145
CHROMOSOME 18Q DELETION SYNDROME	0.00760346	0.11614973808795145
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.007535574	0.11511271795240281
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.007527484	0.114989135875147
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.007527484	0.114989135875147
OPITZ G/BBB SYNDROME	0.007513794	0.11478000872587231
COCKAYNE SYNDROME A; CSA	0.00749898	0.11455371145857099
YOU-HOOVER-FONG SYNDROME; YHFS	0.007410594	0.11320353525581045
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.007410594	0.11320353525581045
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.007410594	0.11320353525581045
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.007396904	0.11299440810653577
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.007396904	0.11299440810653577
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0073107039999999995	0.11167762503367401
PERMANENT NEONATAL DIABETES MELLITUS	0.007271334	0.11107621262556999
TRANSIENT NEONATAL DIABETES MELLITUS	0.007271334	0.11107621262556999
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.007263454	0.11095583848851488
KRABBE DISEASE	0.007257644	0.11086708547629531
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.007255364	0.11083225641125906
LAMB-SHAFFER SYNDROME	0.007255364	0.11083225641125906
MARTSOLF SYNDROME	0.00724701	0.11070464149489379
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.007202954	0.11003164619259682
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.007202954	0.11003164619259682
KLEEFSTRA SYNDROME 2; KLEFS2	0.007202953999999999	0.11003164619259682
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0071824540000000004	0.10971849012538493
PETERS PLUS SYNDROME	0.0071824540000000004	0.10971849012538493
CK SYNDROME	0.0071384740000000006	0.10904665579192252
RAHMAN SYNDROME	0.0071384740000000006	0.10904665579192252
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.0071384740000000006	0.10904665579192252
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00713012	0.10891904087555725
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00713012	0.10891904087555725
8P23.1 MICRODELETION SYNDROME	0.006999214	0.10691933316168206
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006998374	0.10690650140087923
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.006998374	0.10690650140087923
SARCOIDOSIS	0.00699086	0.10679171824531676
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.0069900200000000004	0.10677888648451396
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.006984684	0.10669737425160455
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.006984684	0.10669737425160455
POSTENCEPHALITIC PARKINSONISM	0.006983420000000001	0.10667806550677744
JUVENILE PAGET DISEASE	0.00698193	0.10665530440725814
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00698193	0.10665530440725814
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.006903684	0.1054600258884746
IMMUNODEFICIENCY 23; IMD23	0.006903684	0.1054600258884746
DISTAL MONOSOMY 19P13.3	0.006903684	0.1054600258884746
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.006903684	0.1054600258884746
MUCOPOLYSACCHARIDOSIS TYPE 2	0.006903684	0.1054600258884746
CAMPOMELIC DYSPLASIA	0.00686504	0.1048697037879216
MICROPHTHALMIA, SYNDROMIC 1	0.00686504	0.1048697037879216
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00686504	0.1048697037879216
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00686504	0.1048697037879216
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00685135	0.10466057663864689
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00685135	0.10466057663864689
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00685135	0.10466057663864689
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00685135	0.10466057663864689
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.006834864	0.10440873805698567
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.006834864	0.10440873805698567
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.006834864	0.10440873805698567
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.006834864	0.10440873805698567
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.006834864	0.10440873805698567
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.006834864	0.10440873805698567
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.006834864	0.10440873805698567
GABA-TRANSAMINASE DEFICIENCY	0.006834864	0.10440873805698567
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.006834864	0.10440873805698567
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.006834864	0.10440873805698567
EARLY MYOCLONIC ENCEPHALOPATHY	0.006834864	0.10440873805698567
OGDEN SYNDROME	0.006834864	0.10440873805698567
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.006834864	0.10440873805698567
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.006834864	0.10440873805698567
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.006834864	0.10440873805698567
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.006834864	0.10440873805698567
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.006834864	0.10440873805698567
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.006834864	0.10440873805698567
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.006834864	0.10440873805698567
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.006834864	0.10440873805698567
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.006834864	0.10440873805698567
ALPHA-MANNOSIDOSIS	0.006812894	0.10407312640836881
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.006799204	0.10386399925909413
RETICULAR DYSGENESIS	0.00672578	0.10274238115768111
SHORT SYNDROME	0.0067120899999999995	0.10253325400840643
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.0067120899999999995	0.10253325400840643
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00670981	0.1024984249433702
SCARF SYNDROME	0.00670981	0.1024984249433702
CARTILAGE-HAIR HYPOPLASIA	0.00670981	0.1024984249433702
XP21 MICRODELETION SYNDROME	0.006680524	0.102051054768523
L1 SYNDROME	0.006680524	0.102051054768523
NEPHROGENIC DIABETES INSIPIDUS	0.006680524	0.102051054768523
HEREDITARY FOLATE MALABSORPTION	0.006680524	0.102051054768523
CONO-SPONDYLAR DYSPLASIA	0.0066574	0.10169781472470796
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.006645254	0.10151227357386133
SMITH-MAGENIS SYNDROME	0.006645254	0.10151227357386133
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.006645254	0.10151227357386133
KAPUR-TORIELLO SYNDROME	0.0066369	0.10138465865749606
LATHOSTEROLOSIS	0.0066369	0.10138465865749606
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0066369	0.10138465865749606
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.0066369	0.10138465865749606
MELNICK-NEEDLES SYNDROME	0.00659292	0.10071282432403367
KOOLEN-DE VRIES SYNDROME; KDVS	0.006540774	0.09991624694448088
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.006540774	0.09991624694448088
KOOLEN-DE VRIES SYNDROME	0.006540774	0.09991624694448088
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.006540774	0.09991624694448088
GM1 GANGLIOSIDOSIS	0.00645366	0.09858550169379318
PITT-HOPKINS-LIKE SYNDROME	0.006452820000000001	0.09857266993299038
TORIELLO-LACASSIE-DROSTE SYNDROME	0.006452820000000001	0.09857266993299038
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.006452820000000001	0.09857266993299038
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.006452820000000001	0.09857266993299038
XP22.13P22.2 DUPLICATION SYNDROME	0.006452820000000001	0.09857266993299038
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0064391299999999995	0.09836354278371569
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00637182	0.09733532156986041
CRANIOMETAPHYSEAL DYSPLASIA	0.00635813	0.09712619442058573
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00635813	0.09712619442058573
ACROCRANIOFACIAL DYSOSTOSIS	0.00635813	0.09712619442058573
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00635813	0.09712619442058573
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00635813	0.09712619442058573
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00635813	0.09712619442058573
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00635813	0.09712619442058573
BRITTLE CORNEA SYNDROME	0.00635813	0.09712619442058573
FRONTOMETAPHYSEAL DYSPLASIA	0.00635813	0.09712619442058573
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00635813	0.09712619442058573
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00635813	0.09712619442058573
BRANCHIOOTIC SYNDROME	0.00635813	0.09712619442058573
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00635813	0.09712619442058573
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00635813	0.09712619442058573
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00635813	0.09712619442058573
ABRUZZO-ERICKSON SYNDROME	0.00635813	0.09712619442058573
PSEUDO-TORCH SYNDROME 2	0.00628931	0.0960749065890968
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.00628931	0.0960749065890968
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.00628931	0.0960749065890968
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00628931	0.0960749065890968
VISCERAL STEATOSIS, CONGENITAL	0.00628931	0.0960749065890968
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00628931	0.0960749065890968
GLYCINE ENCEPHALOPATHY	0.00628931	0.0960749065890968
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.00628931	0.0960749065890968
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00628931	0.0960749065890968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00628931	0.0960749065890968
HEMOCHROMATOSIS, TYPE 2A	0.00628931	0.0960749065890968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00628931	0.0960749065890968
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00628931	0.0960749065890968
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.00628931	0.0960749065890968
ENCEPHALITIS LETHARGICA	0.00628931	0.0960749065890968
EVANS SYNDROME	0.00628931	0.0960749065890968
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00628931	0.0960749065890968
GLYCINE ENCEPHALOPATHY; GCE	0.00628931	0.0960749065890968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00628931	0.0960749065890968
KUFOR-RAKEB SYNDROME	0.00628931	0.0960749065890968
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00628931	0.0960749065890968
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00628931	0.0960749065890968
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00628931	0.0960749065890968
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00628931	0.0960749065890968
POSTERIOR URETHRAL VALVE	0.00628931	0.0960749065890968
EISENMENGER SYNDROME	0.00628931	0.0960749065890968
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00628931	0.0960749065890968
HEMOCHROMATOSIS TYPE 2	0.00628931	0.0960749065890968
CIRRHOSIS, FAMILIAL	0.00628931	0.0960749065890968
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00628931	0.0960749065890968
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.00628931	0.0960749065890968
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00628931	0.0960749065890968
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00628931	0.0960749065890968
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00628931	0.0960749065890968
MYXEDEMA	0.00628931	0.0960749065890968
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00628931	0.0960749065890968
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.00628931	0.0960749065890968
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00628931	0.0960749065890968
TYPHOID	0.00628931	0.0960749065890968
EMANUEL SYNDROME	0.006275694	0.09586690985684523
2P15P16.1 MICRODELETION SYNDROME	0.006275694	0.09586690985684523
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.006275694	0.09586690985684523
MICROPHTHALMIA, LENZ TYPE	0.006267340000000001	0.09573929494047996
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.006267340000000001	0.09573929494047996
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.006267340000000001	0.09573929494047996
COHEN SYNDROME	0.006262004	0.09565778270757054
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.006262004	0.09565778270757054
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00625365	0.09553016779120528
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00625365	0.09553016779120528
CREST SYNDROME	0.00613497	0.09371722330063412
INTESTINAL BOTULISM	0.00613497	0.09371722330063412
LYME DISEASE	0.00613497	0.09371722330063412
PRIMARY PARATHYROID HYPERPLASIA	0.00613497	0.09371722330063412
IMMUNOGLOBULIN A VASCULITIS	0.00613497	0.09371722330063412
BABESIOSIS	0.00613497	0.09371722330063412
EPISODIC ATAXIA TYPE 6	0.00613497	0.09371722330063412
HALL-RIGGS SYNDROME	0.00613497	0.09371722330063412
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.00613497	0.09371722330063412
FAMILIAL PAROXYSMAL ATAXIA	0.00613497	0.09371722330063412
COLD AGGLUTININ DISEASE	0.00613497	0.09371722330063412
PORPHYRIA	0.00613497	0.09371722330063412
FAMILIAL MEDITERRANEAN FEVER	0.00613497	0.09371722330063412
MICROSCOPIC POLYANGIITIS	0.00613497	0.09371722330063412
PAROXYSMAL HEMICRANIA	0.00613497	0.09371722330063412
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00613497	0.09371722330063412
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00613497	0.09371722330063412
CHOLESTERYL ESTER STORAGE DISEASE	0.00613497	0.09371722330063412
HYDATIDIFORM MOLE	0.00613497	0.09371722330063412
BOTULISM	0.00613497	0.09371722330063412
RHEUMATIC FEVER	0.00613497	0.09371722330063412
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00613497	0.09371722330063412
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00613497	0.09371722330063412
AMYOTROPHIC LATERAL SCLEROSIS	0.00613497	0.09371722330063412
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00613497	0.09371722330063412
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.00613497	0.09371722330063412
KAWASAKI DISEASE	0.00613497	0.09371722330063412
GRISCELLI SYNDROME TYPE 2	0.00613497	0.09371722330063412
PORPHYRIA VARIEGATA	0.00613497	0.09371722330063412
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00613497	0.09371722330063412
LEPTOSPIROSIS	0.00613497	0.09371722330063412
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00613497	0.09371722330063412
FOODBORNE BOTULISM	0.00613497	0.09371722330063412
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00613497	0.09371722330063412
DRACUNCULIASIS	0.00613497	0.09371722330063412
HEREDITARY COPROPORPHYRIA	0.00613497	0.09371722330063412
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.00613497	0.09371722330063412
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00613497	0.09371722330063412
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00613497	0.09371722330063412
NIPAH VIRUS DISEASE	0.00613497	0.09371722330063412
HUGHES-STOVIN SYNDROME	0.00613497	0.09371722330063412
PAROXYSMAL COLD HEMOGLOBINURIA	0.00613497	0.09371722330063412
INHALATIONAL BOTULISM	0.00613497	0.09371722330063412
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0060997000000000004	0.09317844210597248
FLOATING-HARBOR SYNDROME	0.0060997000000000004	0.09317844210597248
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0060997000000000004	0.09317844210597248
MEIER-GORLIN SYNDROME 6; MGORS6	0.0060997000000000004	0.09317844210597248
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.0060997000000000004	0.09317844210597248
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.0060997000000000004	0.09317844210597248
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.0060997000000000004	0.09317844210597248
COOPER-JABS SYNDROME	0.0060997000000000004	0.09317844210597248
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0060997000000000004	0.09317844210597248
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.006079064	0.09286320851558297
GALACTOSE EPIMERASE DEFICIENCY	0.006065374	0.0926540813663083
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.006065374	0.0926540813663083
SALT-AND-PEPPER SYNDROME	0.006065374	0.0926540813663083
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.006018124	0.09193229482114915
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.006018124	0.09193229482114915
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.006018124	0.09193229482114915
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.006018124	0.09193229482114915
20P12.3 MICRODELETION SYNDROME	0.006010034	0.09180871274389334
GERODERMA OSTEODYSPLASTICA	0.006010034	0.09180871274389334
20Q11.2 MICRODUPLICATION SYNDROME	0.006010034	0.09180871274389334
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006010034	0.09180871274389334
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.006010034	0.09180871274389334
MAN1B1-CDG	0.006010034	0.09180871274389334
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.006010034	0.09180871274389334
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.006010034	0.09180871274389334
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.006010034	0.09180871274389334
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.006010034	0.09180871274389334
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.006010034	0.09180871274389334
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.006010034	0.09180871274389334
DESBUQUOIS DYSPLASIA 2; DBQD2	0.006010034	0.09180871274389334
HAREL-YOON SYNDROME; HAYOS	0.006010034	0.09180871274389334
CATEL-MANZKE SYNDROME; CATMANS	0.006010034	0.09180871274389334
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.005995220000000001	0.09158241547659202
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.005995220000000001	0.09158241547659202
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.005893144	0.0900231121245568
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.005893144	0.0900231121245568
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.005893144	0.0900231121245568
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.005893144	0.0900231121245568
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.005893144	0.0900231121245568
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.005893144	0.0900231121245568
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.005893144	0.0900231121245568
WRINKLY SKIN SYNDROME	0.005893144	0.0900231121245568
SECKEL SYNDROME 8; SCKL8	0.005893144	0.0900231121245568
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.005893144	0.0900231121245568
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.005893144	0.0900231121245568
HYPEREKPLEXIA 4; HKPX4	0.005893144	0.0900231121245568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.005893144	0.0900231121245568
MONOSOMY 18P	0.005893144	0.0900231121245568
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.005806944	0.08870632905169504
CHROMOSOME 19P13.13 DELETION SYNDROME	0.005806944	0.08870632905169504
19P13.13 MICRODELETION SYNDROME	0.005806944	0.08870632905169504
2Q23.1 MICRODUPLICATION SYNDROME	0.005806944	0.08870632905169504
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.005806944	0.08870632905169504
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.005806944	0.08870632905169504
GALACTOSEMIA	0.00579859	0.08857871413532976
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00579859	0.08857871413532976
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.005753884	0.08789578949431633
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.005753884	0.08789578949431633
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.005753044	0.0878829577335135
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.005753044	0.0878829577335135
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.005753044	0.0878829577335135
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.005753044	0.0878829577335135
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.005753044	0.0878829577335135
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.005753044	0.0878829577335135
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.005753044	0.0878829577335135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.005753044	0.0878829577335135
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.005753044	0.0878829577335135
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.005753044	0.0878829577335135
SPINOCEREBELLAR ATAXIA TYPE 13	0.005753044	0.0878829577335135
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.005753044	0.0878829577335135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0057393539999999995	0.08767383058423882
SLC35A2-CDG	0.0057393539999999995	0.08767383058423882
BRAIN-LUNG-THYROID SYNDROME	0.0057393539999999995	0.08767383058423882
16Q24.3 MICRODELETION SYNDROME	0.005730140000000001	0.08753307838895637
4Q21 MICRODELETION SYNDROME	0.005730140000000001	0.08753307838895637
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00571645	0.08732395123968167
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00571645	0.08732395123968167
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00553351	0.08452937704769412
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00553351	0.08452937704769412
PLAGUE	0.00553351	0.08452937704769412
KRABBE DISEASE	0.00553351	0.08452937704769412
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00551982	0.08432024989841942
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.005480924	0.08372607826962557
MATERNAL PHENYLKETONURIA	0.005480924	0.08372607826962557
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.005480924	0.08372607826962557
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.005480924	0.08372607826962557
CHROMOSOME 16P13.2 DELETION SYNDROME	0.005480924	0.08372607826962557
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.005480924	0.08372607826962557
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.005480924	0.08372607826962557
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.005480924	0.08372607826962557
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.005480924	0.08372607826962557
6Q TERMINAL DELETION SYNDROME	0.005480924	0.08372607826962557
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005480924	0.08372607826962557
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.005480924	0.08372607826962557
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.005480924	0.08372607826962557
PENOSCROTAL TRANSPOSITION	0.00546448	0.08347488127600447
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00546448	0.08347488127600447
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00546448	0.08347488127600447
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.00546448	0.08347488127600447
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00546448	0.08347488127600447
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.00546448	0.08347488127600447
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00546448	0.08347488127600447
AMISH NEMALINE MYOPATHY	0.00546448	0.08347488127600447
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00546448	0.08347488127600447
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00546448	0.08347488127600447
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00546448	0.08347488127600447
ACROCAPITOFEMORAL DYSPLASIA	0.00546448	0.08347488127600447
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.00546448	0.08347488127600447
PARANA HARD SKIN SYNDROME	0.00546448	0.08347488127600447
SPINOCEREBELLAR ATAXIA TYPE 43	0.00546448	0.08347488127600447
ULNAR-MAMMARY SYNDROME	0.00546448	0.08347488127600447
BRUCK SYNDROME 2	0.00546448	0.08347488127600447
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00546448	0.08347488127600447
ARTERIAL TORTUOSITY SYNDROME	0.00546448	0.08347488127600447
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.00546448	0.08347488127600447
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00546448	0.08347488127600447
NEONATAL MARFAN SYNDROME	0.00546448	0.08347488127600447
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00546448	0.08347488127600447
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00546448	0.08347488127600447
ASPARTYLGLUCOSAMINURIA	0.00546448	0.08347488127600447
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00546448	0.08347488127600447
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00546448	0.08347488127600447
DYSMORPHISM-PECTUS CARINATUM-JOINT LAXITY SYNDROME	0.00546448	0.08347488127600447
ODONTOCHONDRODYSPLASIA; ODCD	0.00546448	0.08347488127600447
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00546448	0.08347488127600447
TEEBI-SHALTOUT SYNDROME; TBSH	0.00546448	0.08347488127600447
ELLIS-VAN CREVELD SYNDROME	0.00546448	0.08347488127600447
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00546448	0.08347488127600447
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00546448	0.08347488127600447
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00546448	0.08347488127600447
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00546448	0.08347488127600447
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00546448	0.08347488127600447
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00546448	0.08347488127600447
LOEYS-DIETZ SYNDROME	0.00546448	0.08347488127600447
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.005399924	0.08248872990649563
ZECHI-CEIDE SYNDROME	0.005399924	0.08248872990649563
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.005399924	0.08248872990649563
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.005399924	0.08248872990649563
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.005399924	0.08248872990649563
OTOFACIOCERVICAL SYNDROME	0.005399924	0.08248872990649563
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.005399924	0.08248872990649563
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00534759	0.08168928065666793
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00534759	0.08168928065666793
WARBURG MICRO SYNDROME 1	0.00534759	0.08168928065666793
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00534759	0.08168928065666793
WARBURG MICRO SYNDROME 3; WARBM3	0.00534759	0.08168928065666793
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.00534759	0.08168928065666793
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00534759	0.08168928065666793
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00534759	0.08168928065666793
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00534759	0.08168928065666793
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00534759	0.08168928065666793
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00534759	0.08168928065666793
CENTRAL CORE DISEASE	0.00534759	0.08168928065666793
CARPENTER SYNDROME	0.00534759	0.08168928065666793
3Q27.3 MICRODELETION SYNDROME	0.00534759	0.08168928065666793
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00534759	0.08168928065666793
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.00534759	0.08168928065666793
ACRORENAL-MANDIBULAR SYNDROME	0.00534759	0.08168928065666793
CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	0.00534759	0.08168928065666793
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00534759	0.08168928065666793
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00534759	0.08168928065666793
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.00534759	0.08168928065666793
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00534759	0.08168928065666793
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00534759	0.08168928065666793
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00534759	0.08168928065666793
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00534759	0.08168928065666793
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00534759	0.08168928065666793
SCHOLTE SYNDROME; SHLTS	0.00534759	0.08168928065666793
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00534759	0.08168928065666793
PRIMARY DYSTONIA, DYT4 TYPE	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00534759	0.08168928065666793
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00534759	0.08168928065666793
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00534759	0.08168928065666793
OROFACIODIGITAL SYNDROME XI; OFD11	0.00534759	0.08168928065666793
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.00534759	0.08168928065666793
GERODERMA OSTEODYSPLASTICUM; GO	0.00534759	0.08168928065666793
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.00534759	0.08168928065666793
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00534759	0.08168928065666793
NEMALINE MYOPATHY 4	0.00534759	0.08168928065666793
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00534759	0.08168928065666793
ANE SYNDROME	0.00534759	0.08168928065666793
EPISODIC ATAXIA TYPE 1	0.00534759	0.08168928065666793
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00534759	0.08168928065666793
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00534759	0.08168928065666793
%109500 BASILAR IMPRESSION, PRIMARY	0.00534759	0.08168928065666793
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00534759	0.08168928065666793
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.00534759	0.08168928065666793
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00534759	0.08168928065666793
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00534759	0.08168928065666793
MENTAL RETARDATION, X-LINKED 19	0.00534759	0.08168928065666793
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00534759	0.08168928065666793
MEND SYNDROME	0.005295444	0.08089270327711516
MEND SYNDROME; MEND	0.005295444	0.08089270327711516
MICRO SYNDROME	0.005295444	0.08089270327711516
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00526139	0.08037249758380619
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00526139	0.08037249758380619
SPINOCEREBELLAR ATAXIA TYPE 25	0.00526139	0.08037249758380619
OROMANDIBULAR DYSTONIA	0.00520833	0.07956195802642747
VARIANT ABETA2M AMYLOIDOSIS	0.00520833	0.07956195802642747
EOSINOPHILIC FASCIITIS	0.00520833	0.07956195802642747
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00520833	0.07956195802642747
CHRONIC HICCUP	0.00520833	0.07956195802642747
INFLAMMATORY BOWEL DISEASE 11	0.00520833	0.07956195802642747
ATTRV30M AMYLOIDOSIS	0.00520833	0.07956195802642747
MULTIPLE MYELOMA	0.00520833	0.07956195802642747
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00520833	0.07956195802642747
PERRY SYNDROME	0.00520833	0.07956195802642747
ACRODERMATITIS ENTEROPATHICA	0.00520833	0.07956195802642747
JUVENILE DERMATOMYOSITIS	0.00520833	0.07956195802642747
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.00520833	0.07956195802642747
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00520833	0.07956195802642747
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00520833	0.07956195802642747
YAO SYNDROME	0.00520833	0.07956195802642747
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00520833	0.07956195802642747
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.07956195802642747
PLEURAL MESOTHELIOMA	0.00520833	0.07956195802642747
CHRONIC GRAFT VERSUS HOST DISEASE	0.00520833	0.07956195802642747
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00520833	0.07956195802642747
LEISHMANIASIS	0.00520833	0.07956195802642747
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.00520833	0.07956195802642747
ISAAC SYNDROME	0.00520833	0.07956195802642747
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00520833	0.07956195802642747
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00520833	0.07956195802642747
PERRY SYNDROME	0.00520833	0.07956195802642747
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00520833	0.07956195802642747
WILD TYPE ATTR AMYLOIDOSIS	0.00520833	0.07956195802642747
OSTEOSARCOMA	0.00520833	0.07956195802642747
REACTIVE ARTHRITIS	0.00520833	0.07956195802642747
KIKUCHI-FUJIMOTO DISEASE	0.00520833	0.07956195802642747
HUNTINGTON DISEASE-LIKE 1	0.00520833	0.07956195802642747
THYROTOXIC PERIODIC PARALYSIS	0.00520833	0.07956195802642747
TUBERCULOSIS	0.00520833	0.07956195802642747
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00520833	0.07956195802642747
MU-HEAVY CHAIN DISEASE	0.00520833	0.07956195802642747
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.00520833	0.07956195802642747
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00520833	0.07956195802642747
BULLOUS PEMPHIGOID	0.00520833	0.07956195802642747
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00520833	0.07956195802642747
PEMPHIGUS VULGARIS	0.00520833	0.07956195802642747
ACUTE PROMYELOCYTIC LEUKEMIA	0.00520833	0.07956195802642747
HUNTINGTON DISEASE-LIKE 2	0.00520833	0.07956195802642747
CONGENITAL ENTEROCYTE HEPARAN SULFATE DEFICIENCY	0.00520833	0.07956195802642747
JUVENILE HUNTINGTON DISEASE	0.00520833	0.07956195802642747
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.00520833	0.07956195802642747
INSULIN AUTOIMMUNE SYNDROME	0.00520833	0.07956195802642747
FOCAL MYOSITIS	0.00520833	0.07956195802642747
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00520833	0.07956195802642747
BUDD-CHIARI SYNDROME	0.00520833	0.07956195802642747
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00520833	0.07956195802642747
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00520749	0.07954912626562465
BETA-MANNOSIDOSIS	0.00520749	0.07954912626562465
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00520749	0.07954912626562465
PROLIDASE DEFICIENCY	0.00520749	0.07954912626562465
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00520749	0.07954912626562465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.0051938	0.07933999911634997
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.0051938	0.07933999911634997
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0051938	0.07933999911634997
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0050908640000000005	0.07776755848539756
BARDET-BIEDL SYNDROME 1; BBS1	0.0050908640000000005	0.07776755848539756
TRISOMY 17P	0.0050908640000000005	0.07776755848539756
MYHRE SYNDROME	0.0050908640000000005	0.07776755848539756
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.0050908640000000005	0.07776755848539756
CODAS SYNDROME	0.005077174	0.07755843133612289
1Q21.1 MICRODELETION SYNDROME	0.005077174	0.07755843133612289
FUCOSIDOSIS	0.005030364	0.07684336618947951
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.005030364	0.07684336618947951
HURLER SYNDROME	0.005030364	0.07684336618947951
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.005030364	0.07684336618947951
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.005016674	0.07663423904020482
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.005016674	0.07663423904020482
CDAGS SYNDROME	0.005016674	0.07663423904020482
DUPLICATION/INVERSION 15Q11	0.00493537	0.0753922468017367
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00493537	0.0753922468017367
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00493537	0.0753922468017367
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00493537	0.0753922468017367
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00493537	0.0753922468017367
PHAVER SYNDROME	0.00485437	0.07415489843860676
FONTAINE PROGEROID SYNDROME; FPS	0.00485437	0.07415489843860676
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00485437	0.07415489843860676
3MC SYNDROME 1	0.00485437	0.07415489843860676
%608572 BURN-MCKEOWN SYNDROME	0.00485437	0.07415489843860676
OTOFACIOCERVICAL SYNDROME	0.00485437	0.07415489843860676
OTOSCLEROSIS	0.00485437	0.07415489843860676
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.00485437	0.07415489843860676
ALOPECIA ANTIBODY DEFICIENCY	0.00485437	0.07415489843860676
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00485437	0.07415489843860676
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00485437	0.07415489843860676
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00485437	0.07415489843860676
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.00485437	0.07415489843860676
MULTIPLE SYNOSTOSES SYNDROME	0.00485437	0.07415489843860676
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00485437	0.07415489843860676
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00485437	0.07415489843860676
DIAMOND-BLACKFAN ANEMIA 10	0.00485437	0.07415489843860676
CLEFT VELUM	0.00485437	0.07415489843860676
ISOLATED CLEFT LIP	0.00485437	0.07415489843860676
CLEFT LIP/PALATE	0.00485437	0.07415489843860676
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00485437	0.07415489843860676
PRIMARY CILIARY DYSKINESIA	0.00485437	0.07415489843860676
AGNATHIA-OTOCEPHALY COMPLEX	0.00485437	0.07415489843860676
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00485437	0.07415489843860676
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.00485437	0.07415489843860676
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00485437	0.07415489843860676
JOHNSON NEUROECTODERMAL SYNDROME	0.00485437	0.07415489843860676
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00485437	0.07415489843860676
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00485437	0.07415489843860676
CILIARY DYSKINESIA, PRIMARY, 33	0.00485437	0.07415489843860676
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00485437	0.07415489843860676
FRASER SYNDROME	0.00485437	0.07415489843860676
TREACHER COLLINS SYNDROME 3; TCS3	0.00485437	0.07415489843860676
CRANIODIAPHYSEAL DYSPLASIA	0.00485437	0.07415489843860676
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00485437	0.07415489843860676
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00485437	0.07415489843860676
PIGMENTED VILLONODULAR SYNOVITIS	0.00485437	0.07415489843860676
FRONTONASAL DYSPLASIA	0.00485437	0.07415489843860676
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00485437	0.07415489843860676
MARSHALL-SMITH SYNDROME	0.00485437	0.07415489843860676
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00485437	0.07415489843860676
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00485437	0.07415489843860676
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00485437	0.07415489843860676
TREACHER COLLINS SYNDROME 2; TCS2	0.00485437	0.07415489843860676
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00485437	0.07415489843860676
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.00485437	0.07415489843860676
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00485437	0.07415489843860676
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00485437	0.07415489843860676
FAMILIAL EXPANSILE OSTEOLYSIS	0.00485437	0.07415489843860676
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00485437	0.07415489843860676
RHYNS SYNDROME; RHYNS	0.00485437	0.07415489843860676
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00485437	0.07415489843860676
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00485437	0.07415489843860676
LARSEN SYNDROME	0.00485437	0.07415489843860676
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00485437	0.07415489843860676
RICHARDS-RUNDLE SYNDROME; RRNS	0.004812094	0.07350909424848723
MUENKE SYNDROME	0.004812094	0.07350909424848723
DESANTO-SHINAWI SYNDROME	0.004812094	0.07350909424848723
ZTTK SYNDROME; ZTTKS	0.004758244	0.07268648672559157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.004758244	0.07268648672559157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.004758244	0.07268648672559157
2Q31.1 MICRODELETION SYNDROME	0.004758244	0.07268648672559157
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.004758244	0.07268648672559157
PELGER-HUET ANOMALY; PHA	0.004758244	0.07268648672559157
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004758244	0.07268648672559157
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004758244	0.07268648672559157
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.004758244	0.07268648672559157
MARINESCO-SJOGREN SYNDROME; MSS	0.004758244	0.07268648672559157
HARROD SYNDROME	0.00474989	0.07255887180922628
METATROPIC DYSPLASIA	0.00474989	0.07255887180922628
SPONASTRIME DYSPLASIA	0.00474989	0.07255887180922628
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.00474989	0.07255887180922628
ASPARTYLGLUCOSAMINURIA; AGU	0.00474989	0.07255887180922628
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.004561614	0.06968278538432932
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004561614	0.06968278538432932
NAVAJO NEUROHEPATOPATHY	0.004561614	0.06968278538432932
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.004561614	0.06968278538432932
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004561614	0.06968278538432932
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.004561614	0.06968278538432932
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.004561614	0.06968278538432932
NIEMANN-PICK DISEASE, TYPE A	0.004561614	0.06968278538432932
RENPENNING SYNDROME 1; RENS1	0.00454531	0.06943372701750869
TOWNES-BROCKS SYNDROME	0.00454531	0.06943372701750869
CRI-DU-CHAT SYNDROME	0.00454531	0.06943372701750869
8Q21.11 MICRODELETION SYNDROME	0.00454531	0.06943372701750869
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00453162	0.06922459986823401
NEONATAL ADRENOLEUKODYSTROPHY	0.00453162	0.06922459986823401
LAURENCE-MOON SYNDROME	0.00453162	0.06922459986823401
DUANE-RADIAL RAY SYNDROME; DRRS	0.00453162	0.06922459986823401
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00453162	0.06922459986823401
MARSHALL SYNDROME	0.00453162	0.06922459986823401
CONGENITAL RUBELLA SYNDROME	0.00453162	0.06922459986823401
SANDHOFF DISEASE	0.0044848100000000005	0.06850953472159065
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0044848100000000005	0.06850953472159065
CLEIDOCRANIAL DYSPLASIA; CCD	0.0044848100000000005	0.06850953472159065
THANATOPHORIC DYSPLASIA	0.0044848100000000005	0.06850953472159065
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0044848100000000005	0.06850953472159065
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0044848100000000005	0.06850953472159065
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0044848100000000005	0.06850953472159065
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0044848100000000005	0.06850953472159065
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0044848100000000005	0.06850953472159065
THANATOPHORIC DYSPLASIA TYPE 2	0.0044848100000000005	0.06850953472159065
CAMPOMELIC DYSPLASIA	0.0044848100000000005	0.06850953472159065
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0044848100000000005	0.06850953472159065
PRIMROSE SYNDROME; PRIMS	0.0044848100000000005	0.06850953472159065
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0044848100000000005	0.06850953472159065
THANATOPHORIC DYSPLASIA TYPE 1	0.0044848100000000005	0.06850953472159065
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.0044848100000000005	0.06850953472159065
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0044848100000000005	0.06850953472159065
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00447112	0.06830040757231595
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00447112	0.06830040757231595
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00447112	0.06830040757231595
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00447112	0.06830040757231595
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00447112	0.06830040757231595
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.00447112	0.06830040757231595
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00447112	0.06830040757231595
JOUBERT SYNDROME 35; JBTS35	0.004235594	0.06470253460225985
7P22.1 MICRODUPLICATION SYNDROME	0.004235594	0.06470253460225985
HOLMES-GANG SYNDROME	0.004235594	0.06470253460225985
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.004235594	0.06470253460225985
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004235594	0.06470253460225985
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.004235594	0.06470253460225985
SAY-BARBER-MILLER SYNDROME	0.004235594	0.06470253460225985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.004235594	0.06470253460225985
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.06470253460225985
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004235594	0.06470253460225985
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004235594	0.06470253460225985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004235594	0.06470253460225985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004235594	0.06470253460225985
MONOSOMY 13Q34	0.004235594	0.06470253460225985
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.004235594	0.06470253460225985
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004235594	0.06470253460225985
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.004235594	0.06470253460225985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004235594	0.06470253460225985
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004235594	0.06470253460225985
WILSON-TURNER SYNDROME	0.004235594	0.06470253460225985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004235594	0.06470253460225985
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.004235594	0.06470253460225985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004235594	0.06470253460225985
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.004235594	0.06470253460225985
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004235594	0.06470253460225985
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.004235594	0.06470253460225985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.004235594	0.06470253460225985
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.004235594	0.06470253460225985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004235594	0.06470253460225985
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.004235594	0.06470253460225985
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.004235594	0.06470253460225985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.004235594	0.06470253460225985
ROIFMAN-CHITAYAT SYNDROME	0.004235594	0.06470253460225985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004235594	0.06470253460225985
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004235594	0.06470253460225985
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.004235594	0.06470253460225985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.004235594	0.06470253460225985
HOLOPROSENCEPHALY 5; HPE5	0.004235594	0.06470253460225985
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004235594	0.06470253460225985
TRANSALDOLASE DEFICIENCY	0.004235594	0.06470253460225985
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.004235594	0.06470253460225985
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00421269	0.0643526552577027
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00421269	0.0643526552577027
MASA SYNDROME	0.00421269	0.0643526552577027
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00421269	0.0643526552577027
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00421269	0.0643526552577027
URBAN-ROGERS-MEYER SYNDROME	0.00421269	0.0643526552577027
TRISOMY 20P	0.00421269	0.0643526552577027
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00421269	0.0643526552577027
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00421269	0.0643526552577027
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00421269	0.0643526552577027
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.00401606	0.061348953916440456
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00401606	0.061348953916440456
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.061348953916440456
HYPOADRENOCORTICISM, FAMILIAL	0.00401606	0.061348953916440456
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00401606	0.061348953916440456
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00401606	0.061348953916440456
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.061348953916440456
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00401606	0.061348953916440456
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00401606	0.061348953916440456
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.00401606	0.061348953916440456
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00401606	0.061348953916440456
HYPER-IGD SYNDROME	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00401606	0.061348953916440456
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00401606	0.061348953916440456
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00401606	0.061348953916440456
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00401606	0.061348953916440456
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00401606	0.061348953916440456
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00401606	0.061348953916440456
HYPERLIPOPROTEINEMIA, TYPE I	0.00401606	0.061348953916440456
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00401606	0.061348953916440456
PROLACTINOMA	0.00401606	0.061348953916440456
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00401606	0.061348953916440456
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00401606	0.061348953916440456
CHYLOMICRON RETENTION DISEASE	0.00401606	0.061348953916440456
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00401606	0.061348953916440456
ACID PHOSPHATASE DEFICIENCY	0.00401606	0.061348953916440456
VALINEMIA	0.00401606	0.061348953916440456
CYSTINOSIS	0.00401606	0.061348953916440456
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.061348953916440456
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00401606	0.061348953916440456
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00401606	0.061348953916440456
ACQUIRED METHEMOGLOBINEMIA	0.00401606	0.061348953916440456
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00401606	0.061348953916440456
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00401606	0.061348953916440456
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.061348953916440456
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00401606	0.061348953916440456
NON-FUNCTIONING PITUITARY ADENOMA	0.00401606	0.061348953916440456
ANGIOEDEMA, HEREDITARY, TYPE III	0.00401606	0.061348953916440456
HEREDITARY ANGIOEDEMA TYPE 1	0.00401606	0.061348953916440456
CHYLOMICRON RETENTION DISEASE	0.00401606	0.061348953916440456
VISCERAL MYOPATHY; VSCM	0.00401606	0.061348953916440456
LESCH-NYHAN SYNDROME; LNS	0.00401606	0.061348953916440456
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00401606	0.061348953916440456
RELAPSING FEVER	0.00401606	0.061348953916440456
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00401606	0.061348953916440456
DEND SYNDROME	0.00401606	0.061348953916440456
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00401606	0.061348953916440456
HELLP SYNDROME	0.00401606	0.061348953916440456
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00401606	0.061348953916440456
ALPHA-METHYLACETOACETIC ACIDURIA	0.00401606	0.061348953916440456
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00401606	0.061348953916440456
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00401606	0.061348953916440456
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00401606	0.061348953916440456
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00401606	0.061348953916440456
CONGENITAL SHORT BOWEL SYNDROME	0.00401606	0.061348953916440456
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00401606	0.061348953916440456
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00401606	0.061348953916440456
NEUROLEPTIC MALIGNANT SYNDROME	0.00401606	0.061348953916440456
ADNP SYNDROME	0.00401606	0.061348953916440456
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00401606	0.061348953916440456
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00401606	0.061348953916440456
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00401606	0.061348953916440456
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.00401606	0.061348953916440456
ATRESIA OF SMALL INTESTINE	0.00401606	0.061348953916440456
CONGENITAL PANCREATIC CYST	0.00401606	0.061348953916440456
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.00401606	0.061348953916440456
AA AMYLOIDOSIS	0.00401606	0.061348953916440456
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.00401606	0.061348953916440456
PORPHYRIA VARIEGATA	0.00401606	0.061348953916440456
BENIGN OCCIPITAL EPILEPSY	0.00401606	0.061348953916440456
LIVER FAILURE, INFANTILE, TRANSIENT	0.00401606	0.061348953916440456
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00401606	0.061348953916440456
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.061348953916440456
EPISODIC ATAXIA, TYPE 6	0.00401606	0.061348953916440456
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00401606	0.061348953916440456
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00401606	0.061348953916440456
HYPOPHOSPHATASIA, INFANTILE	0.00401606	0.061348953916440456
PORPHYRIA, ACUTE HEPATIC	0.00401606	0.061348953916440456
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00401606	0.061348953916440456
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00401606	0.061348953916440456
INHALATIONAL ANTHRAX	0.00401606	0.061348953916440456
CAROLI DISEASE, ISOLATED	0.00401606	0.061348953916440456
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00401606	0.061348953916440456
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00401606	0.061348953916440456
EPISODIC ATAXIA, TYPE 3	0.00401606	0.061348953916440456
ENTERIC ANENDOCRINOSIS	0.00401606	0.061348953916440456
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00401606	0.061348953916440456
GRAFT VERSUS HOST DISEASE	0.00401606	0.061348953916440456
GITELMAN SYNDROME	0.00401606	0.061348953916440456
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0038455340000000003	0.058744014818031834
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0038455340000000003	0.058744014818031834
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0038455340000000003	0.058744014818031834
LEBER CONGENITAL AMAUROSIS	0.0038455340000000003	0.058744014818031834
CONGENITAL HYPOTHYROIDISM	0.0038455340000000003	0.058744014818031834
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0038455340000000003	0.058744014818031834
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.0038455340000000003	0.058744014818031834
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0038455340000000003	0.058744014818031834
OTOPALATODIGITAL SYNDROME TYPE 2	0.0038455340000000003	0.058744014818031834
LATHOSTEROLOSIS	0.0038455340000000003	0.058744014818031834
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.0038455340000000003	0.058744014818031834
YUNIS-VARON SYNDROME	0.0038455340000000003	0.058744014818031834
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0038455340000000003	0.058744014818031834
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0038455340000000003	0.058744014818031834
CHOPS SYNDROME; CHOPS	0.0038455340000000003	0.058744014818031834
3Q29 MICRODUPLICATION SYNDROME	0.0038455340000000003	0.058744014818031834
USHER SYNDROME TYPE 1	0.003831844	0.058534887668757155
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.003831844	0.058534887668757155
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.003831844	0.058534887668757155
MULTIPLE SULFATASE DEFICIENCY	0.003831844	0.058534887668757155
VICI SYNDROME	0.003831844	0.058534887668757155
OCULOFACIOCARDIODENTAL SYNDROME	0.003831844	0.058534887668757155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.003831844	0.058534887668757155
INFANTILE REFSUM DISEASE	0.003831844	0.058534887668757155
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.003831844	0.058534887668757155
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.003831844	0.058534887668757155
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.003831844	0.058534887668757155
49,XXXYY SYNDROME	0.00369004	0.056368703134370986
IRIDOGONIODYSGENESIS, TYPE 2	0.00369004	0.056368703134370986
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00369004	0.056368703134370986
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.056368703134370986
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.056368703134370986
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.056368703134370986
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.056368703134370986
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00369004	0.056368703134370986
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00369004	0.056368703134370986
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00369004	0.056368703134370986
HAIRY ELBOWS	0.00369004	0.056368703134370986
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.056368703134370986
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00369004	0.056368703134370986
ISOLATED BILIARY ATRESIA	0.00369004	0.056368703134370986
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00369004	0.056368703134370986
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.056368703134370986
LICHTENSTEIN SYNDROME	0.00369004	0.056368703134370986
VERVERI-BRADY SYNDROME; VERBRAS	0.00369004	0.056368703134370986
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.056368703134370986
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.056368703134370986
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00369004	0.056368703134370986
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00369004	0.056368703134370986
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00369004	0.056368703134370986
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00369004	0.056368703134370986
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.056368703134370986
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.056368703134370986
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.056368703134370986
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00369004	0.056368703134370986
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00369004	0.056368703134370986
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.056368703134370986
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.056368703134370986
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00369004	0.056368703134370986
RODRIGUES BLINDNESS	0.00369004	0.056368703134370986
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.056368703134370986
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.056368703134370986
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00369004	0.056368703134370986
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.056368703134370986
ZECHI-CEIDE SYNDROME	0.00369004	0.056368703134370986
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.056368703134370986
EPILEPSY-TELANGIECTASIA	0.00369004	0.056368703134370986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.056368703134370986
601095 HARROD SYNDROME	0.00369004	0.056368703134370986
LARON SYNDROME	0.00369004	0.056368703134370986
KENNERKNECHT SYNDROME	0.00369004	0.056368703134370986
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.056368703134370986
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.056368703134370986
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.056368703134370986
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00369004	0.056368703134370986
UROFACIAL SYNDROME	0.00369004	0.056368703134370986
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.056368703134370986
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00369004	0.056368703134370986
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00369004	0.056368703134370986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00369004	0.056368703134370986
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.056368703134370986
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.00369004	0.056368703134370986
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.056368703134370986
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00369004	0.056368703134370986
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0035734140000000005	0.054587135354143904
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.0035734140000000005	0.054587135354143904
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.0035734140000000005	0.054587135354143904
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.003573414	0.05458713535414389
DISTAL TRISOMY 6P	0.003573414	0.05458713535414389
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.003573414	0.05458713535414389
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.003573414	0.05458713535414389
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.003573414	0.05458713535414389
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.003573414	0.05458713535414389
MIETENS SYNDROME	0.003573414	0.05458713535414389
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.003573414	0.05458713535414389
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003573414	0.05458713535414389
1Q21.1 MICRODUPLICATION SYNDROME	0.003573414	0.05458713535414389
FARBER DISEASE	0.003512914	0.05366294305822584
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.003512914	0.05366294305822584
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.003512914	0.05366294305822584
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.003512914	0.05366294305822584
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.003512914	0.05366294305822584
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.003512914	0.05366294305822584
WIEACKER-WOLFF SYNDROME	0.003512914	0.05366294305822584
DISTAL 16P11.2 MICRODELETION SYNDROME	0.003512914	0.05366294305822584
SHASHI-PENA SYNDROME; SHAPNS	0.003512914	0.05366294305822584
PRADER-WILLI SYNDROME; PWS	0.003512914	0.05366294305822584
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.003512914	0.05366294305822584
15Q14 MICRODELETION SYNDROME	0.003512914	0.05366294305822584
TRISOMY 9P	0.003512914	0.05366294305822584
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003512914	0.05366294305822584
SCHAAF-YANG SYNDROME; SHFYNG	0.003512914	0.05366294305822584
COLE-CARPENTER SYNDROME	0.003512914	0.05366294305822584
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.003512914	0.05366294305822584
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.003512914	0.05366294305822584
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003512914	0.05366294305822584
DISTAL MONOSOMY 15Q	0.0033083340000000004	0.050537798266508255
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.0033083340000000004	0.050537798266508255
COFFIN-SIRIS SYNDROME 7; CSS7	0.0033083340000000004	0.050537798266508255
CHARGE SYNDROME	0.0033083340000000004	0.050537798266508255
OPTIC ATROPHY 11; OPA11	0.0033083340000000004	0.050537798266508255
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0033083340000000004	0.050537798266508255
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0033083340000000004	0.050537798266508255
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0033083340000000004	0.050537798266508255
CHAR SYNDROME	0.0033083340000000004	0.050537798266508255
DISTAL MONOSOMY 6P	0.0033083340000000004	0.050537798266508255
KABUKI SYNDROME 1	0.0033083340000000004	0.050537798266508255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0033083340000000004	0.050537798266508255
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0033083340000000004	0.050537798266508255
BOHRING-OPITZ SYNDROME	0.0033083340000000004	0.050537798266508255
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0033083340000000004	0.050537798266508255
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0033083340000000004	0.050537798266508255
16P11.2P12.2 MICRODELETION SYNDROME	0.0033083340000000004	0.050537798266508255
15Q24 MICRODELETION SYNDROME	0.0033083340000000004	0.050537798266508255
ISOLATED PLAGIOCEPHALY	0.0033083340000000004	0.050537798266508255
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.0033083340000000004	0.050537798266508255
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0033083340000000004	0.050537798266508255
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00329998	0.050410183350142974
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00329998	0.050410183350142974
AGEL AMYLOIDOSIS	0.00329998	0.050410183350142974
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00329998	0.050410183350142974
CENANI-LENZ SYNDROME	0.00329998	0.050410183350142974
SPASTIC PARAPARESIS AND DEAFNESS	0.00329998	0.050410183350142974
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00329998	0.050410183350142974
LISSENCEPHALY 5; LIS5	0.00329998	0.050410183350142974
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00329998	0.050410183350142974
NATHALIE SYNDROME	0.00329998	0.050410183350142974
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00329998	0.050410183350142974
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00329998	0.050410183350142974
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00329998	0.050410183350142974
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00329998	0.050410183350142974
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00329998	0.050410183350142974
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00329998	0.050410183350142974
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0032946440000000002	0.05032867111723357
LEIGH SYNDROME; LS	0.0032946440000000002	0.05032867111723357
PONTINE TEGMENTAL CAP DYSPLASIA	0.0032946440000000002	0.05032867111723357
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0032946440000000002	0.05032867111723357
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0032946440000000002	0.05032867111723357
CRANIOSYNOSTOSIS 6; CRS6	0.0032946440000000002	0.05032867111723357
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.0032946440000000002	0.05032867111723357
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.0032946440000000002	0.05032867111723357
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0032946440000000002	0.05032867111723357
CHROMOSOME 10Q26 DELETION SYNDROME	0.0032946440000000002	0.05032867111723357
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0032946440000000002	0.05032867111723357
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0032946440000000002	0.05032867111723357
HYPERTRYPTOPHANEMIA; HYPTRP	0.0032946440000000002	0.05032867111723357
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0032946440000000002	0.05032867111723357
DUANE RETRACTION SYNDROME	0.0032946440000000002	0.05032867111723357
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032946440000000002	0.05032867111723357
USHER SYNDROME	0.00328629	0.05020105620086829
STICKLER SYNDROME TYPE 1	0.00328629	0.05020105620086829
STICKLER SYNDROME TYPE 2	0.00328629	0.05020105620086829
VOGT-KOYANAGI-HARADA DISEASE	0.00328629	0.05020105620086829
NATHALIE SYNDROME	0.00328629	0.05020105620086829
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00328629	0.05020105620086829
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00328629	0.05020105620086829
COFS SYNDROME	0.00328629	0.05020105620086829
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00328629	0.05020105620086829
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00328629	0.05020105620086829
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00328629	0.05020105620086829
REFSUM DISEASE	0.00328629	0.05020105620086829
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00328629	0.05020105620086829
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00328629	0.05020105620086829
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00328629	0.05020105620086829
USHER SYNDROME TYPE 2	0.00328629	0.05020105620086829
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00328629	0.05020105620086829
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00328629	0.05020105620086829
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00328629	0.05020105620086829
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00328629	0.05020105620086829
SHORT SYNDROME	0.00328629	0.05020105620086829
USHER SYNDROME TYPE 3	0.00328629	0.05020105620086829
REFSUM DISEASE	0.00328629	0.05020105620086829
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00328629	0.05020105620086829
RELAPSING POLYCHONDRITIS	0.00328629	0.05020105620086829
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00328629	0.05020105620086829
STICKLER SYNDROME, TYPE II	0.00328629	0.05020105620086829
NAIL-PATELLA SYNDROME	0.00328629	0.05020105620086829
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00328629	0.05020105620086829
NEURAMINIDASE DEFICIENCY	0.00328629	0.05020105620086829
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00328629	0.05020105620086829
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00328629	0.05020105620086829
PRIMARY CUTIS VERTICIS GYRATA	0.0030278600000000003	0.04625330388625504
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.0030278600000000003	0.04625330388625504
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.0030278600000000003	0.04625330388625504
STEINERT MYOTONIC DYSTROPHY	0.0030278600000000003	0.04625330388625504
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0030278600000000003	0.04625330388625504
HIDROTIC ECTODERMAL DYSPLASIA	0.0030278600000000003	0.04625330388625504
GROENOUW TYPE I CORNEAL DYSTROPHY	0.0030278600000000003	0.04625330388625504
LEBER CONGENITAL AMAUROSIS 16	0.0030278600000000003	0.04625330388625504
DYSEQUILIBRIUM SYNDROME	0.0030278600000000003	0.04625330388625504
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.0030278600000000003	0.04625330388625504
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.0030278600000000003	0.04625330388625504
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0030278600000000003	0.04625330388625504
WOOLLY HAIR	0.0030278600000000003	0.04625330388625504
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.0030278600000000003	0.04625330388625504
NANCE-HORAN SYNDROME	0.0030278600000000003	0.04625330388625504
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.0030278600000000003	0.04625330388625504
MORNING GLORY DISC ANOMALY	0.0030278600000000003	0.04625330388625504
COATS DISEASE	0.0030278600000000003	0.04625330388625504
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.0030278600000000003	0.04625330388625504
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0030278600000000003	0.04625330388625504
MUSCLE-EYE-BRAIN DISEASE	0.0030278600000000003	0.04625330388625504
COWCHOCK SYNDROME; COWCK	0.00302121	0.04615171911323263
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00302121	0.04615171911323263
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00302121	0.04615171911323263
AYME-GRIPP SYNDROME; AYGRP	0.00302121	0.04615171911323263
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00302121	0.04615171911323263
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00302121	0.04615171911323263
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.045329111590336986
HIP DYSPLASIA, BEUKES TYPE	0.00296736	0.045329111590336986
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00296736	0.045329111590336986
BETHLEM MYOPATHY 2; BTHLM2	0.00296736	0.045329111590336986
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.00296736	0.045329111590336986
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00296736	0.045329111590336986
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00296736	0.045329111590336986
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00296736	0.045329111590336986
FAMILIAL SCHEUERMANN DISEASE	0.00296736	0.045329111590336986
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00296736	0.045329111590336986
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.045329111590336986
OROFACIODIGITAL SYNDROME III	0.00296736	0.045329111590336986
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00296736	0.045329111590336986
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00296736	0.045329111590336986
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.00296736	0.045329111590336986
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00296736	0.045329111590336986
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00296736	0.045329111590336986
HOLT-ORAM SYNDROME	0.00296736	0.045329111590336986
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.045329111590336986
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00296736	0.045329111590336986
GENITOPALATOCARDIAC SYNDROME	0.00296736	0.045329111590336986
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.00296736	0.045329111590336986
14Q12 MICRODELETION SYNDROME	0.00296736	0.045329111590336986
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00296736	0.045329111590336986
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00296736	0.045329111590336986
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00296736	0.045329111590336986
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00296736	0.045329111590336986
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00296736	0.045329111590336986
CRISPONI SYNDROME	0.00296736	0.045329111590336986
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00296736	0.045329111590336986
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00296736	0.045329111590336986
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00296736	0.045329111590336986
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00296736	0.045329111590336986
GAUCHER DISEASE TYPE 1	0.00296736	0.045329111590336986
PSEUDOACHONDROPLASIA	0.00296736	0.045329111590336986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00296736	0.045329111590336986
FRANK-TER HAAR SYNDROME	0.00296736	0.045329111590336986
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00296736	0.045329111590336986
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00296736	0.045329111590336986
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.00296736	0.045329111590336986
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.00296736	0.045329111590336986
PYCNODYSOSTOSIS	0.00296736	0.045329111590336986
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00296736	0.045329111590336986
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.00296736	0.045329111590336986
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.00296736	0.045329111590336986
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00296736	0.045329111590336986
HURLER-SCHEIE SYNDROME	0.00296736	0.045329111590336986
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00296736	0.045329111590336986
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00296736	0.045329111590336986
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00296736	0.045329111590336986
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00296736	0.045329111590336986
RHIZOMELIC SYNDROME, URBACH TYPE	0.00296736	0.045329111590336986
DESBUQUOIS DYSPLASIA 1	0.00296736	0.045329111590336986
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00296736	0.045329111590336986
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00296736	0.045329111590336986
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00296736	0.045329111590336986
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00296736	0.045329111590336986
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00296736	0.045329111590336986
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00296736	0.045329111590336986
CLARK-BARAITSER SYNDROME	0.00296736	0.045329111590336986
OSTEOMESOPYKNOSIS	0.00296736	0.045329111590336986
SPONDYLOENCHONDRODYSPLASIA	0.00296736	0.045329111590336986
EHLERS-DANLOS SYNDROME, TYPE VI	0.00296736	0.045329111590336986
ATKIN-FLAITZ SYNDROME	0.00296736	0.045329111590336986
RUVALCABA SYNDROME	0.00296736	0.045329111590336986
BRUCK SYNDROME	0.00296736	0.045329111590336986
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00296736	0.045329111590336986
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.00296736	0.045329111590336986
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00296736	0.045329111590336986
RETT SYNDROME, CONGENITAL VARIANT	0.00296736	0.045329111590336986
SJÖGREN-LARSSON SYNDROME	0.00296736	0.045329111590336986
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.00296736	0.045329111590336986
MENTAL RETARDATION, X-LINKED 82	0.00296736	0.045329111590336986
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00296736	0.045329111590336986
METATROPIC DYSPLASIA	0.00296736	0.045329111590336986
LOWE OCULOCEREBRORENAL SYNDROME	0.00296736	0.045329111590336986
SCHEUERMANN DISEASE	0.00296736	0.045329111590336986
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00296736	0.045329111590336986
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00296736	0.045329111590336986
WEISMANN-NETTER SYNDROME	0.00296736	0.045329111590336986
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00296736	0.045329111590336986
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00296736	0.045329111590336986
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00296736	0.045329111590336986
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00296736	0.045329111590336986
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00296736	0.045329111590336986
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.00296736	0.045329111590336986
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00296736	0.045329111590336986
TYPICAL NEMALINE MYOPATHY	0.00296736	0.045329111590336986
3M SYNDROME	0.00296736	0.045329111590336986
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00296736	0.045329111590336986
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00296736	0.045329111590336986
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00296736	0.045329111590336986
PELVISCAPULAR DYSPLASIA	0.0027627800000000003	0.04220396679861938
FREEMAN-SHELDON SYNDROME	0.0027627800000000003	0.04220396679861938
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.0027627800000000003	0.04220396679861938
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.0027627800000000003	0.04220396679861938
DISTAL MONOSOMY 10P	0.0027627800000000003	0.04220396679861938
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0027627800000000003	0.04220396679861938
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027627800000000003	0.04220396679861938
IVIC SYNDROME	0.0027627800000000003	0.04220396679861938
GAUCHER DISEASE	0.0027627800000000003	0.04220396679861938
6P22 MICRODELETION SYNDROME	0.0027627800000000003	0.04220396679861938
17Q23.1Q23.2 MICRODELETION SYNDROME	0.0027627800000000003	0.04220396679861938
RENAL COLOBOMA SYNDROME	0.0027627800000000003	0.04220396679861938
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.0027627800000000003	0.04220396679861938
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0027627800000000003	0.04220396679861938
MOEBIUS SYNDROME	0.0027627800000000003	0.04220396679861938
SLC39A8-CDG	0.0027627800000000003	0.04220396679861938
IVIC SYNDROME	0.0027627800000000003	0.04220396679861938
ACROCALLOSAL SYNDROME; ACLS	0.0027627800000000003	0.04220396679861938
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.0027627800000000003	0.04220396679861938
MOSAIC TRISOMY 8	0.0027627800000000003	0.04220396679861938
CONGENITAL HYDROCEPHALUS	0.00274909	0.0419948396493447
FETAL IODINE SYNDROME	0.00274909	0.0419948396493447
JOHANSON-BLIZZARD SYNDROME; JBS	0.00274909	0.0419948396493447
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00274909	0.0419948396493447
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00274909	0.0419948396493447
CHANARIN-DORFMAN SYNDROME	0.00274909	0.0419948396493447
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00274909	0.0419948396493447
15Q26 OVERGROWTH SYNDROME	0.00274909	0.0419948396493447
PROXIMAL SYMPHALANGISM	0.00274909	0.0419948396493447
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00274909	0.0419948396493447
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00274909	0.0419948396493447
STIFF SKIN SYNDROME	0.00274909	0.0419948396493447
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00274909	0.0419948396493447
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00274909	0.0419948396493447
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00274909	0.0419948396493447
COG5-CDG	0.00274909	0.0419948396493447
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00274909	0.0419948396493447
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00274909	0.0419948396493447
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00274909	0.0419948396493447
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00274909	0.0419948396493447
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0023280840000000002	0.035563591686778175
CONGENITAL VARICELLA SYNDROME	0.0023280840000000002	0.035563591686778175
OCULO-PALATO-CEREBRAL SYNDROME	0.0023280840000000002	0.035563591686778175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.0023280840000000002	0.035563591686778175
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0023280840000000002	0.035563591686778175
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.0023280840000000002	0.035563591686778175
MEVALONIC ACIDURIA	0.0023280840000000002	0.035563591686778175
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0023280840000000002	0.035563591686778175
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.0023280840000000002	0.035563591686778175
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0023280840000000002	0.035563591686778175
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0023280840000000002	0.035563591686778175
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0023280840000000002	0.035563591686778175
WALKER-WARBURG SYNDROME	0.0023280840000000002	0.035563591686778175
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.0023280840000000002	0.035563591686778175
PEROXISOME BIOGENESIS DISORDER 10B	0.0023280840000000002	0.035563591686778175
SENIOR-LOKEN SYNDROME	0.0023280840000000002	0.035563591686778175
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0023280840000000002	0.035563591686778175
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0023280840000000002	0.035563591686778175
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0023280840000000002	0.035563591686778175
PELLAGRA-LIKE SYNDROME	0.0023280840000000002	0.035563591686778175
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0023280840000000002	0.035563591686778175
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.0023280840000000002	0.035563591686778175
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.0023280840000000002	0.035563591686778175
ALDH18A1-RELATED DE BARSY SYNDROME	0.0023280840000000002	0.035563591686778175
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.0023280840000000002	0.035563591686778175
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.0023280840000000002	0.035563591686778175
LISSENCEPHALY 8; LIS8	0.0023280840000000002	0.035563591686778175
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0023280840000000002	0.035563591686778175
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0023280840000000002	0.035563591686778175
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.0020630040000000002	0.031514254599142526
SMITH-MAGENIS SYNDROME; SMS	0.0020630040000000002	0.031514254599142526
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0020630040000000002	0.031514254599142526
NARP SYNDROME	0.0020630040000000002	0.031514254599142526
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0020630040000000002	0.031514254599142526
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0020630040000000002	0.031514254599142526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0020630040000000002	0.031514254599142526
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0020630040000000002	0.031514254599142526
KEUTEL SYNDROME	0.0020630040000000002	0.031514254599142526
GENITOPATELLAR SYNDROME	0.0020630040000000002	0.031514254599142526
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.0020630040000000002	0.031514254599142526
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.0020630040000000002	0.031514254599142526
PELIZAEUS-MERZBACHER DISEASE	0.0020630040000000002	0.031514254599142526
SWEENEY-COX SYNDROME; SWCOS	0.0020630040000000002	0.031514254599142526
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0020630040000000002	0.031514254599142526
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0020630040000000002	0.031514254599142526
RECOMBINANT 8 SYNDROME	0.0020630040000000002	0.031514254599142526
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0020630040000000002	0.031514254599142526
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0020630040000000002	0.031514254599142526
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0020630040000000002	0.031514254599142526
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0020630040000000002	0.031514254599142526
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.0020630040000000002	0.031514254599142526
17Q12 MICRODELETION SYNDROME	0.0020630040000000002	0.031514254599142526
14Q22Q23 MICRODELETION SYNDROME	0.0020630040000000002	0.031514254599142526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0020630040000000002	0.031514254599142526
WARSAW BREAKAGE SYNDROME; WABS	0.0020630040000000002	0.031514254599142526
CHROMOSOME 1P35 DELETION SYNDROME	0.0020630040000000002	0.031514254599142526
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0020630040000000002	0.031514254599142526
HSD10 DISEASE	0.0020630040000000002	0.031514254599142526
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0020630040000000002	0.031514254599142526
22Q11.2 MICRODUPLICATION SYNDROME	0.0020630040000000002	0.031514254599142526
RFT1-CDG	0.0020630040000000002	0.031514254599142526
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.0020630040000000002	0.031514254599142526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0020630040000000002	0.031514254599142526
ABLEPHARON MACROSTOMIA SYNDROME	0.0020630040000000002	0.031514254599142526
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0020630040000000002	0.031514254599142526
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0020630040000000002	0.031514254599142526
17P11.2 MICRODUPLICATION SYNDROME	0.0020630040000000002	0.031514254599142526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0020630040000000002	0.031514254599142526
TARP SYNDROME	0.0020630040000000002	0.031514254599142526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0020630040000000002	0.031514254599142526
CORNELIA DE LANGE SYNDROME 3	0.0020630040000000002	0.031514254599142526
POTOCKI-LUPSKI SYNDROME	0.0020630040000000002	0.031514254599142526
FRIED SYNDROME	0.0020630040000000002	0.031514254599142526
BRESEK SYNDROME	0.0020630040000000002	0.031514254599142526
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.0020630040000000002	0.031514254599142526
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0020630040000000002	0.031514254599142526
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0020630040000000002	0.031514254599142526
EAR-PATELLA-SHORT STATURE SYNDROME	0.0020630040000000002	0.031514254599142526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0020630040000000002	0.031514254599142526
TAY-SACHS DISEASE	0.0020630040000000002	0.031514254599142526
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0020630040000000002	0.031514254599142526
HURLER SYNDROME	0.0020630040000000002	0.031514254599142526
COFFIN-SIRIS SYNDROME 3; CSS3	0.0020630040000000002	0.031514254599142526
COFFIN-SIRIS SYNDROME 4; CSS4	0.0020630040000000002	0.031514254599142526
LYMPHEDEMA, HEREDITARY, III	0.0020630040000000002	0.031514254599142526
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0020630040000000002	0.031514254599142526
GENITOPATELLAR SYNDROME; GTPTS	0.0020630040000000002	0.031514254599142526
20Q11.2 MICRODELETION SYNDROME	0.0020630040000000002	0.031514254599142526
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0020630040000000002	0.031514254599142526
HYDROXYKYNURENINURIA	0.0020630040000000002	0.031514254599142526
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.002049314	0.03130512744986784
NOONAN SYNDROME 11; NS11	0.002049314	0.03130512744986784
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002049314	0.03130512744986784
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.002049314	0.03130512744986784
STEEL SYNDROME; STLS	0.002049314	0.03130512744986784
PEROXISOME BIOGENESIS DISORDER 3B	0.002049314	0.03130512744986784
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002049314	0.03130512744986784
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002049314	0.03130512744986784
TOWNES-BROCKS SYNDROME 1; TBS1	0.002049314	0.03130512744986784
INFANTILE LIVER FAILURE SYNDROME 1	0.002049314	0.03130512744986784
BILATERAL POLYMICROGYRIA	0.002049314	0.03130512744986784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002049314	0.03130512744986784
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.002049314	0.03130512744986784
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002049314	0.03130512744986784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.002049314	0.03130512744986784
6Q25 MICRODELETION SYNDROME	0.002049314	0.03130512744986784
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.002049314	0.03130512744986784
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.002049314	0.03130512744986784
PEROXISOME BIOGENESIS DISORDER 6B	0.002049314	0.03130512744986784
WAARDENBURG-SHAH SYNDROME	0.002049314	0.03130512744986784
AYMÉ-GRIPP SYNDROME	0.002049314	0.03130512744986784
8Q12 MICRODUPLICATION SYNDROME	0.002049314	0.03130512744986784
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.002049314	0.03130512744986784
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.002049314	0.03130512744986784
DONNAI-BARROW SYNDROME	0.002049314	0.03130512744986784
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002049314	0.03130512744986784
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.002049314	0.03130512744986784
BARAITSER-WINTER SYNDROME 1; BRWS1	0.002049314	0.03130512744986784
PEROXISOME BIOGENESIS DISORDER 5B	0.002049314	0.03130512744986784
16P13.11 MICRODELETION SYNDROME	0.002049314	0.03130512744986784
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.002049314	0.03130512744986784
VICI SYNDROME; VICIS	0.002049314	0.03130512744986784
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002049314	0.03130512744986784
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.002049314	0.03130512744986784
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002049314	0.03130512744986784
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.002049314	0.03130512744986784
CHROMOSOME 2Q37 DELETION SYNDROME	0.002049314	0.03130512744986784
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.002049314	0.03130512744986784
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002049314	0.03130512744986784
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.002049314	0.03130512744986784
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.002049314	0.03130512744986784
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.002049314	0.03130512744986784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.002049314	0.03130512744986784
CEDNIK SYNDROME	0.002049314	0.03130512744986784
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002049314	0.03130512744986784
EAST SYNDROME	0.002049314	0.03130512744986784
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.002049314	0.03130512744986784
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002049314	0.03130512744986784
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.002049314	0.03130512744986784
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.002049314	0.03130512744986784
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.002049314	0.03130512744986784
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002049314	0.03130512744986784
GAUCHER DISEASE, TYPE II	0.001790884	0.02735737513525459
15Q13.3 MICRODELETION SYNDROME	0.001790884	0.02735737513525459
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	0.02735737513525459
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001790884	0.02735737513525459
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.001790884	0.02735737513525459
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001790884	0.02735737513525459
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001790884	0.02735737513525459
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001790884	0.02735737513525459
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	0.02735737513525459
MONOSOMY 9P	0.001790884	0.02735737513525459
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001790884	0.02735737513525459
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001790884	0.02735737513525459
ADENYLOSUCCINASE DEFICIENCY	0.001790884	0.02735737513525459
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001790884	0.02735737513525459
MUCOLIPIDOSIS IV; ML4	0.001790884	0.02735737513525459
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.02735737513525459
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001790884	0.02735737513525459
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.001790884	0.02735737513525459
OCULOECTODERMAL SYNDROME; OES	0.001790884	0.02735737513525459
HADZISELIMOVIC SYNDROME	0.001790884	0.02735737513525459
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.02735737513525459
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001790884	0.02735737513525459
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.001790884	0.02735737513525459
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.02735737513525459
CHAR SYNDROME	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001790884	0.02735737513525459
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.001790884	0.02735737513525459
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001790884	0.02735737513525459
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001790884	0.02735737513525459
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001790884	0.02735737513525459
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001790884	0.02735737513525459
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001790884	0.02735737513525459
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001790884	0.02735737513525459
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001790884	0.02735737513525459
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.02735737513525459
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	0.02735737513525459
PYRIDOXINE-DEPENDENT EPILEPSY	0.001790884	0.02735737513525459
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001790884	0.02735737513525459
SCHINDLER DISEASE, TYPE I	0.001790884	0.02735737513525459
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.02735737513525459
JOUBERT SYNDROME	0.001790884	0.02735737513525459
TETRASOMY X	0.001790884	0.02735737513525459
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.02735737513525459
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.001790884	0.02735737513525459
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001790884	0.02735737513525459
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001790884	0.02735737513525459
MEHMO SYNDROME; MEHMO	0.001790884	0.02735737513525459
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001790884	0.02735737513525459
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001790884	0.02735737513525459
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.001790884	0.02735737513525459
ANGELMAN SYNDROME	0.001790884	0.02735737513525459
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001790884	0.02735737513525459
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.02735737513525459
MENTAL RETARDATION, X-LINKED 90	0.001790884	0.02735737513525459
ADAMS-OLIVER SYNDROME 2; AOS2	0.001790884	0.02735737513525459
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001790884	0.02735737513525459
NEPHRONOPHTHISIS 11; NPHP11	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001790884	0.02735737513525459
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.001790884	0.02735737513525459
49,XXXXY SYNDROME	0.001790884	0.02735737513525459
48,XXXY SYNDROME	0.001790884	0.02735737513525459
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001790884	0.02735737513525459
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001790884	0.02735737513525459
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001790884	0.02735737513525459
AARSKOG-SCOTT SYNDROME	0.001790884	0.02735737513525459
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	0.02735737513525459
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001790884	0.02735737513525459
ARTERIAL TORTUOSITY SYNDROME	0.001790884	0.02735737513525459
X SMALL RINGS	0.001790884	0.02735737513525459
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001790884	0.02735737513525459
C SYNDROME	0.001790884	0.02735737513525459
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.02735737513525459
6Q16 MICRODELETION SYNDROME	0.001790884	0.02735737513525459
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001790884	0.02735737513525459
GABRIELE-DE VRIES SYNDROME; GADEVS	0.001790884	0.02735737513525459
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001790884	0.02735737513525459
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001790884	0.02735737513525459
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001790884	0.02735737513525459
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001790884	0.02735737513525459
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001790884	0.02735737513525459
FLOATING-HARBOR SYNDROME	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.001790884	0.02735737513525459
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001790884	0.02735737513525459
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001790884	0.02735737513525459
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001790884	0.02735737513525459
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001790884	0.02735737513525459
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001790884	0.02735737513525459
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.001790884	0.02735737513525459
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.001790884	0.02735737513525459
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001790884	0.02735737513525459
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.001790884	0.02735737513525459
PENTASOMY X	0.001790884	0.02735737513525459
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001790884	0.02735737513525459
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001790884	0.02735737513525459
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001790884	0.02735737513525459
JOUBERT SYNDROME WITH RENAL DEFECT	0.001790884	0.02735737513525459
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001790884	0.02735737513525459
HARTNUP DISEASE	0.001790884	0.02735737513525459
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001790884	0.02735737513525459
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001790884	0.02735737513525459
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001790884	0.02735737513525459
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001790884	0.02735737513525459
1Q44 MICRODELETION SYNDROME	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001790884	0.02735737513525459
HELSMOORTEL-VAN DER AA SYNDROME	0.001790884	0.02735737513525459
SCHIZENCEPHALY	0.001790884	0.02735737513525459
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001790884	0.02735737513525459
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001790884	0.02735737513525459
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION	0.001790884	0.02735737513525459
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001790884	0.02735737513525459
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001790884	0.02735737513525459
FETAL TRIMETHADIONE SYNDROME	0.001790884	0.02735737513525459
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.001790884	0.02735737513525459
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.001790884	0.02735737513525459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001790884	0.02735737513525459
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.001790884	0.02735737513525459
SENIOR-LOKEN SYNDROME 9	0.001790884	0.02735737513525459
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.001790884	0.02735737513525459
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001790884	0.02735737513525459
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001790884	0.02735737513525459
BAKER-GORDON SYNDROME; BAGOS	0.001790884	0.02735737513525459
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001790884	0.02735737513525459
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001790884	0.02735737513525459
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.001790884	0.02735737513525459
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001790884	0.02735737513525459
TOLUENE EMBRYOPATHY	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.001790884	0.02735737513525459
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001790884	0.02735737513525459
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.001790884	0.02735737513525459
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001790884	0.02735737513525459
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001790884	0.02735737513525459
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001790884	0.02735737513525459
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001790884	0.02735737513525459
2Q32Q33 MICRODELETION SYNDROME	0.001790884	0.02735737513525459
PHENYLKETONURIA	0.00178253	0.02722976021888931
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00178253	0.02722976021888931
PACHYONYCHIA CONGENITA	0.00178253	0.02722976021888931
GALACTOKINASE DEFICIENCY	0.00178253	0.02722976021888931
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.00178253	0.02722976021888931
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.00178253	0.02722976021888931
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00178253	0.02722976021888931
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.00178253	0.02722976021888931
%609376 CATARACT 35; CTRCT35;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	0.00178253	0.02722976021888931
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00178253	0.02722976021888931
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	0.00178253	0.02722976021888931
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00178253	0.02722976021888931
X-LINKED RETINOSCHISIS	0.00178253	0.02722976021888931
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00178253	0.02722976021888931
GALACTOKINASE DEFICIENCY	0.00178253	0.02722976021888931
CEREBROTENDINOUS XANTHOMATOSIS	0.00178253	0.02722976021888931
2Q24 MICRODELETION SYNDROME	0.00178253	0.02722976021888931
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00178253	0.02722976021888931
MONILETHRIX	0.00178253	0.02722976021888931
MICROPHTHALMIA, ISOLATED 5	0.00178253	0.02722976021888931
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00178253	0.02722976021888931
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00178253	0.02722976021888931
MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	0.00178253	0.02722976021888931
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.00178253	0.02722976021888931
DENT DISEASE	0.00178253	0.02722976021888931
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00178253	0.02722976021888931
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.00178253	0.02722976021888931
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00178253	0.02722976021888931
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00178253	0.02722976021888931
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00178253	0.02722976021888931
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00178253	0.02722976021888931
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00178253	0.02722976021888931
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00178253	0.02722976021888931
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00178253	0.02722976021888931
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00178253	0.02722976021888931
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00178253	0.02722976021888931
MEGALOCORNEA	0.00178253	0.02722976021888931
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00178253	0.02722976021888931
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00178253	0.02722976021888931
SCALP-EAR-NIPPLE SYNDROME	0.00178253	0.02722976021888931
PROXIMAL MYOTONIC MYOPATHY	0.00178253	0.02722976021888931
BIRDSHOT CHORIORETINOPATHY	0.00178253	0.02722976021888931
FRONTOFACIONASAL DYSPLASIA	0.00178253	0.02722976021888931
AMOEBIC KERATITIS	0.00178253	0.02722976021888931
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00178253	0.02722976021888931
COENZYME Q10 DEFICIENCY	0.00178253	0.02722976021888931
TRICHOMEGALY; TCMGLY	0.00178253	0.02722976021888931
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00178253	0.02722976021888931
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00178253	0.02722976021888931
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00178253	0.02722976021888931
TRIPLOIDY	0.00178253	0.02722976021888931
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00178253	0.02722976021888931
WEILL-MARCHESANI SYNDROME	0.00178253	0.02722976021888931
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00178253	0.02722976021888931
ISOLATED ECTOPIA LENTIS	0.00178253	0.02722976021888931
RETINITIS PIGMENTOSA 84; RP84	0.00178253	0.02722976021888931
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.00178253	0.02722976021888931
ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	0.00178253	0.02722976021888931
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00178253	0.02722976021888931
ANIRIDIA AND ABSENT PATELLA	0.00178253	0.02722976021888931
ANIRIDIA	0.00178253	0.02722976021888931
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00178253	0.02722976021888931
CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	0.00178253	0.02722976021888931
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00178253	0.02722976021888931
MYOTONIC DYSTROPHY 1	0.00178253	0.02722976021888931
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00178253	0.02722976021888931
ANIRIDIA 2	0.00178253	0.02722976021888931
ANIRIDIA 3	0.00178253	0.02722976021888931
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.00178253	0.02722976021888931
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00178253	0.02722976021888931
ENHANCED S-CONE SYNDROME	0.00178253	0.02722976021888931
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00178253	0.02722976021888931
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00178253	0.02722976021888931
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00178253	0.02722976021888931
ANTERIOR SEGMENT DYSGENESIS 8	0.00178253	0.02722976021888931
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00178253	0.02722976021888931
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00178253	0.02722976021888931
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00178253	0.02722976021888931
SPINAL MUSCULAR ATROPHY-DANDY-WALKER MALFORMATION-CATARACTS SYNDROME	0.00178253	0.02722976021888931
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00178253	0.02722976021888931
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00178253	0.02722976021888931
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00178253	0.02722976021888931
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00178253	0.02722976021888931
DERMATITIS, ATOPIC	0.00178253	0.02722976021888931
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00178253	0.02722976021888931
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00178253	0.02722976021888931
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00178253	0.02722976021888931
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00178253	0.02722976021888931
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00178253	0.02722976021888931
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00178253	0.02722976021888931
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00178253	0.02722976021888931
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00178253	0.02722976021888931
ISOLATED ANIRIDIA	0.00178253	0.02722976021888931
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.00178253	0.02722976021888931
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00178253	0.02722976021888931
116100 CATARACT, MEMBRANOUS	0.00178253	0.02722976021888931
CONE-ROD DYSTROPHY 16	0.00178253	0.02722976021888931
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00178253	0.02722976021888931
CATARACT AND CONGENITAL ICHTHYOSIS	0.00178253	0.02722976021888931
STROMME SYNDROME; STROMS	0.00178253	0.02722976021888931
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00178253	0.02722976021888931
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00178253	0.02722976021888931
MECKEL SYNDROME	0.00178253	0.02722976021888931
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.00178253	0.02722976021888931
IRIS PIGMENT LAYER, CLEAVAGE OF	0.00178253	0.02722976021888931
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00178253	0.02722976021888931
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00178253	0.02722976021888931
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.00178253	0.02722976021888931
RETINITIS PIGMENTOSA 4; RP4	0.00178253	0.02722976021888931
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00178253	0.02722976021888931
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00178253	0.02722976021888931
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00178253	0.02722976021888931
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00178253	0.02722976021888931
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00178253	0.02722976021888931
HYPERTROPHIC NEUROPATHY AND CATARACT	0.00178253	0.02722976021888931
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00178253	0.02722976021888931
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00178253	0.02722976021888931
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00178253	0.02722976021888931
CATARACT, CRYSTALLINE CORALLIFORM	0.00178253	0.02722976021888931
BARDET-BIEDL SYNDROME 18; BBS18	0.00178253	0.02722976021888931
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00178253	0.02722976021888931
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00178253	0.02722976021888931
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00178253	0.02722976021888931
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00178253	0.02722976021888931
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00178253	0.02722976021888931
ALG2-CDG	0.00178253	0.02722976021888931
HYPOGONADISM-CATARACT SYNDROME	0.00178253	0.02722976021888931
INTERMEDIATE UVEITIS	0.00178253	0.02722976021888931
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00178253	0.02722976021888931
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00178253	0.02722976021888931
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00178253	0.02722976021888931
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00178253	0.02722976021888931
IDIOPATHIC PANUVEITIS	0.00178253	0.02722976021888931
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00178253	0.02722976021888931
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00178253	0.02722976021888931
ALG8-CDG	0.00178253	0.02722976021888931
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.00178253	0.02722976021888931
EXFOLIATION SYNDROME; XFS	0.00178253	0.02722976021888931
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00178253	0.02722976021888931
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00178253	0.02722976021888931
CATARACT-MICROCORNEA SYNDROME	0.00178253	0.02722976021888931
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.00178253	0.02722976021888931
KEARNS-SAYRE SYNDROME	0.00151745	0.02318042313125366
BARBER-SAY SYNDROME; BBRSAY	0.00151745	0.02318042313125366
RICHARDS-RUNDLE SYNDROME	0.00151745	0.02318042313125366
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.02318042313125366
RHYNS SYNDROME	0.00151745	0.02318042313125366
XYLOSIDASE DEFICIENCY	0.00151745	0.02318042313125366
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00151745	0.02318042313125366
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00151745	0.02318042313125366
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00151745	0.02318042313125366
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00151745	0.02318042313125366
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00151745	0.02318042313125366
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00151745	0.02318042313125366
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00151745	0.02318042313125366
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.02318042313125366
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.02318042313125366
TUNE DEAFNESS	0.00151745	0.02318042313125366
ADRENOLEUKODYSTROPHY	0.00151745	0.02318042313125366
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.02318042313125366
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.02318042313125366
FRIEDREICH ATAXIA	0.00151745	0.02318042313125366
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.02318042313125366
MYASTHENIA GRAVIS	0.00151745	0.02318042313125366
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00151745	0.02318042313125366
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.02318042313125366
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00151745	0.02318042313125366
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.02318042313125366
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00151745	0.02318042313125366
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00151745	0.02318042313125366
COXOAURICULAR SYNDROME	0.00151745	0.02318042313125366
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.02318042313125366
GYRATE ATROPHY OF CHOROID AND RETINA	0.00151745	0.02318042313125366
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.02318042313125366
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00151745	0.02318042313125366
CANAVAN DISEASE	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA TYPE 18	0.00151745	0.02318042313125366
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.02318042313125366
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00151745	0.02318042313125366
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.02318042313125366
DISTAL TRISOMY 14Q	0.00151745	0.02318042313125366
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00151745	0.02318042313125366
AUROCEPHALOSYNDACTYLY	0.00151745	0.02318042313125366
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00151745	0.02318042313125366
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.02318042313125366
DEMENTIA, FAMILIAL DANISH	0.00151745	0.02318042313125366
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00151745	0.02318042313125366
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.02318042313125366
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.02318042313125366
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.02318042313125366
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00151745	0.02318042313125366
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.02318042313125366
CLEIDOCRANIAL DYSPLASIA	0.00151745	0.02318042313125366
CAMURATI-ENGELMANN DISEASE	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.02318042313125366
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00151745	0.02318042313125366
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00151745	0.02318042313125366
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00151745	0.02318042313125366
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00151745	0.02318042313125366
THALIDOMIDE EMBRYOPATHY	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00151745	0.02318042313125366
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00151745	0.02318042313125366
FETAL METHYLMERCURY SYNDROME	0.00151745	0.02318042313125366
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00151745	0.02318042313125366
GRACILE SYNDROME	0.00151745	0.02318042313125366
CAT-EYE SYNDROME	0.00151745	0.02318042313125366
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00151745	0.02318042313125366
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.02318042313125366
DIABETIC EMBRYOPATHY	0.00151745	0.02318042313125366
DYSOSTEOSCLEROSIS	0.00151745	0.02318042313125366
RETINAL VENOUS BEADING	0.00151745	0.02318042313125366
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.00151745	0.02318042313125366
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00151745	0.02318042313125366
CHARGE-LIKE SYNDROME, X-LINKED	0.00151745	0.02318042313125366
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00151745	0.02318042313125366
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00151745	0.02318042313125366
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00151745	0.02318042313125366
SCLEROSTEOSIS 2; SOST2	0.00151745	0.02318042313125366
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00151745	0.02318042313125366
USHER SYNDROME, TYPE ID	0.00151745	0.02318042313125366
ACRODYSOSTOSIS	0.00151745	0.02318042313125366
NON-DISTAL MONOSOMY 20Q	0.00151745	0.02318042313125366
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00151745	0.02318042313125366
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00151745	0.02318042313125366
DEAFNESS-CRANIOFACIAL SYNDROME	0.00151745	0.02318042313125366
CONE-ROD DYSTROPHY 1; CORD1	0.00151745	0.02318042313125366
ABCD SYNDROME	0.00151745	0.02318042313125366
DYSOSTEOSCLEROSIS	0.00151745	0.02318042313125366
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.02318042313125366
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00151745	0.02318042313125366
MELNICK-NEEDLES SYNDROME	0.00151745	0.02318042313125366
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00151745	0.02318042313125366
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00151745	0.02318042313125366
MESOMELIA-SYNOSTOSES SYNDROME	0.00151745	0.02318042313125366
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.02318042313125366
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00151745	0.02318042313125366
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00151745	0.02318042313125366
DEAFNESS, X-LINKED 7; DFNX7	0.00151745	0.02318042313125366
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.02318042313125366
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00151745	0.02318042313125366
WILDERVANCK SYNDROME	0.00151745	0.02318042313125366
MENIERE DISEASE	0.00151745	0.02318042313125366
7Q11.23 MICRODUPLICATION SYNDROME	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.02318042313125366
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00151745	0.02318042313125366
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00151745	0.02318042313125366
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00151745	0.02318042313125366
BARBER-SAY SYNDROME	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.02318042313125366
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.02318042313125366
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00151745	0.02318042313125366
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.02318042313125366
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.02318042313125366
3MC SYNDROME	0.00151745	0.02318042313125366
ACQUIRED PARTIAL LIPODYSTROPHY	0.00151745	0.02318042313125366
AXENFELD-RIEGER SYNDROME	0.00151745	0.02318042313125366
X-LINKED HYPOPHOSPHATEMIA	0.00151745	0.02318042313125366
COXOAURICULAR SYNDROME	0.00151745	0.02318042313125366
OPTICOCOCHLEODENTATE DEGENERATION	0.00151745	0.02318042313125366
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00151745	0.02318042313125366
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.02318042313125366
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00151745	0.02318042313125366
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.02318042313125366
FETAL IODINE DEFICIENCY DISORDER	0.00151745	0.02318042313125366
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.02318042313125366
WAARDENBURG-SHAH SYNDROME	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA TYPE 36	0.00151745	0.02318042313125366
WAARDENBURG SYNDROME TYPE 3	0.00151745	0.02318042313125366
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00151745	0.02318042313125366
GALACTOSIALIDOSIS	0.00151745	0.02318042313125366
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.02318042313125366
PFEIFFER SYNDROME TYPE 1	0.00151745	0.02318042313125366
PFEIFFER SYNDROME TYPE 3	0.00151745	0.02318042313125366
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.00151745	0.02318042313125366
BRITTLE CORNEA SYNDROME	0.00151745	0.02318042313125366
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.02318042313125366
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00151745	0.02318042313125366
OHDO SYNDROME	0.00151745	0.02318042313125366
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00151745	0.02318042313125366
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00151745	0.02318042313125366
OTOSCLEROSIS 8; OTSC8	0.00151745	0.02318042313125366
3MC SYNDROME 3	0.00151745	0.02318042313125366
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.02318042313125366
OTOPALATODIGITAL SYNDROME TYPE 1	0.00151745	0.02318042313125366
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00151745	0.02318042313125366
HARDIKAR SYNDROME	0.00151745	0.02318042313125366
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.02318042313125366
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.02318042313125366
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.02318042313125366
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00151745	0.02318042313125366
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00151745	0.02318042313125366
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00151745	0.02318042313125366
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00151745	0.02318042313125366
DISTAL MONOSOMY 3P	0.00151745	0.02318042313125366
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00151745	0.02318042313125366
PILI TORTI	0.00151745	0.02318042313125366
TIETZ SYNDROME	0.00151745	0.02318042313125366
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00151745	0.02318042313125366
ARACHNOIDITIS	0.00151745	0.02318042313125366
OSTEOPETROSIS AND RELATED DISORDERS	0.00151745	0.02318042313125366
MICROTRIPLICATION 11Q24.1	0.00151745	0.02318042313125366
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.02318042313125366
ISOLATED KLIPPEL-FEIL SYNDROME	0.00151745	0.02318042313125366
GLYCOGEN STORAGE DISEASE II	0.00151745	0.02318042313125366
KLEEFSTRA SYNDROME	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.02318042313125366
LOCKED-IN SYNDROME	0.00151745	0.02318042313125366
ISOLATED BRACHYCEPHALY	0.00151745	0.02318042313125366
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00151745	0.02318042313125366
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00151745	0.02318042313125366
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00151745	0.02318042313125366
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.02318042313125366
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00151745	0.02318042313125366
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00151745	0.02318042313125366
BRANCHIOOTIC SYNDROME 2	0.00151745	0.02318042313125366
46,XX GONADAL DYSGENESIS	0.00151745	0.02318042313125366
FEINGOLD SYNDROME 1; FGLDS1	0.00151745	0.02318042313125366
CHIARI MALFORMATION TYPE I	0.00151745	0.02318042313125366
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.02318042313125366
TIBIAL HEMIMELIA	0.00151745	0.02318042313125366
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA TYPE 31	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.02318042313125366
ANUS, IMPERFORATE	0.00151745	0.02318042313125366
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.02318042313125366
H SYNDROME	0.00151745	0.02318042313125366
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.00151745	0.02318042313125366
SCLEROSTEOSIS 1; SOST1	0.00151745	0.02318042313125366
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00151745	0.02318042313125366
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00151745	0.02318042313125366
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.02318042313125366
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00151745	0.02318042313125366
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.02318042313125366
GORDON SYNDROME	0.00151745	0.02318042313125366
OTOSCLEROSIS 3; OTSC3	0.00151745	0.02318042313125366
NAGER SYNDROME	0.00151745	0.02318042313125366
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00151745	0.02318042313125366
BARDET-BIEDL SYNDROME	0.00151745	0.02318042313125366
SPINOCEREBELLAR ATAXIA 13	0.00151745	0.02318042313125366
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.02318042313125366
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00151745	0.02318042313125366
RAPADILINO SYNDROME	0.00151745	0.02318042313125366
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.02318042313125366
ATYPICAL RETT SYNDROME	0.00151745	0.02318042313125366
BOR SYNDROME	0.00151745	0.02318042313125366
184705 STEINFELD SYNDROME	0.00151745	0.02318042313125366
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.02318042313125366
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.02318042313125366
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.02318042313125366
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.02318042313125366
GOLDENHAR SYNDROME	0.00151745	0.02318042313125366
SIFRIM-HITZ-WEISS SYNDROME	0.00151745	0.02318042313125366
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.00151745	0.02318042313125366
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00150376	0.022971295981978977
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00150376	0.022971295981978977
THYROCEREBRORETINAL SYNDROME	0.00150376	0.022971295981978977
MADRAS MOTOR NEURON DISEASE	0.00150376	0.022971295981978977
ERMINE PHENOTYPE	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.022971295981978977
FEINGOLD SYNDROME	0.00150376	0.022971295981978977
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00150376	0.022971295981978977
ALBINISM-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.022971295981978977
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.00150376	0.022971295981978977
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00150376	0.022971295981978977
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.022971295981978977
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00150376	0.022971295981978977
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00150376	0.022971295981978977
CADASIL	0.00150376	0.022971295981978977
ERMINE PHENOTYPE	0.00150376	0.022971295981978977
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00150376	0.022971295981978977
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.00150376	0.022971295981978977
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.022971295981978977
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00150376	0.022971295981978977
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00150376	0.022971295981978977
NASODIGITOACOUSTIC SYNDROME	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00150376	0.022971295981978977
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00150376	0.022971295981978977
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00150376	0.022971295981978977
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.022971295981978977
3P25.3 MICRODELETION SYNDROME	0.00150376	0.022971295981978977
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00150376	0.022971295981978977
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.022971295981978977
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.022971295981978977
NEUTRAL LIPID STORAGE MYOPATHY	0.00150376	0.022971295981978977
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.022971295981978977
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.022971295981978977
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.022971295981978977
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.022971295981978977
ACROCALLOSAL SYNDROME	0.00150376	0.022971295981978977
SPINOCEREBELLAR ATAXIA TYPE 37	0.00150376	0.022971295981978977
FOUNTAIN SYNDROME	0.00150376	0.022971295981978977
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.022971295981978977
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.022971295981978977
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00150376	0.022971295981978977
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.00150376	0.022971295981978977
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00150376	0.022971295981978977
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00150376	0.022971295981978977
MYH9-RELATED DISEASE	0.00150376	0.022971295981978977
USHER SYNDROME, TYPE IIIA	0.00150376	0.022971295981978977
COGAN SYNDROME	0.00150376	0.022971295981978977
AMISH INFANTILE EPILEPSY SYNDROME	0.00150376	0.022971295981978977
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.022971295981978977
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.022971295981978977
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.022971295981978977
HYPERLEUCINE-ISOLEUCINEMIA	0.00150376	0.022971295981978977
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.022971295981978977
BJÖRNSTAD SYNDROME	0.00150376	0.022971295981978977
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.022971295981978977
WOODHOUSE-SAKATI SYNDROME	0.00150376	0.022971295981978977
ACUTE BILIRUBIN ENCEPHALOPATHY	0.00150376	0.022971295981978977
SEVERE COMBINED IMMUNODEFICIENCY	0.00150376	0.022971295981978977
USHER SYNDROME, TYPE IG	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.022971295981978977
OTODENTAL DYSPLASIA	0.00150376	0.022971295981978977
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.022971295981978977
SHEEHAN SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.022971295981978977
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.022971295981978977
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00150376	0.022971295981978977
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00150376	0.022971295981978977
OPTIC ATROPHY 8	0.00150376	0.022971295981978977
HAMAMY SYNDROME; HMMS	0.00150376	0.022971295981978977
BRACHYDACTYLY, TYPE B2	0.00150376	0.022971295981978977
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.022971295981978977
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
KERATODERMA HEREDITARIUM MUTILANS	0.00150376	0.022971295981978977
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.022971295981978977
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.022971295981978977
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00150376	0.022971295981978977
STICKLER SYNDROME, TYPE III	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.022971295981978977
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00150376	0.022971295981978977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00150376	0.022971295981978977
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.022971295981978977
FAMILIAL LONG QT SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.022971295981978977
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.022971295981978977
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.022971295981978977
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00150376	0.022971295981978977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00150376	0.022971295981978977
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.022971295981978977
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00150376	0.022971295981978977
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00150376	0.022971295981978977
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.022971295981978977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00150376	0.022971295981978977
SPINOCEREBELLAR ATAXIA 31	0.00150376	0.022971295981978977
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.022971295981978977
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.022971295981978977
TRIPLE A SYNDROME	0.00150376	0.022971295981978977
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00150376	0.022971295981978977
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.022971295981978977
KEIPERT SYNDROME	0.00150376	0.022971295981978977
STICKLER SYNDROME, TYPE V; STL5	0.00150376	0.022971295981978977
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.022971295981978977
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00150376	0.022971295981978977
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.022971295981978977
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00150376	0.022971295981978977
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.022971295981978977
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00150376	0.022971295981978977
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
MYOPATHY AND DIABETES MELLITUS	0.00150376	0.022971295981978977
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.022971295981978977
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.022971295981978977
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00150376	0.022971295981978977
JOHANSON-BLIZZARD SYNDROME	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.022971295981978977
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00150376	0.022971295981978977
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00150376	0.022971295981978977
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00150376	0.022971295981978977
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00150376	0.022971295981978977
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00150376	0.022971295981978977
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.022971295981978977
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.022971295981978977
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.022971295981978977
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.022971295981978977
WAARDENBURG SYNDROME TYPE 2	0.00150376	0.022971295981978977
LOWE-KOHN-COHEN SYNDROME	0.00150376	0.022971295981978977
RETINITIS PIGMENTOSA 59; RP59	0.00150376	0.022971295981978977
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.022971295981978977
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00150376	0.022971295981978977
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.022971295981978977
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.022971295981978977
WAARDENBURG SYNDROME, TYPE IIB	0.00150376	0.022971295981978977
PANHYPOPHYSITIS	0.00150376	0.022971295981978977
ADENOHYPOPHYSITIS	0.00150376	0.022971295981978977
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00150376	0.022971295981978977
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.022971295981978977
DEAFNESS-CRANIOFACIAL SYNDROME	0.00150376	0.022971295981978977
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.022971295981978977
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00150376	0.022971295981978977
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.022971295981978977
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.00150376	0.022971295981978977
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.022971295981978977
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.022971295981978977
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.022971295981978977
KEARNS-SAYRE SYNDROME; KSS	0.00150376	0.022971295981978977
KALLMANN SYNDROME	0.00150376	0.022971295981978977
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00150376	0.022971295981978977
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.022971295981978977
WORSTER-DROUGHT SYNDROME	0.00150376	0.022971295981978977
WOLFRAM SYNDROME	0.00150376	0.022971295981978977
IMMUNODEFICIENCY 47	0.00150376	0.022971295981978977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.022971295981978977
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00150376	0.022971295981978977
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.022971295981978977
KEIPERT SYNDROME; KPTS	0.00150376	0.022971295981978977
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00150376	0.022971295981978977
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.022971295981978977
DEAFNESS, X-LINKED 1	0.00150376	0.022971295981978977
FRONTOMETAPHYSEAL DYSPLASIA	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.022971295981978977
THYROCEREBRORENAL SYNDROME	0.00150376	0.022971295981978977
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00150376	0.022971295981978977
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.022971295981978977
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00150376	0.022971295981978977
CRANDALL SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, Y-LINKED 1	0.00150376	0.022971295981978977
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.022971295981978977
GEMIGNANI SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.022971295981978977
SCLEROSTEOSIS	0.00150376	0.022971295981978977
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00150376	0.022971295981978977
RENIER-GABREELS-JASPER SYNDROME	0.00150376	0.022971295981978977
JUBERG-MARSIDI SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.022971295981978977
WOLFRAM SYNDROME 2; WFS2	0.00150376	0.022971295981978977
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.022971295981978977
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.022971295981978977
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.022971295981978977
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.022971295981978977
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00150376	0.022971295981978977
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.022971295981978977
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00150376	0.022971295981978977
HURLER-SCHEIE SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.022971295981978977
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00150376	0.022971295981978977
SCHEIE SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.022971295981978977
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.022971295981978977
CRANIOFRONTONASAL DYSPLASIA	0.00150376	0.022971295981978977
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.022971295981978977
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00150376	0.022971295981978977
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00150376	0.022971295981978977
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.022971295981978977
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.022971295981978977
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.022971295981978977
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.00150376	0.022971295981978977
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.019023543667365726
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00124533	0.019023543667365726
16P12.1P12.3 TRIPLICATION SYNDROME	0.00124533	0.019023543667365726
FRAGILE X SYNDROME	0.00124533	0.019023543667365726
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00124533	0.019023543667365726
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00124533	0.019023543667365726
LEIGH SYNDROME	0.00124533	0.019023543667365726
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.019023543667365726
ALAGILLE SYNDROME	0.00124533	0.019023543667365726
ANGELMAN SYNDROME	0.00124533	0.019023543667365726
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00124533	0.019023543667365726
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00124533	0.019023543667365726
ANTLEY-BIXLER SYNDROME	0.00124533	0.019023543667365726
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.019023543667365726
GAUCHER DISEASE TYPE 3	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA TYPE 42	0.00124533	0.019023543667365726
PETERS ANOMALY	0.00124533	0.019023543667365726
ABDUCENS PALSY	0.00124533	0.019023543667365726
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00124533	0.019023543667365726
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00124533	0.019023543667365726
MUCOLIPIDOSIS TYPE IV	0.00124533	0.019023543667365726
MULTIMINICORE MYOPATHY	0.00124533	0.019023543667365726
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.019023543667365726
GAUCHER DISEASE TYPE 2	0.00124533	0.019023543667365726
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00124533	0.019023543667365726
PETERS ANOMALY	0.00124533	0.019023543667365726
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.019023543667365726
MENTAL RETARDATION, X-LINKED 1	0.00124533	0.019023543667365726
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	0.019023543667365726
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00124533	0.019023543667365726
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00124533	0.019023543667365726
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00124533	0.019023543667365726
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00124533	0.019023543667365726
MOWAT-WILSON SYNDROME	0.00124533	0.019023543667365726
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.019023543667365726
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00124533	0.019023543667365726
GASTROCUTANEOUS SYNDROME	0.00124533	0.019023543667365726
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.019023543667365726
FEMORAL-FACIAL SYNDROME	0.00124533	0.019023543667365726
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	0.019023543667365726
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.019023543667365726
EEM SYNDROME	0.00124533	0.019023543667365726
X-LINKED RETINAL DYSPLASIA	0.00124533	0.019023543667365726
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.019023543667365726
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00124533	0.019023543667365726
TRISOMY 4P	0.00124533	0.019023543667365726
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00124533	0.019023543667365726
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.019023543667365726
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00124533	0.019023543667365726
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00124533	0.019023543667365726
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.019023543667365726
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	0.019023543667365726
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00124533	0.019023543667365726
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00124533	0.019023543667365726
SOTOS SYNDROME 2	0.00124533	0.019023543667365726
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00124533	0.019023543667365726
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00124533	0.019023543667365726
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.019023543667365726
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.019023543667365726
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00124533	0.019023543667365726
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.019023543667365726
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00124533	0.019023543667365726
1Q41Q42 MICRODELETION SYNDROME	0.00124533	0.019023543667365726
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00124533	0.019023543667365726
ROBINOW-SORAUF SYNDROME	0.00124533	0.019023543667365726
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.019023543667365726
WHITE FORELOCK WITH MALFORMATIONS	0.00124533	0.019023543667365726
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00124533	0.019023543667365726
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.019023543667365726
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.019023543667365726
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.019023543667365726
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.019023543667365726
MENTAL RETARDATION, X-LINKED 21	0.00124533	0.019023543667365726
ODONTOCHONDRODYSPLASIA	0.00124533	0.019023543667365726
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00124533	0.019023543667365726
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.019023543667365726
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.019023543667365726
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.019023543667365726
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	0.019023543667365726
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00124533	0.019023543667365726
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00124533	0.019023543667365726
SECKEL SYNDROME 1; SCKL1	0.00124533	0.019023543667365726
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00124533	0.019023543667365726
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00124533	0.019023543667365726
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00124533	0.019023543667365726
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00124533	0.019023543667365726
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00124533	0.019023543667365726
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.019023543667365726
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00124533	0.019023543667365726
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00124533	0.019023543667365726
RETINAL CONE DYSTROPHY 3B	0.00124533	0.019023543667365726
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00124533	0.019023543667365726
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00124533	0.019023543667365726
PITT-HOPKINS SYNDROME	0.00124533	0.019023543667365726
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00124533	0.019023543667365726
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00124533	0.019023543667365726
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00124533	0.019023543667365726
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00124533	0.019023543667365726
SECKEL SYNDROME 5; SCKL5	0.00124533	0.019023543667365726
DISTAL MONOSOMY 7Q36	0.00124533	0.019023543667365726
NON-DISTAL MONOSOMY 10Q	0.00124533	0.019023543667365726
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.019023543667365726
JACKSON-WEISS SYNDROME	0.00124533	0.019023543667365726
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.019023543667365726
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	0.019023543667365726
HYPERTELORISM, TEEBI TYPE	0.00124533	0.019023543667365726
CRANIOFACIAL DYSSYNOSTOSIS	0.00124533	0.019023543667365726
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00124533	0.019023543667365726
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.019023543667365726
CEREBROFACIOTHORACIC DYSPLASIA	0.00124533	0.019023543667365726
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00124533	0.019023543667365726
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00124533	0.019023543667365726
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.019023543667365726
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00124533	0.019023543667365726
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.00124533	0.019023543667365726
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.019023543667365726
BENCZE SYNDROME	0.00124533	0.019023543667365726
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.019023543667365726
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	0.019023543667365726
5Q14.3 MICRODELETION SYNDROME	0.00124533	0.019023543667365726
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.00124533	0.019023543667365726
QAZI-MARKOUIZOS SYNDROME	0.00124533	0.019023543667365726
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00124533	0.019023543667365726
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.019023543667365726
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00124533	0.019023543667365726
PROGEROID SYNDROME, PETTY TYPE	0.00124533	0.019023543667365726
SENGERS SYNDROME	0.00124533	0.019023543667365726
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.019023543667365726
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00124533	0.019023543667365726
OPTIC ATROPHY 1; OPA1	0.00124533	0.019023543667365726
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.019023543667365726
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.019023543667365726
SMITH-KINGSMORE SYNDROME; SKS	0.00124533	0.019023543667365726
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.019023543667365726
MALAN OVERGROWTH SYNDROME	0.00124533	0.019023543667365726
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00124533	0.019023543667365726
GAUCHER DISEASE, TYPE IIIC	0.00124533	0.019023543667365726
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00124533	0.019023543667365726
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.019023543667365726
GLUTATHIONURIA	0.00124533	0.019023543667365726
LAMBOTTE SYNDROME	0.00124533	0.019023543667365726
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.019023543667365726
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00124533	0.019023543667365726
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00124533	0.019023543667365726
LERI PLEONOSTEOSIS	0.00124533	0.019023543667365726
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.019023543667365726
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00124533	0.019023543667365726
DESMOSTEROLOSIS	0.00124533	0.019023543667365726
NANOPHTHALMOS	0.00124533	0.019023543667365726
JACOBSEN SYNDROME	0.00124533	0.019023543667365726
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00124533	0.019023543667365726
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.019023543667365726
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00124533	0.019023543667365726
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.019023543667365726
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00124533	0.019023543667365726
OCULAR ALBINISM	0.00124533	0.019023543667365726
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.019023543667365726
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00124533	0.019023543667365726
GAPO SYNDROME; GAPOS	0.00124533	0.019023543667365726
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.019023543667365726
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00124533	0.019023543667365726
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00124533	0.019023543667365726
SUMMITT SYNDROME	0.00124533	0.019023543667365726
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.008333831467888865
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.008333831467888865
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000545554	0.008333831467888865
ARGININEMIA	0.000545554	0.008333831467888865
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.008333831467888865
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.008333831467888865
CULLER-JONES SYNDROME; CJS	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.008333831467888865
AICARDI-GOUTIERES SYNDROME 7	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.008333831467888865
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.008333831467888865
XIA-GIBBS SYNDROME	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.008333831467888865
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.008333831467888865
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000545554	0.008333831467888865
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.008333831467888865
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.008333831467888865
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.008333831467888865
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.008333831467888865
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.008333831467888865
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.008333831467888865
JOUBERT SYNDROME 8	0.000545554	0.008333831467888865
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.008333831467888865
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.008333831467888865
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.008333831467888865
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.008333831467888865
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.008333831467888865
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.008333831467888865
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.008333831467888865
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.008333831467888865
GRISCELLI SYNDROME TYPE 1	0.000545554	0.008333831467888865
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.008333831467888865
WEBB-DATTANI SYNDROME; WEDAS	0.000545554	0.008333831467888865
GLASS SYNDROME	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.008333831467888865
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.008333831467888865
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.008333831467888865
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.008333831467888865
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.008333831467888865
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.008333831467888865
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.008333831467888865
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.008333831467888865
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.008333831467888865
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000545554	0.008333831467888865
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.008333831467888865
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000545554	0.008333831467888865
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.008333831467888865
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000545554	0.008333831467888865
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.008333831467888865
COFFIN-SIRIS SYNDROME 2; CSS2	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.008333831467888865
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.008333831467888865
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.008333831467888865
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.008333831467888865
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.008333831467888865
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.008333831467888865
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.008333831467888865
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000545554	0.008333831467888865
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.008333831467888865
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.008333831467888865
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.008333831467888865
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.008333831467888865
JOUBERT SYNDROME 15	0.000545554	0.008333831467888865
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.008333831467888865
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.008333831467888865
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.008333831467888865
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000545554	0.008333831467888865
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.008333831467888865
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.008333831467888865
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.008333831467888865
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.008333831467888865
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888865
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.008333831467888865
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.008333831467888865
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.008333831467888865
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.008333831467888865
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.008333831467888865
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.008333831467888865
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.008333831467888865
DPAGT1-CDG	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.008333831467888865
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.008333831467888865
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.008333831467888865
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000545554	0.008333831467888865
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.008333831467888865
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.008333831467888865
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.008333831467888865
LISSENCEPHALY 4	0.000545554	0.008333831467888865
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.008333831467888865
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.008333831467888865
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.008333831467888865
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.008333831467888865
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.008333831467888865
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.008333831467888865
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.008333831467888865
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.008333831467888865
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888865
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.008333831467888865
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.008333831467888865
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.008333831467888865
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.008333831467888865
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.008333831467888865
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.008333831467888865
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.008333831467888865
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.008333831467888865
HOLOPROSENCEPHALY 11	0.000545554	0.008333831467888865
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.008333831467888865
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.008333831467888865
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.008333831467888865
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000545554	0.008333831467888865
COACH SYNDROME	0.000545554	0.008333831467888865
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.000545554	0.008333831467888865
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.008333831467888865
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.008333831467888865
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.008333831467888865
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.008333831467888865
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.008333831467888865
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.008333831467888865
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.008333831467888865
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.008333831467888865
SULFOCYSTEINURIA	0.000545554	0.008333831467888865
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.008333831467888865
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.008333831467888865
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.008333831467888865
REVESZ SYNDROME	0.000545554	0.008333831467888865
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.000545554	0.008333831467888865
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.008333831467888865
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.008333831467888865
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000545554	0.008333831467888865
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.008333831467888865
JOUBERT SYNDROME 10	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000545554	0.008333831467888865
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.008333831467888865
XQ25 DUPLICATION SYNDROME	0.000545554	0.008333831467888865
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.008333831467888865
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000545554	0.008333831467888865
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.008333831467888865
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.008333831467888865
ZEBRA BODY MYOPATHY	0.000545554	0.008333831467888865
RIGID SPINE SYNDROME	0.000545554	0.008333831467888865
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.008333831467888865
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.008333831467888865
OGDEN SYNDROME; OGDNS	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.008333831467888865
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.008333831467888865
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.008333831467888865
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.008333831467888865
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.008333831467888865
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888865
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.008333831467888865
MACDERMOT-WINTER SYNDROME	0.000545554	0.008333831467888865
LANDAU-KLEFFNER SYNDROME	0.000545554	0.008333831467888865
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.008333831467888865
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.008333831467888865
12Q14 MICRODELETION SYNDROME	0.000545554	0.008333831467888865
KETOADIPICACIDURIA	0.000545554	0.008333831467888865
ARIMA SYNDROME	0.000545554	0.008333831467888865
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.008333831467888865
HYPERPROLINEMIA, TYPE I	0.000545554	0.008333831467888865
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.008333831467888865
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.008333831467888865
HARTNUP DISORDER	0.000545554	0.008333831467888865
XQ28 (MECP2) DUPLICATION	0.000545554	0.008333831467888865
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.008333831467888865
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.008333831467888865
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.008333831467888865
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.008333831467888865
ADAMS-OLIVER SYNDROME 1; AOS1	0.000545554	0.008333831467888865
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.008333831467888865
48,XYYY SYNDROME	0.000545554	0.008333831467888865
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.008333831467888865
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.008333831467888865
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.008333831467888865
PEHO SYNDROME; PEHO	0.000545554	0.008333831467888865
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.008333831467888865
OROTIC ACIDURIA	0.000545554	0.008333831467888865
LISSENCEPHALY 2; LIS2	0.000545554	0.008333831467888865
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.008333831467888865
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.008333831467888865
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.008333831467888865
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000545554	0.008333831467888865
ELEJALDE DISEASE	0.000545554	0.008333831467888865
NETHERTON SYNDROME; NETH	0.000545554	0.008333831467888865
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.008333831467888865
JAWAD SYNDROME	0.000545554	0.008333831467888865
MOSAIC TRISOMY 9	0.000545554	0.008333831467888865
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.008333831467888865
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.008333831467888865
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.008333831467888865
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.008333831467888865
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.008333831467888865
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.008333831467888865
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.008333831467888865
LISSENCEPHALY 1; LIS1	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.008333831467888865
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.008333831467888865
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.008333831467888865
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.008333831467888865
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.008333831467888865
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.008333831467888865
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.008333831467888865
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.008333831467888865
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.008333831467888865
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.008333831467888865
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.008333831467888865
SALLA DISEASE	0.000545554	0.008333831467888865
FRIAS SYNDROME	0.000545554	0.008333831467888865
HOLOPROSENCEPHALY 7	0.000545554	0.008333831467888865
JOUBERT SYNDROME 6	0.000545554	0.008333831467888865
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.008333831467888865
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.008333831467888865
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.008333831467888865
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.008333831467888865
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000545554	0.008333831467888865
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.008333831467888865
PFEIFFER SYNDROME TYPE 2	0.000545554	0.008333831467888865
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.008333831467888865
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.008333831467888865
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.008333831467888865
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.008333831467888865
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.008333831467888865
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.008333831467888865
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.008333831467888865
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.008333831467888865
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.008333831467888865
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000545554	0.008333831467888865
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.008333831467888865
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.008333831467888865
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.008333831467888865
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.008333831467888865
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.008333831467888865
THYROID HEMIAGENESIS	0.000545554	0.008333831467888865
THYROID HYPOPLASIA	0.000545554	0.008333831467888865
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.008333831467888865
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.008333831467888865
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.008333831467888865
THYROID ECTOPIA	0.000545554	0.008333831467888865
TARP SYNDROME; TARPS	0.000545554	0.008333831467888865
WAISMAN SYNDROME; WSMN	0.000545554	0.008333831467888865
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.008333831467888865
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.008333831467888865
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.008333831467888865
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.008333831467888865
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000545554	0.008333831467888865
SHUKLA-VERNON SYNDROME; SHUVER	0.000545554	0.008333831467888865
ATHYREOSIS	0.000545554	0.008333831467888865
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.008333831467888865
CURRY-JONES SYNDROME	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.008333831467888865
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.008333831467888865
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.008333831467888865
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888865
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.008333831467888865
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.008333831467888865
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.008333831467888865
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.008333831467888865
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.008333831467888865
TIMOTHY SYNDROME; TS	0.000545554	0.008333831467888865
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.008333831467888865
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.008333831467888865
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.008333831467888865
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.008333831467888865
LOWRY-MACLEAN SYNDROME	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 2	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.008333831467888865
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.008333831467888865
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.008333831467888865
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.008333831467888865
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.008333831467888865
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.008333831467888865
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.008333831467888865
DIGEORGE SYNDROME; DGS	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.008333831467888865
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.008333831467888865
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.008333831467888865
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.008333831467888865
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.008333831467888865
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.008333831467888865
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.008333831467888865
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.008333831467888865
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.008333831467888865
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.008333831467888865
TEMTAMY SYNDROME	0.000545554	0.008333831467888865
TRISOMY 8Q	0.000545554	0.008333831467888865
MOSAIC TRISOMY 14	0.000545554	0.008333831467888865
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.008333831467888865
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.008333831467888865
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.008333831467888865
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.008333831467888865
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.008333831467888865
15Q11Q13 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
SEPTOOPTIC DYSPLASIA	0.000545554	0.008333831467888865
MAPLE SYRUP URINE DISEASE	0.000545554	0.008333831467888865
MICROVILLUS INCLUSION DISEASE	0.000545554	0.008333831467888865
ICF SYNDROME	0.000545554	0.008333831467888865
HYPERTRICHOSIS CUBITI	0.000545554	0.008333831467888865
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.008333831467888865
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.008333831467888865
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.008333831467888865
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.008333831467888865
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.008333831467888865
XQ25 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.008333831467888865
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.008333831467888865
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000545554	0.008333831467888865
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.008333831467888865
DISTAL MONOSOMY 9P	0.000545554	0.008333831467888865
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.008333831467888865
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.008333831467888865
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.008333831467888865
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.008333831467888865
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.008333831467888865
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000545554	0.008333831467888865
NETHERTON SYNDROME	0.000545554	0.008333831467888865
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.008333831467888865
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.008333831467888865
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.008333831467888865
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.008333831467888865
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.008333831467888865
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.008333831467888865
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000545554	0.008333831467888865
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.008333831467888865
2P21 MICRODELETION SYNDROME	0.000545554	0.008333831467888865
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.008333831467888865
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.008333831467888865
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.008333831467888865
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.008333831467888865
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.008333831467888865
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.008333831467888865
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.008333831467888865
AUSTRALIA ANTIGEN	0.000545554	0.008333831467888865
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000545554	0.008333831467888865
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000545554	0.008333831467888865
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.008333831467888865
8P11.2 DELETION SYNDROME	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.008333831467888865
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.008333831467888865
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.008333831467888865
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.008333831467888865
DISTAL MONOSOMY 1Q	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.008333831467888865
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.008333831467888865
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.008333831467888865
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.008333831467888865
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.008333831467888865
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.008333831467888865
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.008333831467888865
STT3A-CDG	0.000545554	0.008333831467888865
PROPIONIC ACIDEMIA	0.000545554	0.008333831467888865
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.008333831467888865
TRISOMY X	0.000545554	0.008333831467888865
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.008333831467888865
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.008333831467888865
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.008333831467888865
ISOVALERIC ACIDEMIA	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.008333831467888865
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.008333831467888865
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
STT3B-CDG	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.008333831467888865
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.008333831467888865
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.008333831467888865
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.008333831467888865
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.008333831467888865
COG2-CDG	0.000545554	0.008333831467888865
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.008333831467888865
DYSTONIA-APHONIA SYNDROME	0.000545554	0.008333831467888865
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.008333831467888865
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.000545554	0.008333831467888865
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.008333831467888865
GRISCELLI SYNDROME	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.008333831467888865
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.008333831467888865
PRADER-WILLI-LIKE SYNDROME	0.000545554	0.008333831467888865
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.008333831467888865
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.008333831467888865
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.008333831467888865
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.008333831467888865
FILIPPI SYNDROME	0.000545554	0.008333831467888865
ABETAL34V AMYLOIDOSIS	0.000545554	0.008333831467888865
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.008333831467888865
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.008333831467888865
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.008333831467888865
W SYNDROME	0.000545554	0.008333831467888865
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.008333831467888865
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.008333831467888865
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.008333831467888865
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.008333831467888865
OKAMOTO SYNDROME	0.000545554	0.008333831467888865
COG4-CDG	0.000545554	0.008333831467888865
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.008333831467888865
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.008333831467888865
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.008333831467888865
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.008333831467888865
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.008333831467888865
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000545554	0.008333831467888865
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.008333831467888865
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.008333831467888865
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.008333831467888865
PEHO SYNDROME	0.000545554	0.008333831467888865
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.008333831467888865
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.008333831467888865
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.008333831467888865
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.008333831467888865
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.008333831467888865
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000545554	0.008333831467888865
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.008333831467888865
SIALURIA	0.000545554	0.008333831467888865
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.008333831467888865
OXOGLUTARIC ACIDURIA	0.000545554	0.008333831467888865
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.000545554	0.008333831467888865
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.008333831467888865
HEREDITARY OROTIC ACIDURIA	0.000545554	0.008333831467888865
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000545554	0.008333831467888865
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.008333831467888865
1P21.3 MICRODELETION SYNDROME	0.000545554	0.008333831467888865
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.008333831467888865
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.008333831467888865
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.008333831467888865
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.008333831467888865
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.008333831467888865
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.008333831467888865
SECKEL SYNDROME 9; SCKL9	0.000545554	0.008333831467888865
EVEN-PLUS SYNDROME	0.000545554	0.008333831467888865
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.008333831467888865
LUSCAN-LUMISH SYNDROME; LLS	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.008333831467888865
JOUBERT SYNDROME 26	0.000545554	0.008333831467888865
JOUBERT SYNDROME 25	0.000545554	0.008333831467888865
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000545554	0.008333831467888865
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.008333831467888865
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.008333831467888865
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.008333831467888865
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888865
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.008333831467888865
JOUBERT SYNDROME 24	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.008333831467888865
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.008333831467888865
RING CHROMOSOME 14 SYNDROME	0.000545554	0.008333831467888865
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.008333831467888865
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.008333831467888865
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.008333831467888865
JOUBERT SYNDROME 28	0.000545554	0.008333831467888865
JOUBERT SYNDROME 27	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.008333831467888865
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.008333831467888865
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.008333831467888865
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.000545554	0.008333831467888865
RABSON-MENDENHALL SYNDROME	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.008333831467888865
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.008333831467888865
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.008333831467888865
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.008333831467888865
COFFIN-SIRIS SYNDROME 5	0.000545554	0.008333831467888865
HEART AND BRAIN MALFORMATION SYNDROME	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.008333831467888865
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.008333831467888865
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.008333831467888865
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.008333831467888865
AU-KLINE SYNDROME; AUKS	0.000545554	0.008333831467888865
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.008333831467888865
NOONAN SYNDROME 9; NS9	0.000545554	0.008333831467888865
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.008333831467888865
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.008333831467888865
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.008333831467888865
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.008333831467888865
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.008333831467888865
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.008333831467888865
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.008333831467888865
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.008333831467888865
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.008333831467888865
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.008333831467888865
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.008333831467888865
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.008333831467888865
ALG1-CDG	0.000545554	0.008333831467888865
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.008333831467888865
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.008333831467888865
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.008333831467888865
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.008333831467888865
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.008333831467888865
AL-RAQAD SYNDROME; ARS	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.008333831467888865
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.008333831467888865
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000545554	0.008333831467888865
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.008333831467888865
ALG6-CDG	0.000545554	0.008333831467888865
ALG3-CDG	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.008333831467888865
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.008333831467888865
ALAZAMI-YUAN SYNDROME	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.008333831467888865
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000545554	0.008333831467888865
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.008333831467888865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.008333831467888865
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.008333831467888865
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.008333831467888865
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.008333831467888865
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.008333831467888865
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.008333831467888865
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.008333831467888865
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.008333831467888865
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000545554	0.008333831467888865
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.008333831467888865
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.008333831467888865
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.008333831467888865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.008333831467888865
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.008333831467888865
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000545554	0.008333831467888865
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.008333831467888865
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.008333831467888865
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.008333831467888865
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.008333831467888865
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.008333831467888865
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.008333831467888865
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.008333831467888865
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.008333831467888865
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.008333831467888865
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.008333831467888865
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.008333831467888865
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.008333831467888865
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.000545554	0.008333831467888865
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.008333831467888865
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.008333831467888865
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.008333831467888865
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000545554	0.008333831467888865
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.008333831467888865
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.008333831467888865
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.008333831467888865
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000545554	0.008333831467888865
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.008333831467888865
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.008333831467888865
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.008333831467888865
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.008333831467888865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.008333831467888865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000545554	0.008333831467888865
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.008333831467888865
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.008333831467888865
MECKEL SYNDROME 13; MKS13	0.000545554	0.008333831467888865
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.008333831467888865
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.008333831467888865
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.008333831467888865
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.008333831467888865
